|
1
| 1 | UNITED STATES FEDERAL TRADE COMMISSION
|
| 2 | and
|
| 3 | UNITED STATES DEPARTMENT OF JUSTICE
|
| 4 |
|
| 5 |
|
| 6 |
|
| 7 | SHERMAN ACT SECTION 2 JOINT HEARING
|
| 8 | ACADEMIC TESTIMONY
|
| 9 | WEDNESDAY, JANUARY 31, 2007
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 | HELD AT:
|
| 15 | UNIVERSITY OF CALIFORNIA AT BERKELEY
|
| 16 | 2220 PIEDMONT AVENUE
|
| 17 | WELLS FARGO ROOM
|
| 18 | BERKELEY, CALIFORNIA
|
| 19 | 9:30 A.M. TO 4:30 P.M.
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 | Reported and transcribed by:
|
| 25 | Kathleen Carr Meheen, CSR 8748 |
2
| 1 | MODERATORS
|
| 2 | Morning Session:
|
| 3 | WILLIAM E. COHEN
|
| 4 | Deputy General Counsel for Policy Studies
|
| 5 | Federal Trade Commission
|
| 6 | and
|
| 7 | JOSEPH J. MATELIS
|
| 8 | Attorney, Legal Policy Section
|
| 9 | Antitrust Division, U.S. Department of Justice
|
| 10 |
|
| 11 | PANELISTS
|
| 12 | Morning Session:
|
| 13 | Aaron Edlin
|
| 14 | Joseph Farrell
|
| 15 | Howard Shelanski
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
3
| 1 | MODERATORS
|
| 2 | Afternoon Session:
|
| 3 | KAREN GRIMM
|
| 4 | Assistant General Counsel for Policy Studies
|
| 5 | Federal Trade Commission
|
| 6 | and
|
| 7 | JUNE K. LEE
|
| 8 | Economist
|
| 9 | Antitrust Division, U.S. Department of Justice
|
| 10 |
|
| 11 | PANELISTS
|
| 12 | Afternoon Session:
|
| 13 | Timothy Bresnahan
|
| 14 | Richard Gilbert
|
| 15 | Daniel Rubinfeld
|
| 16 | Carl Shapiro
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
4
5
| 1 | P R O C E E D I N G S
|
| 2 | * * * * *
|
| 3 | MR. COHEN: Good morning. I'm Joe Cohen, Deputy
|
| 4 | General Counsel for Policy Studies at the Federal Trade
|
| 5 | Commission and I'm going to be one of the moderators at
|
| 6 | this morning's session. My co-moderator is Joe Matelis,
|
| 7 | an attorney in the Antitrust Division at the U.S.
|
| 8 | Department of Justice.
|
| 9 | Before I start I'd like to cover a couple of
|
| 10 | housekeeping rules. First, as a courtesy to our speakers,
|
| 11 | please turn off your cell phones, Blackberries, anything
|
| 12 | that might ring or clang or make noise.
|
| 13 | Second, because these are set up as in a hearing
|
| 14 | structure, we request that the audience not make any
|
| 15 | comments or ask any questions during the session. We have
|
| 16 | to limit it to the moderators and the panelists.
|
| 17 | Before introducing our speakers and starting our
|
| 18 | panel discussion, I would again like to thank the
|
| 19 | University of California at Berkeley for hosting the
|
| 20 | FTC/DOJ Section 2 hearing sessions yesterday and today.
|
| 21 | In particular I'd like to thank Howard Shelanski, once
|
| 22 | again, Richard Gilbert and Carl Shapiro for offering us
|
| 23 | the facilities and making the necessary arrangements.
|
| 24 | I'd also like to thank the Berkeley Center for
|
| 25 | Law & Technology and the Haas Business School for |
6
| 1 | providing the facilities, videotaping, web casting, etc.
|
| 2 | And those who have provided us with logistical support,
|
| 3 | Bob Pardue and others, I thanked you all once already, but
|
| 4 | thank you again.
|
| 5 | We're honored to have assembled this morning a
|
| 6 | distinguished group of the finest lawyers from the
|
| 7 | University of California Berkeley to offer their testimony
|
| 8 | in connection with these hearings. They will provide
|
| 9 | their perspectives on various themes and issues related to
|
| 10 | the complex area of Section 2 jurisprudence, including
|
| 11 | some research and economic analysis.
|
| 12 | We've gathered seven panelists for today's
|
| 13 | sessions. Four will talk this afternoon and three will be
|
| 14 | our morning panelists.
|
| 15 | This morning's panelists are Aaron Edlin, the
|
| 16 | Richard Jennings Professor of Law, University of
|
| 17 | California Berkeley; Joseph Farrell, Professor of
|
| 18 | Economics at -- right here at the University of Berkeley,
|
| 19 | and Howard Shelanski, here, Associate Dean and Professor
|
| 20 | of Law and Director of the Berkeley Center for Law and
|
| 21 | Technology.
|
| 22 | Our format this morning will be pretty simple.
|
| 23 | Each speaker will make an opening presentation from twenty
|
| 24 | to thirty minutes. After the presentations are finished,
|
| 25 | we're going to take a break, probably for about fifteen |
7
| 1 | minutes, and then we'll come back, reconvene, and have a
|
| 2 | moderated discussion with our panelists.
|
| 3 | We're scheduled to conclude this morning's
|
| 4 | session at approximately noon. So, we look forward to
|
| 5 | hearing from our panelists.
|
| 6 | And before we begin, the last group that I want
|
| 7 | to thank are the panelists themselves. We appreciate the
|
| 8 | time and effort and your willingness to share your
|
| 9 | insights with us to make this a successful hearing.
|
| 10 | I'd now like to turn to my DOJ colleague, Joe
|
| 11 | Matelis, our co-moderator, for any remarks he'd like to
|
| 12 | add.
|
| 13 | MR. MATELIS: Thank you, Bill.
|
| 14 | The Department of Justice's Antitrust Division
|
| 15 | is very pleased to participate in today's single-firm
|
| 16 | conduct hearings. We are delighted that such esteemed
|
| 17 | panelists have agreed to share their views with us today.
|
| 18 | And the Antitrust Division takes particular
|
| 19 | pride in noting that five of today's panelists have served
|
| 20 | in the Antitrust Division as Deputy Assistant Attorneys
|
| 21 | General for Economics.
|
| 22 | We expect that today's panelists will discuss a
|
| 23 | wide range of topics that arise in evaluating single-firm
|
| 24 | conduct and antitrust laws and we look forward to the
|
| 25 | presentations and the panel discussions that follow. |
8
| 1 | On behalf of the Antitrust Division, I would
|
| 2 | like to take this opportunity to thank the Berkeley Center
|
| 3 | for Law and Technology and the Competition Policy Center
|
| 4 | at the University of California Berkeley for hosting us
|
| 5 | today.
|
| 6 | Also on behalf of the Antitrust Division, I'd
|
| 7 | like to thank Joe, Aaron and Howard for agreeing to
|
| 8 | volunteer your time and share your insights with us. It's
|
| 9 | a great public service that you're doing and we're very
|
| 10 | appreciative.
|
| 11 | Finally I'd like to thank Bill and his
|
| 12 | colleagues at the FTC for all their hard work in
|
| 13 | organizing today's panel and assembling the great speakers
|
| 14 | that we have lined up today. Thank you.
|
| 15 | MR. COHEN: Our first speaker is going to be
|
| 16 | Aaron Edlin, who has taught at Berkeley since 1993. He
|
| 17 | now holds the Richard Jennings Chair and professorships in
|
| 18 | both the economic department and the law school. He's
|
| 19 | served on the economic side as Senior Economist at the
|
| 20 | Council of Economic Advisers during the years of the
|
| 21 | Clinton Whitehouse. He is co-author with Professors
|
| 22 | Areeda and Kaplow of one of the leading casebooks on
|
| 23 | antitrust and he has published many articles dealing with
|
| 24 | competition policy and antitrust law.
|
| 25 | Aaron? |
9
| 1 | MR. EDLIN: Thank you. Let's see how we get to
|
| 2 | the slides.
|
| 3 | MR. COHEN: And yesterday we had the
|
| 4 | representative from Microsoft [laughter].
|
| 5 | MR. EDLIN: Maybe we could switch speakers?
|
| 6 | MR. COHEN: I am going to introduce Joe Farrell,
|
| 7 | then.
|
| 8 | Joe is Professor of Economics here at Berkeley.
|
| 9 | He's a Fellow of the Econometric Society, former Editor of
|
| 10 | The Journal of Industrial Economics, and former President
|
| 11 | of the Industrial Organization Society
|
| 12 | Professor Farrell was Chief Economist at the
|
| 13 | Federal Communications Commission in 1996 to 1997 and was
|
| 14 | Deputy Assistant Attorney General for Economics at the
|
| 15 | Antitrust Division of the Department of Justice from 2000
|
| 16 | to 2001. From 2001 to 2004, he served on the Computer
|
| 17 | Science and Telecommunications Board of the National
|
| 18 | Academies of Science.
|
| 19 | Joe
|
| 20 | MR. FARRELL: Thank you. So, who am I and why
|
| 21 | am I here? We've just heard who I am. Why am I here?
|
| 22 | Because I've drifted into antitrust from economics. I
|
| 23 | think that's true of a lot of the people here. And one of
|
| 24 | the things that's most striking is that the whole
|
| 25 | unilateral conduct field seems to have drifted a long way |
10
| 1 | from first principles. And it's unsatisfying to me and I
|
| 2 | worry that it leads to bad policy.
|
| 3 | So, what I'd like to do is to try to bring us
|
| 4 | back to some first principles. Because the field has
|
| 5 | drifted so far from first principles, it's not even
|
| 6 | clearly I think understood exactly what those first
|
| 7 | principles are. And I'm going to put forward a suggestion
|
| 8 | about what they might be.
|
| 9 | The suggestion I'm going to put forward is one
|
| 10 | that distinguishes quite importantly between the final
|
| 11 | goal of antitrust, which I think most of us agree is and
|
| 12 | should be economic efficiency, and the protections and the
|
| 13 | process involved in antitrust enforcement. And it does
|
| 14 | not logically follow that, just because the final goal is
|
| 15 | economic efficiency, each case should be analyzed or each
|
| 16 | transaction should be analyzed along the lines of economic
|
| 17 | efficiency.
|
| 18 | Just to give you a simple example, if I go into
|
| 19 | a store and take an iPod off the shelf and put it in my
|
| 20 | pocket and walk out, that's typically illegal if I didn't
|
| 21 | do more than that. And it's illegal even if I can show by
|
| 22 | thoroughly convincing evidence that my economic value for
|
| 23 | the iPod exceeds the store's replacement cost. In other
|
| 24 | words, it was an efficient transaction for me to steal the
|
| 25 | iPod. Well, that doesn't cut any ice in law enforcement |
11
| 1 | as I understand it and probably shouldn't. And the
|
| 2 | economic market system that we have operates by enforcing
|
| 3 | the property rights of the iPod. And that enforcement
|
| 4 | does not look directly at whether the enforcement is in
|
| 5 | the instant efficient or not. And I'm going to claim that
|
| 6 | antitrust often does something rather similar, okay?
|
| 7 | So, before I get to the first substantive slide
|
| 8 | with the provocative title "Analyze This," let me say
|
| 9 | that, as I understand it, the fundamental of antitrust is
|
| 10 | that you are not supposed to restrain trade. That doesn't
|
| 11 | mean you are not supposed to restrain your own trade.
|
| 12 | People often comment that it's all right to restrain your
|
| 13 | own trade. What you're not meant to do is to restrain
|
| 14 | other people's trade.
|
| 15 | And you might ask, well, how can you possibly
|
| 16 | restrain other people's trade unless you actually tie them
|
| 17 | up or something. Well, it turns out that there are
|
| 18 | techniques by which a firm might be able to restrain
|
| 19 | others' trade. And those techniques it seems to me are
|
| 20 | the core problems.
|
| 21 | So, that's all setup. Let's come to my purely
|
| 22 | hypothetical example, "Analyze This." So, let's think
|
| 23 | about the airline market. An airline that I've called
|
| 24 | Northeast Airlines offers a five hundred dollar fare. And
|
| 25 | it's the only airline that's in that market, so consumers |
12
| 1 | buy it. No better deal is available.
|
| 2 | An entrant that I've called Sprite would happily
|
| 3 | sell at three hundred dollars a similar product.
|
| 4 | Consumers would prefer that deal. So, why doesn't it
|
| 5 | happen? Well, it doesn't happen in this instance because
|
| 6 | everybody recognizes that if Sprite enters and offers the
|
| 7 | three hundred dollar deal, Northeast will cut its price to
|
| 8 | two hundred dollars. And Sprite is unable to make a
|
| 9 | profit competing against the two hundred dollar fare.
|
| 10 | So, Sprite anticipates that, doesn't enter, and
|
| 11 | consumers continue to pay five hundred dollars.
|
| 12 | So, before we get into, well, what law might it
|
| 13 | violate and what policies are there and so on, I'd like to
|
| 14 | observe that something is clearly wrong there. And let's
|
| 15 | delve a little bit in a first principle kind of way into
|
| 16 | what it is that's wrong there.
|
| 17 | What's wrong I would argue -- and this is based
|
| 18 | on discussions that Aaron Edlin and I have been having
|
| 19 | over a pretty protracted period of time. What's wrong is
|
| 20 | that Sprite's willingness to sell at three hundred
|
| 21 | dollars, which consumers would prefer to the status quo, ought
|
| 22 | to block Northeast's ability to charge those consumers five
|
| 23 | hundred dollars. In other words, Northeast ought not to
|
| 24 | be able to extract five hundred dollars from consumers,
|
| 25 | given Sprite is willing to sell them the product for three |
13
| 1 | hundred dollars. Okay.
|
| 2 | And you might think that normally in a
|
| 3 | competitive process, whatever that means, not only ought
|
| 4 | it to block it but it would. And here it doesn't. And
|
| 5 | what are the mechanics of how it doesn't.
|
| 6 | Well, the mechanics we just went through.
|
| 7 | Northeast, intentionally or not, thwarts Sprite's and
|
| 8 | consumers' joint wish, given Northeast's five hundred
|
| 9 | dollar price, to trade at three hundred dollars. And the
|
| 10 | way that that works is that if Sprite came in it would not
|
| 11 | have to compete against five hundred but against two
|
| 12 | hundred, and it can't compete against two hundred.
|
| 13 | I am saying nothing yet about what's illegal.
|
| 14 | I'm just saying this is an instance of something going
|
| 15 | wrong in the competitive process.
|
| 16 | So, stepping back, and here are some first
|
| 17 | principles, okay. Economists study by and large two approaches
|
| 18 | to economic efficiency. And there's a little bit of a
|
| 19 | disconnect, I think, between the formal material that you
|
| 20 | spend a lot of time banging into the undergraduates' heads
|
| 21 | in the microeconomics classes and the way that
|
| 22 | professional economists typically think about real world
|
| 23 | problems.
|
| 24 | What we spend the most time with undergraduates
|
| 25 | on is that you can get to an economically efficient |
14
| 1 | outcome via price-taking perfectly competitive
|
| 2 | equilibrium. Okay. However, it's sort of obvious that
|
| 3 | the price-taking equilibrium, whether it would be
|
| 4 | efficient or not, is unrealistic and unobtainable in many
|
| 5 | sectors of the economy that are of antitrust concern. If
|
| 6 | nothing else, large economies of scale make that a
|
| 7 | nonstarter.
|
| 8 | And it's also interesting to note that antitrust
|
| 9 | doesn't just move cautiously, but I would say proudly
|
| 10 | eschews many opportunities to move toward price-taking
|
| 11 | equilibrium. So, in particular, if you have a legitimate
|
| 12 | monopoly, quote, unquote, there is no attempt to try to
|
| 13 | force you to do anything that's closer to price-taking
|
| 14 | behavior. And not only is that potentially difficult and
|
| 15 | problematic to do, but antitrust seems to take the
|
| 16 | attitude, it's difficult, but we wouldn't try even if we
|
| 17 | thought we could do it. Now maybe that's a little
|
| 18 | controversial, but that's my impression.
|
| 19 | The second approach to economic efficiency, which is
|
| 20 | less juicy material for teaching undergraduates because it
|
| 21 | has less of the mid-level mathematics that seems to appeal
|
| 22 | to those who teach undergraduate micro classes, but is
|
| 23 | actually probably more important, is based a little bit on
|
| 24 | the Coase theorem, that's kind of the extreme expression of
|
| 25 | it, or in formal economic terms is often called the core |
15
| 1 | of the economy. And that's the idea that if there is some
|
| 2 | inefficiency, then there's some group of people, possibly
|
| 3 | unmanageably large but possibly not, that would have an
|
| 4 | incentive to contract around it. Okay. And therefore we
|
| 5 | think about just how difficult would that be, and if it
|
| 6 | wouldn't be all that difficult, then we predict that the
|
| 7 | inefficiency will either go away or won't be all that big.
|
| 8 | So, for example, it's not exactly an
|
| 9 | inefficiency but it's a problem for the consumers that
|
| 10 | Northeast is charging such a high fare, and there are
|
| 11 | inefficiencies that go along with that.
|
| 12 | So, Sprite and consumers jointly would like to
|
| 13 | contract around that high fare. And the question is: Why
|
| 14 | doesn't that happen?
|
| 15 | So, just to give you a little bit of jargon so
|
| 16 | as to make you feel that there's real substance to this
|
| 17 | talk, what economists call the core of an economy is a set
|
| 18 | of possible outcomes such that no group of consumers and
|
| 19 | firms could find an alternative that's better for all of
|
| 20 | them. Okay. And the core contains only outcomes that are
|
| 21 | economically efficient, of course, because if you have an
|
| 22 | outcome that's inefficient, then the grand coalition, as
|
| 23 | we call it, that is, the set of all consumers and firms,
|
| 24 | could all do better by doing something else.
|
| 25 | Of course that's not a very realistic process to |
16
| 1 | imagine everybody getting together. But, conditional on
|
| 2 | knowing that something inefficient is not in the core, we
|
| 3 | have a reasonable shot at finding a smaller and more
|
| 4 | manageable blocking coalition.
|
| 5 | What's a blocking coalition? A blocking
|
| 6 | coalition is a group of consumers and firms that can all
|
| 7 | do better than the status quo given their endowments and
|
| 8 | abilities to trade and so on.
|
| 9 | So, in parallel, if you like, with the
|
| 10 | competitive equilibrium analysis, we have core analysis.
|
| 11 | And it suggests a rather different process. Instead of
|
| 12 | suggesting a process where we kind of hammer on the
|
| 13 | economy until most firms are somewhere close to
|
| 14 | price-taking, okay, and which, as I mentioned, is not
|
| 15 | actually feasible in many important sectors of the
|
| 16 | economy, it suggests a process where we protect the
|
| 17 | ability of these blocking coalitions to work around any
|
| 18 | inefficiencies.
|
| 19 | So, a perspective on antitrust is this: That
|
| 20 | antitrust protects the process of forming blocking
|
| 21 | coalitions that block bad outcomes. And how does it
|
| 22 | protect that? Antitrust is -- it says certain things are
|
| 23 | illegal. What sorts of things are illegal? Well, at some
|
| 24 | level, things that thwart the formation of blocking
|
| 25 | coalitions that would otherwise prevent bad outcomes. |
17
| 1 | VThat's three negatives, which is a very large number of
|
| 2 | negatives, okay, but that's the way it is, okay.
|
| 3 | So, the last bullet, just to remind you, not all
|
| 4 | contracts of course are protected by antitrust. Some of
|
| 5 | them are illegal, so there's a little bit of a thorny
|
| 6 | issue there, but I'll just note that in passing.
|
| 7 | So, back to the Northeast and Sprite example,
|
| 8 | Northeast is getting five hundred. Sprite and consumers
|
| 9 | would all be better off trading at three hundred. So,
|
| 10 | that's a blocking coalition that tells us that the five
|
| 11 | hundred dollar fare is not something that would survive in
|
| 12 | the core. And, in particular, there's this particular
|
| 13 | blocking coalition. And Northeast, and, again, I am not
|
| 14 | saying whether they do it on purpose or it's a natural
|
| 15 | outcome of the way the market works, but thwarts the
|
| 16 | blocking coalition by making clear that if the blocking
|
| 17 | coalition tries to form, Northeast will block that in turn
|
| 18 | with the two hundred dollar fare.
|
| 19 | So, how do we assess Northeast's price cut from
|
| 20 | five hundred to two hundred dollars? It seems to me
|
| 21 | there's a very difficult and fundamental tension here. In
|
| 22 | the instant, that is, if Sprite has actually entered and
|
| 23 | is charging three hundred, Northeast then does cut its
|
| 24 | price to two hundred, and the two hundred kind of is then
|
| 25 | the outcome that we're looking at, well, that seems like |
18
| 1 | part of the competitive process as I've described it. We
|
| 2 | had this three hundred dollar outcome. Northeast is
|
| 3 | forming a blocking coalition with consumers to block it
|
| 4 | with a two hundred fare.
|
| 5 | However, in its ex ante impact, the prospect of
|
| 6 | this two hundred dollars thwarts the formation of Sprite's
|
| 7 | blocking coalition against Northeast's five hundred
|
| 8 | dollars. So, depending on which way you look at this, it
|
| 9 | genuinely is at some level somewhat part of the
|
| 10 | competitive process and somewhat a fundamental undermining
|
| 11 | thwarting blocking of the competitive process. Okay.
|
| 12 | Well, that's a pretty fundamental tension. How
|
| 13 | are we going to deal with it? I don't know exactly. I
|
| 14 | don't even know approximately. But one thing that's
|
| 15 | pretty clear I think out of this discussion, knowing what
|
| 16 | Northeast's costs are doesn't tell you anything very
|
| 17 | relevant. Knowing whether Northeast made in any sense a
|
| 18 | sacrifice with this price cut in some actual or but-for
|
| 19 | sense isn't really relevant or doesn't seem to be
|
| 20 | relevant. Okay.
|
| 21 | So, there's a difficult question here. And the
|
| 22 | specific rules and policies that have come to dominate the
|
| 23 | law on this kind of behavior don't look as if they're
|
| 24 | going to be of any help because, of course, until we
|
| 25 | actually work our way through and figure out what the |
19
| 1 | right answer is, you don't quite know what will be of
|
| 2 | help.
|
| 3 | So, what does this suggest about predatory
|
| 4 | pricing. It suggests most fundamentally that predatory is
|
| 5 | an adjective that doesn't apply to the level of price. It
|
| 6 | applies to a pattern of pricing. And, in particular, it
|
| 7 | applies to a pattern of pricing such that the price that
|
| 8 | the entrant expects to have to compete against is very
|
| 9 | different from the price that consumers actually end up
|
| 10 | paying.
|
| 11 | So, is Northeast's price cut primarily a
|
| 12 | blocking coalition to Sprite's three hundred that's the
|
| 13 | essence of the competitive process, or an
|
| 14 | out-of-equilibrium threat to thwart consumers and Sprite
|
| 15 | from blocking the five hundred. That I think might be the
|
| 16 | essence of an antitrust offense. Okay.
|
| 17 | So, one way to answer this that is sensible
|
| 18 | seeming but a little bit ad hoc, departing a bit perhaps
|
| 19 | from first principles, but perhaps not, is to say, well,
|
| 20 | you sort of want to look at how stable that two hundred
|
| 21 | dollars is. If that's really what you've arrived at and
|
| 22 | now you are there and you're going to sort of stay there,
|
| 23 | then that's sort of how the process is meant to work. We
|
| 24 | had originally five hundred, then three hundred, now we've
|
| 25 | got two hundred, and we've got there and that's good. |
20
| 1 | Certainly good for consumers.
|
| 2 | If, on the other hand, what happens is mostly
|
| 3 | that consumers really end up paying five hundred and they
|
| 4 | only pay three hundred or two hundred in the rare and
|
| 5 | short-lived cases where Sprite makes a mistake and enters,
|
| 6 | then that seems like a failure of the process. And,
|
| 7 | again, it doesn't seem to me that there's much prospect
|
| 8 | that sacrifice tests or cost tests are going to be very
|
| 9 | helpful here. So, we don't know until we sort of figure
|
| 10 | it out.
|
| 11 | So, this suggests to Aaron and me a principle we
|
| 12 | call freedom to trade. It's a nice phrase, but we mean
|
| 13 | it. The incumbent is restraining trade when given its
|
| 14 | pricing, etc., etc., etc., and there's a blocking
|
| 15 | coalition, a potential blocking coalition, that would make
|
| 16 | all its, that is, the blocking coalition's, participants
|
| 17 | better off, but the incumbent strategically thwarts the
|
| 18 | formation of that blocking coalition.
|
| 19 | So, we saw one possible way in which the
|
| 20 | incumbent might thwart the formation of a blocking
|
| 21 | coalition, threatening that if that coalition starts to
|
| 22 | form, then the price it charges will change.
|
| 23 | Another way you might do that is through some
|
| 24 | kind of divide-and-conquer strategy that says, offer
|
| 25 | particularly favorable deals to some pivotal members of |
21
| 1 | this blocking coalition while expropriating others. I
|
| 2 | don't want to get into the game theory of how it can work
|
| 3 | and how it can fail. The fact is it can sometimes work,
|
| 4 | but the point I really want to stress here is, when it can
|
| 5 | work, it seems like that is really disrupting the
|
| 6 | competitive process.
|
| 7 | Now, notice that none of this, according to my
|
| 8 | suggestion of what the competitive process is, none of
|
| 9 | this asks, well, just how unpleasant is it for Northeast
|
| 10 | if Sprite comes in and takes away its customers. And that
|
| 11 | would be an important aspect of a direct inquiry into
|
| 12 | economic efficiency. Right? Because if Northeast
|
| 13 | actually has very low costs, and if demand is fairly
|
| 14 | inelastic, then having Northeast charging five hundred
|
| 15 | dollars might be more efficient than having Sprite come in
|
| 16 | and serving customers.
|
| 17 | And I claim that Northeast thwarting this entry
|
| 18 | would be a thwarting of the competitive process without
|
| 19 | asking about that. Okay? So, as I said in the beginning,
|
| 20 | it seems to me that if we're looking at the formation of
|
| 21 | blocking coalitions as the process whereby we move towards
|
| 22 | the core and that's what's economic efficiency, when we
|
| 23 | talk about the formation of blocking coalitions, we don't
|
| 24 | insist in the interim that they actually have to increase
|
| 25 | efficiency. Instead, we know that if you allow the |
22
| 1 | formation of blocking coalitions without that inquiry,
|
| 2 | that process, when it settles down, will get you to
|
| 3 | something that's in the core and therefore really is
|
| 4 | economically efficient
|
| 5 | So, it seems to me that that captures a lot of
|
| 6 | the spirit of the competitive process, that we're
|
| 7 | protecting the process of forming blocking coalitions. We
|
| 8 | believe that in the long run that will lead to economic
|
| 9 | efficiency and it is not necessary and may actually be
|
| 10 | counterproductive to ask about economic efficiency at each
|
| 11 | step.
|
| 12 | That does not mean that I'm advocating a
|
| 13 | consumer surplus criterion. Instead, I'm assuming that the final
|
| 14 | criterion is actually economic efficiency. At each step,
|
| 15 | we do actually look at what consumers want because it's
|
| 16 | presumed, I guess, that if an entrant is willing to offer
|
| 17 | consumers a better deal, then the entrant likes the
|
| 18 | formation of this blocking coalition. So, the question
|
| 19 | becomes: Do consumers also like it. But the fact that
|
| 20 | there's a sense in which we're looking at consumer
|
| 21 | preferences at each step, does not at all imply that the
|
| 22 | final goal is consumer surplus.
|
| 23 | So, that freedom to trade principle is, we
|
| 24 | think, an intriguing and promising way to understand
|
| 25 | antitrust starting -- or a lot of antitrust, anyway, |
23
| 1 | starting from first principles. How far does it get you?
|
| 2 | It gets you to understand, or at least understand the
|
| 3 | difficulties in some cases, like the hypothetical I was
|
| 4 | talking about and some others. But there's a huge range
|
| 5 | of unilateral conduct that gets challenged in antitrust
|
| 6 | that it really doesn't directly help you to understand.
|
| 7 | And let me sketch this out
|
| 8 | And in order to help this, what we're going to
|
| 9 | do is to introduce a different phrase, also a good phrase,
|
| 10 | "level playing field." So, the observations is that
|
| 11 | freedom to trade is potentially at risk where the entrant
|
| 12 | has to compete against the low price, but consumers
|
| 13 | actually pay a high price. That is the case in my
|
| 14 | Northeast/Sprite hypothetical. And I am going to say that
|
| 15 | the playing field is level if those prices are equal.
|
| 16 | That helps us understand, perhaps, predation, divide and
|
| 17 | conquer, exclusive dealing and so on.
|
| 18 | But, in the case of many challenged practices,
|
| 19 | if the incumbent were simply to go away, consumers would
|
| 20 | not be better off. So, a frequent allegation involves the
|
| 21 | incumbent being asked to stick around but just do
|
| 22 | something different.
|
| 23 | So, you can put a lot of unilateral conduct
|
| 24 | complaints into the following framework. The incumbent is
|
| 25 | offering two trades to consumers, not as alternatives |
24
| 1 | typically. I'm going say a price of one hundred dollars
|
| 2 | for Product A and a price of five dollars for Product B.
|
| 3 | And the discrepancy there is meant to reduce confusion
|
| 4 | about which is which. Okay?
|
| 5 | And as a potential blocking coalition, sort of,
|
| 6 | when entrant and consumers enter B at a price of three
|
| 7 | dollars. In other words, there's somebody out there who
|
| 8 | would love to supply B for three dollars, but the entrant
|
| 9 | simply can't do A, so the incumbent is a monopolist in A.
|
| 10 | And the incumbent says, using one technique or another, if
|
| 11 | you want to buy my A, you have to buy my B, or more
|
| 12 | generally links A to B. Okay.
|
| 13 | So, the incumbent might refuse to trade in A if
|
| 14 | the customer deals with the entrant in B, or it might
|
| 15 | raise the price of A from a hundred to, let's say, a
|
| 16 | hundred and ten, which would swamp, of course, any gains
|
| 17 | from buying B at three instead of five. And given that
|
| 18 | we're assuming that there's a monopoly in A, by the way,
|
| 19 | that may well not involve a big profit penalty for the
|
| 20 | incumbent.
|
| 21 | Now, if you look in B, it should look like
|
| 22 | freedom to trade is violated and certainly the playing
|
| 23 | field is not level. But in A and B together, there isn't
|
| 24 | a potential blocking coalition. Nobody but the incumbent,
|
| 25 | I assume, can do A, and consumers don't want to just get |
25
| 1 | the cheaper B and not get A. So, if you take the freedom
|
| 2 | to trade criterion strictly, there is no potential
|
| 3 | blocking coalition, so there can't be a risk that the
|
| 4 | incumbent is thwarting a potential blocking coalition.
|
| 5 | And really what this comes down to is: What's
|
| 6 | the right unit of analysis. Should we be looking at A and
|
| 7 | B together? Should we look at B separately? What should
|
| 8 | we do?
|
| 9 | By the way, I tried to avoid using the term
|
| 10 | "market" in talking about A and B because there's no
|
| 11 | particular reason to think that A and B will be defined in
|
| 12 | the usual way of antitrust markets.
|
| 13 | So, just to illustrate this, in case it's
|
| 14 | getting a little too abstract, a few of the traditional
|
| 15 | boxes, so if A is the tying good, B is the tied good, and
|
| 16 | the incumbent is somehow linking trade of the tied good to
|
| 17 | trade of the tying good.
|
| 18 | Exclusive dealing, A is a bunch of widgets that
|
| 19 | the consumer wants to buy, and B is other widgets, maybe
|
| 20 | it's a different date or maybe just more of them today or
|
| 21 | maybe a different place or something.
|
| 22 | If you look at aftermarkets, A might be the
|
| 23 | original equipment and B might be service to the
|
| 24 | equipment.
|
| 25 | So, in all of these cases, it's not uncommon for |
26
| 1 | there to be someone who wants to make a better offer in B
|
| 2 | and is stymied by some sort of linkage with A.
|
| 3 | So, what have I learned from all this? The
|
| 4 | setup and the going back to first principles has, at least
|
| 5 | for me, clarified the goal and the technique of antitrust.
|
| 6 | I've come to think that, although price-taking equilibrium
|
| 7 | does conduce to economic efficiency and is typically a
|
| 8 | good thing, and is certainly not inconsistent with
|
| 9 | analysis of the kind that gets us towards the core,
|
| 10 | nevertheless the latter is more fundamental to the ideas
|
| 11 | of antitrust than is price-taking equilibrium.
|
| 12 | I also think that it's important to understand,
|
| 13 | and I have made some steps in my own mind at least to
|
| 14 | understanding, that protecting competition as a process is
|
| 15 | potentially, and I think actually very different from
|
| 16 | imposing on each step of the process a requirement that
|
| 17 | has to increase, let's say, economic efficiency, if you
|
| 18 | think that that's the final goal.
|
| 19 | Trying to go much beyond that, based closely on
|
| 20 | first principles as I've been trying to do, turns out to
|
| 21 | be quite thorny. Okay. And I think there's a lesson in
|
| 22 | there, which is it reinforces what you might already have
|
| 23 | known or believed, which is a lot of the rules of thumb,
|
| 24 | rules of law and policies that govern unilateral conduct
|
| 25 | in antitrust has emerged from the kind of slightly vague |
27
| 1 | process that hasn't really linked them very tightly to
|
| 2 | first principles.
|
| 3 | So, to me, it reinforces that these are thorny
|
| 4 | issues. The positive message is, at least for me, it
|
| 5 | brings the thorns into sharper focus. And the particular
|
| 6 | thorn that I think is pervasive here and is brought into
|
| 7 | sharper focus is when, how, in what circumstances, in what
|
| 8 | ways can one in some sense require the incumbent to hold
|
| 9 | fixed its offer in A, and then we analyze level playing
|
| 10 | field or freedom to trade in B.
|
| 11 | Is that always illegitimate? That would be a
|
| 12 | strict interpretation of freedom to trade as the only
|
| 13 | criterion. Is it always legitimate? That would be the
|
| 14 | opposite, I guess. Or is there something in between?
|
| 15 | Ideally, based firmly on these same first
|
| 16 | principles. So, it's not a question of saying, well,
|
| 17 | let's consider a hypothetical and figure out what we
|
| 18 | intuitively think. But I'd like to work towards getting
|
| 19 | there in a way that's closely linked to these first
|
| 20 | principles.
|
| 21 | Thank you.
|
| 22 | (Applause.)
|
| 23 | MR. COHEN: Where are we, Aaron?
|
| 24 | MR. EDLIN: I will after the break, or any time
|
| 25 | I think, be able to project the slides. |
28
| 1 | MR. COHEN: Okay, should we then go on to
|
| 2 | Howard?
|
| 3 | MR. EDLIN: No. I am ready to present,
|
| 4 | MR. COHEN: Fine. We're now going to turn to
|
| 5 | Aaron Edlin.
|
| 6 | MR. EDLIN: Look at that, okay. Great progress.
|
| 7 | Let's do the show.
|
| 8 | So, the title is, "Sacrifice, Extreme Sacrifice,
|
| 9 | and No Economic Sense," three criteria that have been
|
| 10 | bandied about a lot recently and increasingly over the
|
| 11 | past two decades.
|
| 12 | After the colon, the title is: "The case
|
| 13 | against these necessary and sufficient tests for
|
| 14 | monopolization."
|
| 15 | So, of course the big question, the $64,000
|
| 16 | question in Section 2 is: When is exclusion
|
| 17 | anticompetitive and when is it not? The easy case that we
|
| 18 | all understand, presumably, as to how to answer is, if a
|
| 19 | monopoly excludes competitors by consistently charging low
|
| 20 | prices, well that is anticompetitive. It's the essence of
|
| 21 | the competitive process. It's good for consumers.
|
| 22 | What that example goes to prove, however, is
|
| 23 | that we need something other than exclusion to be
|
| 24 | anticompetitive. So, the question is: What plus
|
| 25 | exclusion is anticompetitive. The "what" is clearly not |
29
| 1 | consistently low prices. The question, though, is what
|
| 2 | the "what" is.
|
| 3 | And three possible whats have been, as I said,
|
| 4 | bandied about a lot of late. They all are basic
|
| 5 | sacrifice tests. The basic sacrifice suggested in "Aspen"
|
| 6 | and "Trinko" is foregoing profits now or in one line of
|
| 7 | business to make more later or in another line of business
|
| 8 | as a result of lessened competition.
|
| 9 | There is of course another variant, which is
|
| 10 | extreme sacrifice, which comes more directly out of
|
| 11 | predatory pricing, and you see it applied in "Barry
|
| 12 | Wright" and "American Airlines," which is that the test is
|
| 13 | really about actually losing money, not just not making as
|
| 14 | much as you could, pricing below cost and losing money to
|
| 15 | make more later or in another line of business as a result
|
| 16 | of lessened competition.
|
| 17 | More recently, Greg Werden and Doug Melamed put
|
| 18 | forward, and a DOJ "Trinko" brief puts forward a no
|
| 19 | economic sense test, which is that the action makes no
|
| 20 | economic sense but for a lessening of competition.
|
| 21 | These sacrifice tests are on the move, or have
|
| 22 | been on the move. In one sense from pricing cases to
|
| 23 | non-pricing cases. My reading is that they began and were
|
| 24 | first advocated in the predatory pricing context. Thanks
|
| 25 | to "Areeda and Turner" and "Willig." And they later |
30
| 1 | spread to non-pricing contexts. Thanks, for example, to
|
| 2 | "Aspen," "Trinko" and "Covad."
|
| 3 | They've also been on the move from sufficiency
|
| 4 | once other elements are shown, which is to say, from
|
| 5 | something that's helpful in making a case to something
|
| 6 | that's necessary for the plaintiff to make a case. So, in
|
| 7 | "Barry Wright," we see that there's been no violation,
|
| 8 | where above cost, where the pricing is above cost, which
|
| 9 | says that extreme sacrifice is necessary in pricing cases.
|
| 10 | The DOJ "Trinko" brief advocates the no economic
|
| 11 | sense test as necessary. "Covad" assumes that sacrifice
|
| 12 | is necessary. Doug Ginsberg writes, "'Covad' will have to
|
| 13 | prove Bell Atlantic's refusal to deal caused Bell
|
| 14 | Atlantic's short-term economic losses."
|
| 15 | Scalia's "Trinko" interpretation of "Aspen,"
|
| 16 | which I think is a bit revisionist, is that Ski Company
|
| 17 | sacrifice is necessary to violation. And Werden and
|
| 18 | Melamed have quite explicitly argued that no economic
|
| 19 | sense is the unifying principle of Section 2 violations.
|
| 20 | My fundamental contention which I've been
|
| 21 | arguing for years is that sacrifice is not needed for
|
| 22 | anticompetitive effect and frequently not needed.
|
| 23 | My "Yale Law Journal" article argues that this
|
| 24 | is true for what I call above cost predatory pricing. And
|
| 25 | if you think that below cost is part of the definition of |
31
| 1 | predatory pricing, then what I mean is above cost pricing
|
| 2 | that is exclusionary and anticompetitive. There I explain
|
| 3 | how consumers can be hurt by threats to lower prices, much
|
| 4 | as Joe Farrell explained, even though prices will remain
|
| 5 | above cost, and perhaps even though prices may be profit
|
| 6 | maximizing.
|
| 7 | I ask rhetorically: If sacrifice is wrong
|
| 8 | headed in the predatory pricing context, why are we
|
| 9 | extending it to non-pricing cases? Consider "Aspen."
|
| 10 | Now, suppose, as I think is likely, that Ski Company's
|
| 11 | refusal to sell at retail prices to Highlands increased
|
| 12 | Ski's retail sales to skiers. What I'm thinking there is
|
| 13 | that it certainly is conceivable, perhaps even likely,
|
| 14 | that when Ski Company refused to sell at retail to
|
| 15 | Highlands, what that meant was that, sure, they sold a
|
| 16 | couple less tickets as part of Highlands' adventure packs.
|
| 17 | However, on the other hand, what likely happened was that
|
| 18 | the consumer decided, or many of them did, that they would
|
| 19 | buy a whole week of skiing at Ski Company. So, there may
|
| 20 | have been no sacrifice there of profits, even though they
|
| 21 | refused to sell at retail.
|
| 22 | But would that mean that the refusal was any
|
| 23 | less exclusionary or anticompetitive? I think not. The
|
| 24 | "Aspen" court didn't just rest on what I think is a shaky
|
| 25 | notion of Ski Company's sacrifice, but they also |
32
| 1 | emphasized what they took to be consumer harm, the
|
| 2 | revisionist claims of Trinko about "Aspen"
|
| 3 | notwithstanding.
|
| 4 | Another case or set of cases where I think it's
|
| 5 | fairly clear that sacrifice is not necessary for
|
| 6 | anticompetitive effect are submarine patents. If you seek
|
| 7 | a patented process into an industry standard, that may not
|
| 8 | involve sacrifice of any kind that I can see. But that
|
| 9 | fact doesn't make it a good thing to do.
|
| 10 | Many people have been talking about an extreme
|
| 11 | case where Firm A blows up a competitor's plant. Now,
|
| 12 | Werden and Melamed, and fellow travelers with them,
|
| 13 | emphasize that this isn't a problem for them because the
|
| 14 | cost of the dynamite triggers liability. There is a
|
| 15 | sacrifice; you had to pay for the dynamite. And that is
|
| 16 | what triggers liability and means that there's no economic
|
| 17 | sense to blowing up your competitor's plant but for the
|
| 18 | lessening of competition, which justifies the cost of
|
| 19 | paying for dynamite.
|
| 20 | Like Joe Farrell, I don't -- this reasoning
|
| 21 | doesn't grab me and I feel a great suspicion that the cost
|
| 22 | of the dynamite could really be important here. But one
|
| 23 | way of saying that is to change the hypo. What if Firm A
|
| 24 | is avoiding a dump fee by deposing of surplus dynamite in
|
| 25 | this way. If they didn't blow up the competitor's plant, |
33
| 1 | they would have had to pay a dump fee to dispose of the
|
| 2 | dynamite.
|
| 3 | Well, now I gather that the dynamite has a
|
| 4 | negative cost. So, according to the no economic sense
|
| 5 | test or the sacrifice test, there should be no liability.
|
| 6 | Well, this just can't be. It can't be that it should
|
| 7 | hinge on that. This suggests to me that the sacrifice
|
| 8 | test is not looking at the right thing.
|
| 9 | If the sacrifice test is not looking at the
|
| 10 | right thing, neither is extreme sacrifice. Extreme
|
| 11 | sacrifice, that is losses, are certainly not needed for
|
| 12 | anticompetitive effect. Consider the American Airlines
|
| 13 | case brought by the DOJ unsuccessfully. The judge thought
|
| 14 | there that the extra plane was profitable if you ignore
|
| 15 | effects on other planes. I suggest that everyone reread
|
| 16 | footnote 13 of that case over and over and over again if
|
| 17 | you think that the extreme sacrifice test might make
|
| 18 | sense, as the judge did.
|
| 19 | Marginal revenue, as every economist and econ 1
|
| 20 | student knows, is less than price. For firms with lots of
|
| 21 | market power, which you might think are one of the focuses
|
| 22 | of Section 2, marginal revenue is much lower than price.
|
| 23 | What that means is that monopolies with lots of market
|
| 24 | power can sacrifice enormously without triggering the
|
| 25 | extreme sacrifice test. I think, as I pointed out |
34
| 1 | previously, it is very ironic to give such firms a
|
| 2 | license, such a license, such a grand license to exclude.
|
| 3 | Let's go back and consider the case of blowing
|
| 4 | up your competitor's factory. Could it be a violation
|
| 5 | only if the dynamite is so expensive that its cost exceeds
|
| 6 | Firm A's operating profits? It seems outlandish to me on
|
| 7 | its face, but the extreme sacrifice test says yes.
|
| 8 | And I'll point out that in that case, firms with
|
| 9 | large profits have a substantial and much larger license
|
| 10 | to blow up their competitors than other firms.
|
| 11 | Rhetorically I'll ask why.
|
| 12 | Consider the no economic sense test. Does that
|
| 13 | make sense? Well, apply it to limit pricing. Consider a
|
| 14 | firm that could charge a high price and make lots of
|
| 15 | money, for a while anyway, but this firm chooses a low
|
| 16 | price, less profitable for now. Why? In order to delay
|
| 17 | or prevent entry.
|
| 18 | Suppose there is no economic sense in charging
|
| 19 | this low price before there is entry, except that it
|
| 20 | prevents others from entering. Well, the no economic
|
| 21 | sense test condemns that limit pricing. But note that
|
| 22 | that's the essence of competition. It's what I had as the
|
| 23 | easy case on slide two.
|
| 24 | Werden doesn't apply the test here. Instead he
|
| 25 | grants a safe harbor for charging the low price. |
35
| 1 | Now, if your test would condemn this case and so
|
| 2 | you have to make an exception and grant a safe harbor
|
| 3 | because it's so obvious that this is procompetitive, I'd
|
| 4 | suggest that the test is not getting at the fundamentals.
|
| 5 | This smells bad to me.
|
| 6 | Back to blowing up the competitor's factory, a
|
| 7 | la "Conwood" discussion, Werden, page 425. Proponents of
|
| 8 | the no economic sense test emphasize again that the cost
|
| 9 | of the dynamite makes it illegal. As I pointed out, costs
|
| 10 | might be negative in the dump fee hypothetical.
|
| 11 | My claim would be that blowing up your
|
| 12 | competitor's factory is anticompetitive regardless of the
|
| 13 | cost of the dynamite, regardless of whether it has a
|
| 14 | negative cost, a small positive cost, or costs more than
|
| 15 | the operating profits, regardless of whether you pass the
|
| 16 | no economic sense test.
|
| 17 | The fundamental problem in my view with all
|
| 18 | these sacrifice tests is that these tests don't flow from
|
| 19 | any kind of first principles that are attractive. They
|
| 20 | don't flow from consumer welfare or from efficiency. They
|
| 21 | also don't flow from a notion of how the competitive
|
| 22 | process would work, for example, a process by which rivals
|
| 23 | can offer consumers - by which rivals who can offer
|
| 24 | consumers higher utility actually get to provide that
|
| 25 | higher utility. |
36
| 1 | The tests don't flow from any other principles
|
| 2 | I've been able to discern from reading about them.
|
| 3 | Now, when someone like me points out that there
|
| 4 | are many cases where the tests are not satisfied but the
|
| 5 | action is anticompetitive, what you quickly bump into,
|
| 6 | both in the commentary and in the cases, is a refrain
|
| 7 | about false positives. It's a chorus. Fears and claims
|
| 8 | about these false positives abound. However, I'd suggest
|
| 9 | a modern example that I can put forward are pretty scarce.
|
| 10 | A common argument is that you need a hurdle to
|
| 11 | avoid these false positives. So, sacrifice is not needed
|
| 12 | for anticompetitive effect, but the plaintiffs should be
|
| 13 | required to show it anyway, in order to prevent an avalanche
|
| 14 | of cases from chilling legitimate competition.
|
| 15 | To me, when I hear that, I wonder, why not just
|
| 16 | tax plaintiffs, if that's the goal. Or, if you really
|
| 17 | want to eliminate these false positives, you could
|
| 18 | eliminate Section 2 entirely, or you could eliminate
|
| 19 | Section 2 for any plaintiffs whose name begins with A
|
| 20 | through M, then you get rid of half the false positives.
|
| 21 | Erecting arbitrary hurdles because the right
|
| 22 | test is difficult to administer properly is, I would
|
| 23 | argue, wrong-headed. What commentators should do, and
|
| 24 | ultimately courts, is seek, as best they can, the right
|
| 25 | test. |
37
| 1 | Now, once you've sought the right test, if
|
| 2 | administrative difficulties truly make false positives a
|
| 3 | bigger problem than false negatives, and there is not all
|
| 4 | that much discussion by the refrainers about false
|
| 5 | negatives, there is an answer which doesn't involve
|
| 6 | arbitrary hurdles or abandoning the right test. You could
|
| 7 | raise the standard of proof in that case. You could
|
| 8 | improve jury instructions. You could create procedural
|
| 9 | hurdles like "Dauber" to require rigorous evidence. We
|
| 10 | have a number of those. And, again, I think you'll find
|
| 11 | that modern examples of clear false positives are pretty
|
| 12 | rare.
|
| 13 | What are my conclusions? That patience is
|
| 14 | needed. We should be searching for the right standard, or
|
| 15 | at least better ones, and that administrative difficulties
|
| 16 | don't justify arbitrary tests. And too often they have
|
| 17 | been used to do so.
|
| 18 | Thank you.
|
| 19 | (Applause.)
|
| 20 | MR. COHEN: Okay. Our last presenter this
|
| 21 | morning is Howard Shelanski, Professor of Law at Berkeley
|
| 22 | here, where he is also Associate Dean and the co-director
|
| 23 | of the Berkeley Center for Law and Technology. His
|
| 24 | research focuses on antitrust policy and regulation.
|
| 25 | On the economic side, from 1999 to 2000, |
38
| 1 | Professor Shelanski served as Chief Economist of the
|
| 2 | Federal Communications Commission, and in 1998 to 1999, he
|
| 3 | was a Senior Economist to the President's Council of
|
| 4 | Economic Advisers at the White House.
|
| 5 | On the law side, Professor Shelanski served as a
|
| 6 | clerk to U.S. Supreme Court Justice Antonin Scalia.
|
| 7 | We welcome your presentation.
|
| 8 | MR. SHELANSKI: Thanks very much, Bill. I'm
|
| 9 | really happy to be here. And I want to make a
|
| 10 | presentation that at least in some aspects will connect to
|
| 11 | what my colleague Aaron Edlin was just talking about, in
|
| 12 | the sense that it may give some insights into how to
|
| 13 | choose among different kinds of tests for enforcement
|
| 14 | under Section 2.
|
| 15 | And I want to speak specifically about
|
| 16 | enforcement in the area of unilateral refusals to deal, an
|
| 17 | area that has, I think, become particularly challenging in
|
| 18 | the wake of the "Trinko" case.
|
| 19 | And the broad point that I want to make is this:
|
| 20 | That at the same time that the Department of Justice and
|
| 21 | the Federal Trade Commission are reviewing enforcement
|
| 22 | policy for Section 2 of the Sherman Act, there are
|
| 23 | parallel efforts ongoing, indeed some undertaken in recent
|
| 24 | years by the Federal Trade Commission, to rethink and
|
| 25 | reform intellectual property rights, and particularly to |
39
| 1 | reform it in a way that makes it harder for firms to use
|
| 2 | intellectual property to foreclose competition with weak
|
| 3 | or questionable IP rights.
|
| 4 | And I think that the potential outcomes of IP
|
| 5 | reform could matter for aspects of antitrust reforms, and
|
| 6 | notably for policy toward unilateral refusals to deal.
|
| 7 | So, my main point is that, in thinking about
|
| 8 | Section 2 enforcement, and in particular thinking about
|
| 9 | unilateral refusals to deal, antitrust reform efforts
|
| 10 | should not ignore intellectual property reform processes
|
| 11 | So, I have a general suggestion, which is that
|
| 12 | antitrust authorities should keep an eye on IP reform and
|
| 13 | take into account how it might affect enforcement policies
|
| 14 | under Section 2. Not a terribly original idea in broad.
|
| 15 | Louis Kaplow in 1984 wrote a very nice paper talking about
|
| 16 | how antitrust and IP should be thought of as part of an
|
| 17 | interactive system. But I also want to talk about
|
| 18 | specific conjecture and, as we get further along, you'll
|
| 19 | see why I refer to it as merely conjecture, which is, if
|
| 20 | IP reform is likely to reduce the strength or availability
|
| 21 | of intellectual property protections, antitrust
|
| 22 | authorities might consider enforcing less strictly against
|
| 23 | refusals to deal.
|
| 24 | Now, let me try to explain why. Under "Trinko,"
|
| 25 | there is a presumption against requiring a firm to deal |
40
| 1 | with competitors. Now, there are many things one can read
|
| 2 | into "Trinko". "Trinko" adopts a very strong line against
|
| 3 | duties to deal for firms in the unilateral context. But
|
| 4 | "Trinko" did preserve "Aspen". Very interestingly,
|
| 5 | "Aspen", which is a hard case to teach to students and in
|
| 6 | many ways a hard case to explain. "Aspen" is a case that
|
| 7 | imposed a duty to deal.
|
| 8 | I agree with Aaron Edlin that Justice Scalia
|
| 9 | engaged in some revisionism by finding profit sacrifice in
|
| 10 | that case, but inherently what "Aspen" says is, if there
|
| 11 | is nothing that you gain by refusing to deal, then we are
|
| 12 | going to assume that what you gained is a reduction in
|
| 13 | competition that inures to your benefit. That's one way
|
| 14 | of looking at it. But "Aspen" still exists after
|
| 15 | "Trinko". We have a strong presumption articulated in the
|
| 16 | "Trinko" decision against imposing duties to deal.
|
| 17 | The question that's left for the antitrust
|
| 18 | agencies is the following: Okay, where do we impose the
|
| 19 | duty to deal or not. So, I want to talk a little bit
|
| 20 | about some policy issues that might arise, some background
|
| 21 | issues, and then talk about how IP reform might affect the
|
| 22 | answer to that question of what standard to use in
|
| 23 | imposing a duty to deal.
|
| 24 | Well, the first thing that we need to keep in
|
| 25 | mind of course is that only some refusals to deal cause |
41
| 1 | anticompetitive harm. There are many cases where refusals
|
| 2 | to deal will cause competitive supply to enter the market,
|
| 3 | would cause a firm to invent around the refusal to deal or
|
| 4 | to innovate or produce something itself.
|
| 5 | Mandatory dealing in cases where there isn't
|
| 6 | anticompetitive harm could impede investment and
|
| 7 | innovation by the firms being forced to deal. So, that's
|
| 8 | an argument one often hears. If you go back to some of
|
| 9 | the previous rounds of these hearings, Former Assistant
|
| 10 | Attorney General for Antitrust Eupate has some testimony
|
| 11 | saying exactly this, if you force firms to deal, they're
|
| 12 | not going to innovate. There's some interesting counter
|
| 13 | argument by Professor Steven Fallon that suggests the
|
| 14 | evidence for such innovation deterrence is thin. But we
|
| 15 | have to at least keep in mind the possibility that
|
| 16 | mandatory dealing could impede investment.
|
| 17 | I think that one of the bigger concerns is that
|
| 18 | enforcement of a duty to deal might reduce competitive
|
| 19 | innovation and production not by the firms being forced to
|
| 20 | deal, but by other firms in the marketplace or by the
|
| 21 | would-be buyer, by creating a quasi-regulated purchase
|
| 22 | alternative.
|
| 23 | So, "Trinko" takes into account all of these
|
| 24 | possibilities, that there isn't a lot of -- that there are
|
| 25 | many refusals to deal that are not anticompetitive and |
42
| 1 | imposing a duty to deal in fact may have consequences to
|
| 2 | justify its presumption against the duty to deal. But
|
| 3 | "Trinko" does not necessarily mean refusals to deal are
|
| 4 | evil per se.
|
| 5 | So, refusals to deal can have anticompetitive
|
| 6 | harms. And we would not necessarily want to exempt those
|
| 7 | refusals to deal from enforcement.
|
| 8 | Now, I want to suggest that one necessary
|
| 9 | condition for such harm is that competitors and third
|
| 10 | parties face economic barriers to providing the goods at
|
| 11 | issue or that competitors and third parties face legal
|
| 12 | barriers to providing the goods at issue.
|
| 13 | And I would suggest we should not impose duties
|
| 14 | to deal in goods for which economic or legal barriers to
|
| 15 | competitive supply do not exist. There you get very
|
| 16 | little pay off and you may creat some deterrent effects to
|
| 17 | innovation either on the supply or the demand side.
|
| 18 | But what about refusals that could be
|
| 19 | anticompetitive, for which there are economic barriers or
|
| 20 | legal barriers. There are several standards that we could
|
| 21 | use to identify those situations and to decide whether or
|
| 22 | not to enforce a duty to deal.
|
| 23 | So, one thing we could do is to say, listen, we
|
| 24 | should have per se legality for refusals to deal. This is
|
| 25 | in the spirit of "Trinko", it's a strong reading of |
43
| 1 | "Trinko", but it's a very clean line and we avoid any risk
|
| 2 | of deterring innovation on either the supply or the demand
|
| 3 | side.
|
| 4 | Alternatively, we have a range of rule of reason
|
| 5 | approaches. And I'm just going to very simplistically
|
| 6 | phrase them as potential consumer welfare tests, the kind
|
| 7 | of tests that Professor Salop proposed in an earlier round
|
| 8 | of these hearings; a business justification test, which
|
| 9 | Kolasky suggested in that same round; and a profit
|
| 10 | sacrifice test of various stringency, ranging right up to
|
| 11 | a no business sense kind of test of the kind that Doug
|
| 12 | Melamed has articulated.
|
| 13 | Then we have the old line essential facilities
|
| 14 | approach, which as Justice Scalia tells us, the Supreme
|
| 15 | Court has never adopted. One could quibble about what
|
| 16 | "Onertel" means, but there is some precedent certainly in
|
| 17 | the Appellate Court for the essential facilities approach,
|
| 18 | notably in the Seventh Circuit.
|
| 19 | So, how should the Justice Department and the
|
| 20 | Federal Trade Commission choose among these various
|
| 21 | approaches? Well, I don't much like the per se legality
|
| 22 | approach because per se legality fails to block cases
|
| 23 | where the only effect is anticompetitive. And while often
|
| 24 | justified on the grounds of preserving the refusing firm's
|
| 25 | innovation and investment incentives, there isn't clear |
44
| 1 | evidence that that is [unintelligible]. And I think
|
| 2 | you're likely to have poor welfare effects here.
|
| 3 | I don't much like the essential facilities
|
| 4 | approach either because it does ignore some legitimate
|
| 5 | business justifications. And I think that it may too
|
| 6 | easily allow access and deter innovation and investment by
|
| 7 | the buyer or the third parties. And more -- of great
|
| 8 | concern is it requires a quasi-regulatory solution.
|
| 9 | While I fully agree with my colleague Aaron that
|
| 10 | we should not let administrative difficulties justify a
|
| 11 | bad test, we shouldn't ignore administrative difficulties
|
| 12 | in the test that we actually choose to administer. And
|
| 13 | there's some hard pricing questions that emerge any time
|
| 14 | that we follow the full essential facilities test as it's
|
| 15 | been articulated in the appellate courts.
|
| 16 | Well, this leads to the rule of reason
|
| 17 | alternatives. And I'm not going to exactly say which rule
|
| 18 | of reason alternative I think is best. I think we've
|
| 19 | heard a lot of very interesting and provocative arguments
|
| 20 | for the specific nature of the test.
|
| 21 | I want to oversimplify by assuming that if you
|
| 22 | took all of the rules of reason tests that are proposed
|
| 23 | that you can differentiate them along a spectrum from
|
| 24 | relatively strong enforcement to relatively weak
|
| 25 | enforcement. In other words, they can be differentiated |
45
| 1 | according to the likelihood that we'll find conduct to be
|
| 2 | anticompetitive by how strictly they would enforce against
|
| 3 | refusals to deal and how likely they would be to impose a
|
| 4 | duty to deal.
|
| 5 | So, the policy for the courts and the antitrust
|
| 6 | agencies I think may be how stringent or generous the rule
|
| 7 | of reason test to choose for judging refusals to deal. I
|
| 8 | think that IP rights, intellectual property rights, might
|
| 9 | affect the answer. And here's why.
|
| 10 | Intellectual property rights are a primary
|
| 11 | source of legal barriers to competitive provision of goods
|
| 12 | that an incumbent refuses to sell to rivals. We heard in
|
| 13 | the testimony yesterday from some of the company
|
| 14 | witnesses, notably QUALCOMM and a couple of others, that
|
| 15 | they're very concerned about any rule that might require
|
| 16 | them to deal in particular ways with their intellectual
|
| 17 | property. Intellectual property rights grant them a legal
|
| 18 | ability to give them the ability to impose a legal barrier
|
| 19 | to invent around to innovations that would replicate their
|
| 20 | invention, and therefore gives power, creates an effect
|
| 21 | out of their refusal to deal or refusal to deal on
|
| 22 | particular terms.
|
| 23 | But, logically, any reduction in the strength
|
| 24 | and availability of IP protections could reduce the pool
|
| 25 | of goods for which there are legal barriers to competitive |
46
| 1 | supply. There is an empirical question buried in here
|
| 2 | that I will return to at the end. But I think that IP
|
| 3 | reform could therefore affect the frequency with which
|
| 4 | refusals to deal weaken the conditions for being
|
| 5 | anticompetitive, in turn affecting the likelihood that
|
| 6 | enforcement of the duty to deal was warranted.
|
| 7 | So, what's the benefit of a more discerning
|
| 8 | intellectual property policy if IP reform reduces a firm's
|
| 9 | ability to use IP protections to block competitive supply
|
| 10 | and innovation, then IP reform can limit the need for rule
|
| 11 | of reason exceptions to Trinko's presumption against
|
| 12 | mandatory dealing with rivals.
|
| 13 | Now, one might say, okay, fine, why not have
|
| 14 | intellectual property reform and a fairly liberal duty to
|
| 15 | deal. Won't that unblock lots anticompetitive refusals to
|
| 16 | deal.
|
| 17 | Well, both intellectual property reform and
|
| 18 | duties to deal aim to reduce barriers to competitive
|
| 19 | supply and innovation, but I think that their individual
|
| 20 | welfare effects may not be additive if they're undertaken
|
| 21 | together.
|
| 22 | Suppose that we do not have IP reform and that
|
| 23 | there is some good that is being used anticompetitively to
|
| 24 | block competitive supply. The duty to deal can increase
|
| 25 | welfare with no risk of deterring investment or innovation |
47
| 1 | by the would-be buyer or third parties. The would-be
|
| 2 | buyer or third parties could be blocked by an intellectual
|
| 3 | property barrier to competitive supply or innovation, and
|
| 4 | so requiring that the refusing to sell or deal doesn't
|
| 5 | block any innovation on the demand side by the would-be
|
| 6 | buyer or by third parties. It might deter innovation and
|
| 7 | investment by the incumbent. That is something that we
|
| 8 | need to think about.
|
| 9 | With reduction of legal barriers through IP
|
| 10 | reform, however, the duty to deal now can undermine new
|
| 11 | competition and innovation, reducing welfare. So, the
|
| 12 | firm that is refusing to deal and the good that is
|
| 13 | protected by intellectual property, if they now have a
|
| 14 | weaker intellectual property right, we might want to say,
|
| 15 | well, let's not make them deal because now there's an
|
| 16 | invent around or a replication that didn't exist before.
|
| 17 | So, IP reform raises the likelihood, whether to
|
| 18 | any significant level is another question, but it raises
|
| 19 | the likelihood of false positives in antitrust enforcement
|
| 20 | through imposition of a duty to deal where the conditions
|
| 21 | for anticompetitive harm as a legal barrier do not hold.
|
| 22 | So, let's take a little bit of a closer look at
|
| 23 | the implications of IP reform for Section 2 reform. There
|
| 24 | are several kinds of proposals for intellectual property
|
| 25 | reform that could bear on the effects of refusals to deal. |
48
| 1 | There's just some broad examples
|
| 2 | There are proposals to raise the bar for
|
| 3 | patentability: better pre and post grant opposition
|
| 4 | procedures; more transparent review, both in initial grant
|
| 5 | and post grant of patent grants or annuities.
|
| 6 | There are also proposals to reduce consequences
|
| 7 | of patentability: a narrowed patentable subject matter,
|
| 8 | for example, cutting software out of patentable subject
|
| 9 | matters; expanded research exceptions and reduced
|
| 10 | presumptions of harm in injunction proceedings which might
|
| 11 | push parties to the bargaining table; and limit refusals
|
| 12 | to deal. And these are proposals that can be found in the
|
| 13 | National Academy of Sciences' proposal, in the Federal
|
| 14 | Trade Commission's report of a couple of years ago; in
|
| 15 | draft statute that floated around in 2004; and in a
|
| 16 | variety of ongoing documents one can find these proposals.
|
| 17 | So, the effects of these proposals would likely
|
| 18 | be to make fewer goods subject to IP protections and to
|
| 19 | make those protections less expansive. Some of the most
|
| 20 | prominently discussed IP reforms, and I think this is the
|
| 21 | important point, would reduce the ability of incumbents to
|
| 22 | foreclose competitive provision of goods through the
|
| 23 | exercise of intellectual property rights.
|
| 24 | Depending on circumstances, these refined IP
|
| 25 | protections could have varying effects on incentives to |
49
| 1 | deal. The reduced ability to foreclose competitive
|
| 2 | innovation through the enforcement of an intellectual
|
| 3 | property right might make an incumbent more eager to sell
|
| 4 | to rivals because it would expect greater competitive
|
| 5 | entry in the relevant property market than existed
|
| 6 | pre-reform, and the incumbent may therefore want to take
|
| 7 | the sales for itself for as long as it can.
|
| 8 | Alternatively, an incumbent may be less eager to
|
| 9 | deal if the sale to others would raise the speed or
|
| 10 | likelihood of competitive entry compared to what would
|
| 11 | occur if it keeps the good to itself.
|
| 12 | And which of these incentive effects occurs
|
| 13 | would depend very much on the nature of the good, the
|
| 14 | degree to which the selling firm is vertically integrated.
|
| 15 | There are a number of questions that are factored in.
|
| 16 | But I think on the whole refined intellectual
|
| 17 | property could reduce the incidence and the impact of
|
| 18 | refusals to deal. It is true that refined IP protections
|
| 19 | could reduce the willingness to deal with rivals by
|
| 20 | reducing an incumbent's ability to block replication of or
|
| 21 | innovative alternatives to its technology. But I think
|
| 22 | this effect is most likely where the goods involved are
|
| 23 | easy to reverse engineer and replicate. And these in
|
| 24 | turn, I think, are the goods where refusals to deal would
|
| 25 | be less harmful because the would be-buyer or others will |
50
| 1 | eventually be able to market.
|
| 2 | So, on the whole, I think we'll find
|
| 3 | intellectual property protections should either reduce
|
| 4 | incentives to refusals to deal, or reduce the long-term
|
| 5 | effects of refusing to deal by opening the door to
|
| 6 | competitive supply and innovation.
|
| 7 | So, what are the implications for Section 2
|
| 8 | reform? The latter effect, competitive reinvention or
|
| 9 | replication of the goods at issue in a refusal case should
|
| 10 | be preserved. Antitrust reform should not impede a
|
| 11 | competitive reinvention because they should not provide an
|
| 12 | alternative or option to competitive entry or invention or
|
| 13 | innovation where it is feasible to occur.
|
| 14 | So, I think that if intellectual property reform
|
| 15 | reduced legal barriers to competitive production of the
|
| 16 | relevant good, Section 2 should be less willing to require
|
| 17 | the incumbent to deal. Broad exemptions to the "Trinko"
|
| 18 | presumption against mandated dealing could create a
|
| 19 | quasi-regulatory alternative to buyers that is unnecessary
|
| 20 | and unhelpful to economic welfare.
|
| 21 | So, that's some questions to investigate before
|
| 22 | we know whether intellectual property reform is actually
|
| 23 | going to matter.
|
| 24 | Several key questions. First of all, how likely
|
| 25 | is IP reform and to what extent will it refine the |
51
| 1 | consequences of IP protections for competition. I think
|
| 2 | to question these efforts are under way. They're very
|
| 3 | political and very contentious. What will emerge from
|
| 4 | them is unclear. I think something will, but I think it's
|
| 5 | hard to know exactly what.
|
| 6 | The next question is really an empirical one and
|
| 7 | I think lies at the core of what I'm suggesting today:
|
| 8 | How much of a problem with refusal to deal stems from IP
|
| 9 | protected goods for which the barrier to competitive
|
| 10 | supply is a legal one rather than an economic one that
|
| 11 | stems from scale or something else. If not much, then the
|
| 12 | considerations I'm suggesting can be put aside as
|
| 13 | Section 2 reform proceeds. But if a lot, even if only in
|
| 14 | particular industries or markets, then refusal to deal
|
| 15 | policy should recognize the welfare and complexities that
|
| 16 | intellectual property reform might introduce.
|
| 17 | And the final question is: What effects will
|
| 18 | applied intellectual property protections have on the
|
| 19 | incentive of incumbent firms to deal with rivals. I think
|
| 20 | that's an interesting question to investigate.
|
| 21 | So, I have some tentative conclusions.
|
| 22 | The rule of reason approach for refusals to deal
|
| 23 | has potential advantages over either per se legality or
|
| 24 | the essential facilities test.
|
| 25 | The policy problem is to decide how strict a |
52
| 1 | test the courts and agencies should apply in assessing the
|
| 2 | reasonability of refusals to deal with rivals. And the
|
| 3 | potential results of intellectual property reform may be a
|
| 4 | relevant consideration in that choice, with more refined
|
| 5 | intellectual property rights weighing in favor of less
|
| 6 | strict enforcement against refusals to deal.
|
| 7 | Thank you.
|
| 8 | MR. COHEN: Thank you very much Howard we're now
|
| 9 | going to take a break for roughly fifteen minutes.
|
| 10 | (A brief recess was taken.)
|
| 11 | MR. COHEN: Fine. Before we begin our questions
|
| 12 | and round-table discussions, I think a way to start this
|
| 13 | second session would be to give each of our speakers a few
|
| 14 | minutes to respond to or comment upon some of the issues
|
| 15 | that were raised by the other panelists.
|
| 16 | You can go in whichever order you prefer. We do
|
| 17 | ask as a reminder to speak into the microphone so we can
|
| 18 | get this transcript.
|
| 19 | MR. SHELANSKI: I'll start because I expect
|
| 20 | collusion over here on the right.
|
| 21 | So, I really enjoyed Aaron's and Joe's related
|
| 22 | presentations and I think that they are both in the core
|
| 23 | respects correct. I do have just a couple of observations
|
| 24 | or comments.
|
| 25 | So, one suggestion I would make is if you take |
53
| 1 | Aaron's presentation and Joe's presentation and put them
|
| 2 | together, you could take them as saying that, if a firm
|
| 3 | cuts price in response to entry, one test is that it is
|
| 4 | not acting anticompetitively, it's in a safe harbor if it
|
| 5 | keeps its price low.
|
| 6 | And I just wonder -- the question I would have
|
| 7 | or the thing I would ask them to consider is whether their
|
| 8 | proposals, as compared with other tests that are typically
|
| 9 | used in this area, would increase the ability of
|
| 10 | competitive firms already in the market to raise rivals'
|
| 11 | costs by entering, for example, on the airline route that
|
| 12 | was at five hundred, bringing it down to two hundred, and
|
| 13 | then basically telling the five hundred dollar firm, you
|
| 14 | either need to cut your price and keep it there or face
|
| 15 | some kind of antitrust scrutiny that you will find
|
| 16 | unpleasant.
|
| 17 | Is the raising of rivals' cost prospect greater
|
| 18 | under proposal than under others? I don't know. It's
|
| 19 | just something that I think ought to be thought about
|
| 20 | The other comment that I have is that I am not
|
| 21 | fully persuaded that costs don't matter at all in the
|
| 22 | consideration of whether or not the five hundred dollar
|
| 23 | price is a problem or not. Obviously, as Aaron points
|
| 24 | out, the monopolist has the greater ability to sacrifice
|
| 25 | profits because it has obviously much higher net profits. |
54
| 1 | But I wonder, again, and this may relate to the
|
| 2 | competitive strategy angle here, if the five hundred
|
| 3 | dollar price is not three hundred dollars above the
|
| 4 | competitive equilibrium, but a hundred dollars over the
|
| 5 | competitive equilibrium, we might worry a little bit less
|
| 6 | about the five hundred dollar price being the one that
|
| 7 | we're running into in the market because someone decides
|
| 8 | not to enter at four hundred dollars. Don't we have to
|
| 9 | look at costs to know how great a welfare loss there is to
|
| 10 | the current test? And would that matter to your
|
| 11 | recommendation of what do in in a particular case?
|
| 12 | MR. FARRELL: Well, let me start with that last
|
| 13 | one.
|
| 14 | I think if we knew everything, then you're
|
| 15 | probably right. I would take pretty strongly the
|
| 16 | perspective that the competitive process is about having
|
| 17 | policies that don't require us to know what the
|
| 18 | competitive equilibrium price is likely to be, and that
|
| 19 | therefore enforcement of competition policy and antitrust
|
| 20 | should not depend upon on our being able to say we think
|
| 21 | the competitive price would be X.
|
| 22 | And that's part of why I think the competitive
|
| 23 | process, as I understand it, operates through the
|
| 24 | formation of a blocking coalition that make the
|
| 25 | participants better off, without an inquiry into how much |
55
| 1 | the incumbent loses from this entry.
|
| 2 | So, if you look at the entry in the oligopoly
|
| 3 | literature, the usual citation is the Mankiw and Whinston
|
| 4 | article, 1986 or thereabouts. And if you think about the
|
| 5 | way that regulation has traditionally treated
|
| 6 | cream-skimming and loss of income and profits due to entry
|
| 7 | and, think in terms of access pricing to control and deal
|
| 8 | with that, all of that it seems to me is extremely foreign
|
| 9 | to competition policy. And the reason it's foreign to
|
| 10 | competition policy is I think that the competitive process
|
| 11 | works precisely by ignoring the effects on the incumbent.
|
| 12 | And obviously if you want to increase welfare in the
|
| 13 | small, ignoring something like that that could be quite
|
| 14 | important is a stupid thing to do. But I think as part of
|
| 15 | an overall process, it's brilliant and seems to work
|
| 16 | rather well.
|
| 17 | And I think there are times, perhaps many times,
|
| 18 | when many, perhaps all of us, get confused about that.
|
| 19 | Because there's no doubt, I think there's a consensus that
|
| 20 | the eventual goal of all of this is economic efficiency.
|
| 21 | So, it's always very tempting to look at economic
|
| 22 | efficiency in each instance, and perhaps often is right to
|
| 23 | do so, but I think it's often wrong to do so.
|
| 24 | MR. SHELANSKI: And just a comment here on legal
|
| 25 | precedence. |
56
| 1 | I actually think that you're on pretty good
|
| 2 | ground with some recent legal precedent. I mean, if I
|
| 3 | understood your comments about "Barry Wright" correctly,
|
| 4 | that that case made the mistake of thinking that downward
|
| 5 | pricing was more important than the competitive process.
|
| 6 | Maybe that's a way of summarizing your critique. I don't
|
| 7 | know if that's unfair or not.
|
| 8 | And certainly in Arizona against the Maricopa
|
| 9 | Medical Association case, even though that was a Section 1
|
| 10 | case, the Supreme Court said fairly strongly that we don't
|
| 11 | care about direction price level. What we care about is
|
| 12 | the competitive process and making sure it works well.
|
| 13 | So, there might be some legal standing for you
|
| 14 | to argue that your proposal is more in keeping with modern
|
| 15 | processor oriented thinking instead of the price oriented
|
| 16 | thinking that polluted the predatory pricing process.
|
| 17 | MR. FARRELL: I have something else to say, but
|
| 18 | if you want to respond to that.
|
| 19 | MR. EDLIN: Well, I wasn't going to respond to
|
| 20 | that. I was going to respond to what he said previously,
|
| 21 | which I suppose is not the rule as to how a conversation
|
| 22 | goes.
|
| 23 | But I think Joe is right that, to the extent we
|
| 24 | can, we're certainly better off having an antitrust
|
| 25 | jurisprudence that doesn't focus on things that we are not |
57
| 1 | very apt to know, like costs.
|
| 2 | And as to Howard's point, which is certainly
|
| 3 | correct, that if price is close already to the competitive
|
| 4 | equilibrium, then you shouldn't worry very much about what
|
| 5 | happens no matter what. I agree with that. And one thing
|
| 6 | that -- this gets to the last slide I had, which is, you
|
| 7 | may want to only worry about firms thwarting rivals from
|
| 8 | providing very substantial value increases to consumers,
|
| 9 | and not worry about situations where they are only
|
| 10 | providing minimal value increases. And if the prices are
|
| 11 | already pretty close to the competitive level, then you
|
| 12 | won't find rivals offering to provide very substantial
|
| 13 | value increases to consumers, and so we won't find that
|
| 14 | antitrust interferes very much in those circumstances.
|
| 15 | But now you wanted to respond to what he just
|
| 16 | said.
|
| 17 | MR. FARRELL: Well, I wanted to say something
|
| 18 | else about the role of costs in all of this.
|
| 19 | There's no doubt that sacrifice tests and cost
|
| 20 | tests can be illuminating concerning intent. And it's a
|
| 21 | bit of a paradox, I think, or piquant at least, that
|
| 22 | many of the same people who are very keen on sacrifice
|
| 23 | tests are also the first ones to lay into any attempt to
|
| 24 | use intent evidence in an antitrust case.
|
| 25 | It seems to me that intent is what you can |
58
| 1 | sometimes infer from sacrifice tests, and one needs to be
|
| 2 | careful using intent evidence. Obviously there is the
|
| 3 | pervasive problem of testosterone poisoned sales managers.
|
| 4 | But thoughtful, high level intent may often be the best
|
| 5 | available evidence as to contemporaneous estimates of
|
| 6 | likely effects.
|
| 7 | And so I don't think we should be either too
|
| 8 | credulous or too rude about intent evidence. It's a kind
|
| 9 | of evidence, and it seems to me it's the kind of evidence
|
| 10 | that's most directly brought out by looking at sacrifice.
|
| 11 | Let me say one other thing, though, about how
|
| 12 | cost information might be useful.
|
| 13 | If it's right, as I suggested at one point, that
|
| 14 | you'd want to look at, in my hypothetical Northeast two
|
| 15 | hundred dollar price, and in some sense try to gauge
|
| 16 | whether that is where we've now got to, or whether it's
|
| 17 | just a quick and short-lived fighting price that will
|
| 18 | disappear as soon as the entrant has gone away and will be
|
| 19 | back to five hundred, if that's an important question,
|
| 20 | which it may well be, then it's perhaps somewhat
|
| 21 | informative to look at Northeast's costs, because if two
|
| 22 | hundred is below Northeast's cost, you might say, well,
|
| 23 | that more or less rules out the possibility that it's now
|
| 24 | the permanent price.
|
| 25 | Of course, there's a lot of other evidence about |
59
| 1 | what the permanent price must be, such as what actually
|
| 2 | happened post exit versus what was happening pre-entry.
|
| 3 | And so I certainly don't see that costs would play a
|
| 4 | determinative role there, but it might be relevant to
|
| 5 | thinking about that question.
|
| 6 | MR. COHEN: Okay. I think we'll start things
|
| 7 | off by building on some of Aaron's testimony.
|
| 8 | I'll try the first question. Given the critique
|
| 9 | that you supplied of some of the existing tests as to
|
| 10 | whether conduct is exclusionary, what's your thinking as
|
| 11 | to whether it's sensible to be looking for any single test
|
| 12 | that captures all the elements of what we would want in
|
| 13 | all the various situations to determine whether something
|
| 14 | is exclusionary or not? Is this something that we could
|
| 15 | hope for? Is this something beyond our ability?
|
| 16 | MR. EDLIN: Well, I'd say it's always reasonable
|
| 17 | to hope, and physicists will hope for the grand unified
|
| 18 | theory and they may find it, and we should similarly hope
|
| 19 | here.
|
| 20 | Now, however, I think that what you should not
|
| 21 | hope for is that you'll find the right unified test and it
|
| 22 | will be easy to apply to the facts in any given
|
| 23 | circumstance. Whatever test you think is right is going
|
| 24 | to necessarily lead to huge factual disputes as to how the
|
| 25 | test comes out under the circumstance. I think a lot of |
60
| 1 | people are driven by a desire to get away from that
|
| 2 | problem. And I think ultimately there are only two ways
|
| 3 | to get away from that problem, and one is per se legality
|
| 4 | and the other one is per se illegality, and both of them
|
| 5 | are very convenient, but I think that both of them are the
|
| 6 | wrong answer.
|
| 7 | MR. COHEN: Anyone else?
|
| 8 | Another way of trying to get at sort of the same
|
| 9 | set of issues, I guess, do you have any principles in mind
|
| 10 | that might help us determine areas in which any given test
|
| 11 | is more likely to work in a given setting than another
|
| 12 | setting? For example, are we more likely to have success
|
| 13 | with one of these tests in any price or non-price context?
|
| 14 | Are we more likely to have success with one of these tests
|
| 15 | in a setting where the issue is tying up inputs rather
|
| 16 | than settings which involve some of type of tortious
|
| 17 | conduct? Are there generalities that might guide us?
|
| 18 | MR. EDLIN: I think the main generality I would
|
| 19 | have is that one is more likely to have success with the
|
| 20 | test when it's seen from a sufficiency point of view than
|
| 21 | from a necessity point of view. And it -- or viewed
|
| 22 | differently, that these things are very -- can be very
|
| 23 | helpful evidence, either, as Joe said of intent, or of
|
| 24 | likely effect, which is to say, if you would not do it but
|
| 25 | for substantial diminution in competition, well, that |
61
| 1 | suggests substantial diminution in competition is likely.
|
| 2 | So, the test can be very relevant from that
|
| 3 | point of view. It's when you start to push the
|
| 4 | implication sign the other way, which is what's been
|
| 5 | happening, that I think there's real danger. And the
|
| 6 | danger is across all of the categories that you listed.
|
| 7 | MR. COHEN: I noticed when you went through some
|
| 8 | of the variance of these tests, in a couple of the
|
| 9 | instances, you included a temporal dimension. You
|
| 10 | included short-term sacrifice for long-term profits.
|
| 11 | Does anybody regard the short-term/long-term
|
| 12 | distinction as something that's really needed here? Is it
|
| 13 | just a sacrifice in general? And if short-term/long-term
|
| 14 | matters, what are we talking about for time? Anybody want
|
| 15 | to comment on those temporal formulations?
|
| 16 | MR. FARRELL: Well, I'll make a perhaps slightly
|
| 17 | rude comment. Usually when you don't know quite what
|
| 18 | version of the test you mean, it's because you're not
|
| 19 | really clear on the logic of why the test makes sense in
|
| 20 | the first place.
|
| 21 | So, I think, for example, if you're trying to
|
| 22 | infer intent, then you'd want to ask yourself, all right,
|
| 23 | what is it exactly that the argument here is saying and
|
| 24 | what time scale you're looking over.
|
| 25 | If you're wanting to say there's no possibility |
62
| 1 | that this is a price you would charge in the long run,
|
| 2 | that might tell you about something about what time scale
|
| 3 | you're looking over.
|
| 4 | So, I would go back to the underlying logic.
|
| 5 | And if you don't know how to go back to the underlying
|
| 6 | logic, that's a sign that there are deeper problems than
|
| 7 | just not knowing for what time scale to evaluate things.
|
| 8 | MR. MATELIS: This is a question about false
|
| 9 | positives and false negatives, which you mentioned, Aaron,
|
| 10 | and I'd be interested in all the panels' views.
|
| 11 | I suppose a slightly more spirited defense of
|
| 12 | the concept of false positives, which the Supreme Court
|
| 13 | has mentioned in just about every Section 2 case in the
|
| 14 | last twenty-five years, is that the competitive process is
|
| 15 | likely to fix false positives, whereas false negatives
|
| 16 | become ingrained in precedent and we're stuck with them
|
| 17 | for many, many years, as we were for decades in predatory
|
| 18 | pricing jurisprudence, where plaintiffs were winning cases
|
| 19 | where today I think everyone would agree they might not.
|
| 20 | Is this really a concern? Is the Supreme Court
|
| 21 | wrong stressing the idea of false positives, or is the
|
| 22 | concern overstated in general? How should this play a
|
| 23 | role in devising antitrust policy?
|
| 24 | MR. EDLIN: Well, I think you flipped the false
|
| 25 | positives and false negatives there, so I'll try to answer |
63
| 1 | the question as I think you intended.
|
| 2 | MR. FARRELL: It's what statisticians know as
|
| 3 | Type 3 error [laughter].
|
| 4 | MR. EDLIN: So, as I see it, if you find what
|
| 5 | you consider to be the right test, whether that is a final
|
| 6 | results oriented test like efficiency or consumer welfare,
|
| 7 | or whether it's a process type test such as the freedom to
|
| 8 | trade that Joe and I are suggesting, I think the problem
|
| 9 | of false positives is not so much one of legal precedents
|
| 10 | but one of application, which is to say, if you've got the
|
| 11 | right test, then the real fundamental problem is, in its
|
| 12 | application you may get it wrong.
|
| 13 | And the question is: Will people so fear that
|
| 14 | when the test is applied to them that it will be gotten
|
| 15 | wrong that they don't do many procompetitive things,
|
| 16 | whether that's process or results interpreted.
|
| 17 | And I think we are so far from such a situation
|
| 18 | today that it just doesn't concern me very much. But if
|
| 19 | we were in that situation, I again don't think the right
|
| 20 | thing to do would be to say, well, let's find -- let's
|
| 21 | apply something that substantively doesn't make much
|
| 22 | sense. Rather, I think you should look at the source of
|
| 23 | where the false positives are coming from. If they're
|
| 24 | coming from bad jury instructions, make better jury
|
| 25 | instructions. If they are coming from courts having an |
64
| 1 | insignificant standard of proof where it seems sufficient
|
| 2 | to allege that something bad happened rather than to
|
| 3 | really prove it, then we should crank up the standard of
|
| 4 | proof. And if -- and/or you say that you have to show
|
| 5 | that something really very bad happened, rather than just
|
| 6 | a little bad.
|
| 7 | So, I see the problem of false positives as
|
| 8 | being less in the precedents than in the applications of
|
| 9 | the facts.
|
| 10 | MR. SHELANSKI: I agree with Aaron. I would
|
| 11 | just add that I think a lot of rules look bad from a false
|
| 12 | positive standpoint. They look worse from the false
|
| 13 | positive standpoint at the beginning when the rule is
|
| 14 | articulated, then after there has been experience gained
|
| 15 | in its application.
|
| 16 | I think that, as an agency gains familiarity
|
| 17 | with the application of a rule, understanding of what
|
| 18 | certain fact patterns really mean, as courts get more
|
| 19 | experiences with reviewing cases and get a body of
|
| 20 | precedence and a body of jury instructions, some of the
|
| 21 | more frightening aspects of the rule may be damped down
|
| 22 | and you may get beneficial application.
|
| 23 | I do think there's a difference with respect to
|
| 24 | false positives between public enforcement and private
|
| 25 | enforcement under Section 2. I have a lot of faith in the |
65
| 1 | agencies' abilities to gain a body of knowledge and
|
| 2 | understanding that they then bring to bear in their
|
| 3 | enforcement discretion under any given rules.
|
| 4 | I think with the courts, where there's a perhaps
|
| 5 | much less coherent body of learning, you have to rely on
|
| 6 | any particular district judge's reading perhaps outside of
|
| 7 | its own circuit and perhaps outside of its own circuit,
|
| 8 | and rely on a cohesive body of understanding. And this is
|
| 9 | not -- I am not trying to bash the capability of judges.
|
| 10 | I'm trying to just suggest you may get a less coherent
|
| 11 | development of a body of precedence and knowledge in the
|
| 12 | judiciaries than you get in the agencies.
|
| 13 | So, I think false positive may be worse for
|
| 14 | private enforcement than for public enforcement. But, on
|
| 15 | the whole, I would agree with Aaron, I think the
|
| 16 | application is the key issue. The deterrence effect is
|
| 17 | probably overemphasized in a lot of what one reads, and I
|
| 18 | think it can be offset in light of experience.
|
| 19 | MR. MATELIS: Anything to add, Joe?
|
| 20 | MR. FARRELL: No. I'll reserve my time.
|
| 21 | MR. MATELIS: Okay. Again this is a general
|
| 22 | question based off of something Aaron has mentioned twice
|
| 23 | now.
|
| 24 | What are better jury instructions that we should
|
| 25 | be giving juries in Section 2 cases? This might be |
66
| 1 | another way of saying, if we don't want to instruct them
|
| 2 | on the no economic sense test, on what should we be
|
| 3 | instructing them?
|
| 4 | MR. EDLIN: Well, I think that the two best --
|
| 5 | the two best candidates that I think we should be
|
| 6 | instructing them clearly on, whatever we think the right
|
| 7 | test is, and the two best candidates that I have are a
|
| 8 | results oriented test, which is consumer welfare, or a
|
| 9 | process oriented test, which is that someone is being
|
| 10 | blocked from providing higher value to consumers, which is
|
| 11 | a process oriented test.
|
| 12 | And the instruction should of course distinguish
|
| 13 | all of the standard worries that people have, such as that
|
| 14 | it's not sufficient that rivals are losing money, and
|
| 15 | that's not the issue.
|
| 16 | What I'm really getting at there is, if you
|
| 17 | really -- I think the first thing before suggesting
|
| 18 | approving jury instructions is to come to a clear
|
| 19 | understanding of what antitrust is trying to accomplish.
|
| 20 | The second thing is to see if there really are a
|
| 21 | lot of false positives, and I don't see them. Right now I
|
| 22 | would say the improvement to jury instructions would be to
|
| 23 | not focus on tests that I think are nonsensical, which is
|
| 24 | the primary problem with them now.
|
| 25 | MR. MATELIS: Howard, Joe? |
67
| 1 | MR. FARRELL: Well, in the unlikely event that I
|
| 2 | ever end up on an antitrust trust jury, I guess what I
|
| 3 | would want to hear is: The following specific questions
|
| 4 | have been given some prominence, but you the jury should
|
| 5 | please interpret them to the extent possible in light of
|
| 6 | the kind of fundamental things that Aaron was mentioning.
|
| 7 | MR. COHEN: Okay, let's turn a few questions to
|
| 8 | Joe's presentation.
|
| 9 | I really started with three questions, but as I
|
| 10 | think about it more, they come together into one. I'll
|
| 11 | throw it out in various forms.
|
| 12 | You talked some time early on about whether the
|
| 13 | results of not being able to successfully form a blocking
|
| 14 | coalition results from actions of the five hundred dollar
|
| 15 | airline, whether it happened intentionally or not, I think
|
| 16 | you said at one point, or another time you phrased it,
|
| 17 | whether it's a natural outcome of the way the market
|
| 18 | worked.
|
| 19 | But then your rule you were trying to focus on
|
| 20 | where there's really a problem, you talked about whether
|
| 21 | the incumbent, the five hundred dollar incumbent,
|
| 22 | strategically thwarts the coalition.
|
| 23 | I'm going to ask you to try to give us some
|
| 24 | content about what you mean about "strategically thwarts."
|
| 25 | And maybe you can think about it in terms of a question of |
68
| 1 | whether this approach would make it unlawful for a low
|
| 2 | cost producer merely to develop the reputation as an
|
| 3 | aggressive price competitor.
|
| 4 | Sort of a third way of asking the same question:
|
| 5 | What's happened to the bad conduct element of Section 2 in
|
| 6 | this core analysis?
|
| 7 | MR. FARRELL: Well, so first off, as I
|
| 8 | understand it, where we're surrounded by lawyers here, I
|
| 9 | don't think there is a bad conduct. There's an
|
| 10 | anticompetitive component, anticompetitive conduct.
|
| 11 | And if you accept the ideas that are being put
|
| 12 | forward about what anticompetitiveness means, then there
|
| 13 | can be conduct that is anticompetitive that is harmful for
|
| 14 | competition that isn't necessarily bad in any sense other
|
| 15 | than being harmful to competition.
|
| 16 | Now, there certainly has been a body of thought
|
| 17 | and especially shorthand that says you want it to be bad
|
| 18 | as well in some other way. That I think -- I try to
|
| 19 | interpret that in the following way. Let's suppose that
|
| 20 | in the course of trial, imagine it takes place in this
|
| 21 | order although it wouldn't have to, it's been shown that
|
| 22 | the defendant did some things that harmed consumers by
|
| 23 | excluding competition and were not, let's say, highly
|
| 24 | efficient. And I'm pulling together ideas of various
|
| 25 | sources here, I think. |
69
| 1 | And now we ask, well, was it bad conduct? Well,
|
| 2 | from an economist's point of view, it seems as if in the
|
| 3 | instance it has just been shown to be bad conduct. So,
|
| 4 | the question is what further requirement is being asked
|
| 5 | for here.
|
| 6 | I think the further requirement that's being
|
| 7 | asked for here is the following: That this conduct -- if
|
| 8 | this conduct is condemned, it will have some sort of
|
| 9 | deterrent effect on conduct that sounds like this when
|
| 10 | described. And that deterrent effect will extend of
|
| 11 | course to other places where the competitive implications
|
| 12 | of the conduct might be a little bit different.
|
| 13 | And so what you want in addition to finding this
|
| 14 | conduct was inefficiently anticompetitive and
|
| 15 | anti-consumer here, you want some degree of confidence
|
| 16 | that similar-sounding conduct is going to tend to be not
|
| 17 | such a good thing or a bad thing, in other circumstances
|
| 18 | where maybe it won't be inefficiently anti-consumer,
|
| 19 | anticompetitive.
|
| 20 | Well, that puts a lot of weight on the
|
| 21 | psychological or even philosophical concept of conduct
|
| 22 | that sounds like this. There's a philosopher named I
|
| 23 | believe Grice, who really tested foundations of that kind
|
| 24 | of thing by inventing a word, grue, g-r-u-e, which means
|
| 25 | green up until this morning or blue after this morning. |
70
| 1 | And so all of your past observations that trees are green
|
| 2 | are also observations that trees are grue. What do you
|
| 3 | predict the tree color will be this afternoon.
|
| 4 | Obviously that's playing with words in the way
|
| 5 | that philosophers love to do, but it does suffice to make
|
| 6 | the point that, if what you are looking for in a, quote,
|
| 7 | "bad conduct" problem is something along the lines of
|
| 8 | similar conduct that is going to be bad in other
|
| 9 | circumstances, you need a concept of what's similar. And
|
| 10 | that's not really an economic concept, as far as I can
|
| 11 | tell. It's some sort of intuitive or possibly legal
|
| 12 | concept.
|
| 13 | MR. COHEN: Anyone else?
|
| 14 | I'll shift ahead because your comments invite
|
| 15 | this.
|
| 16 | What kind of difficulties would you expect
|
| 17 | courts have in operationalizing something like this? I
|
| 18 | would hate to go in and try to tell them that trees are
|
| 19 | green in the morning but blue later.
|
| 20 | MR. FARRELL: Well, just to be clear, at least
|
| 21 | in my own mind, I would be delighted if judges were to
|
| 22 | listen, and when we get around to writing, read this kind
|
| 23 | of stuff. But I am not convinced that it's ready for
|
| 24 | courts yet.
|
| 25 | What I think I would like courts to do is put up |
71
| 1 | a lot of resistance to the incorrect tests that are being
|
| 2 | bandied about on the pretext of administrability, bright
|
| 3 | line, sort of vaguely right, perhaps, maybe, although we
|
| 4 | can't exactly tell you why.
|
| 5 | And I would like to see courts, led by the
|
| 6 | Supreme Court, say, look, we really have not sorted out
|
| 7 | yet what administrable concrete tests we need to apply for
|
| 8 | Section 2 liability. For the time being let's do
|
| 9 | so-and-so, but that's not meant to be the final answer.
|
| 10 | Because I think it's pretty clear that nobody is
|
| 11 | in a position to say yet what the final answer should be.
|
| 12 | And I think there's a huge danger, given the way courts
|
| 13 | and lawyers tend to think and talk, that things are going
|
| 14 | to congeal prematurely.
|
| 15 | MR. COHEN: I'm wondering if you're at a point
|
| 16 | yet where you could predict if there are particular types
|
| 17 | of conduct where the analysis you're thinking of is really
|
| 18 | likely to lead to different results than you've been
|
| 19 | getting through viewing perfect competition as the goal?
|
| 20 | You may go through a different process. Do you have any
|
| 21 | idea where the results are likely to come up?
|
| 22 | MR. FARRELL: No. I think the salient
|
| 23 | differences are going to be based on the question of how
|
| 24 | closely you try to examine direct efficiency consequences
|
| 25 | versus trusting the competitive process to do that and not |
72
| 1 | requiring it in the narrow instance.
|
| 2 | You know, technically if there is a perfectly
|
| 3 | competitive equilibrium in an economy, it is then in the
|
| 4 | core. And so I don't think there is a substantive
|
| 5 | tension between the two. I think it's more a question of
|
| 6 | what process each one suggests to you.
|
| 7 | It seems to me the core -- and let me stress,
|
| 8 | I'm not suggesting ever examining an outcome to see
|
| 9 | whether it is in the core. I'm suggesting the process
|
| 10 | that is suggested by that, which is, make it relatively
|
| 11 | easy, or don't allow it to be made artificially difficult
|
| 12 | to form blocking coalitions.
|
| 13 | Whether there is a similar process that is
|
| 14 | suggested by thinking about perfect competition, I am not
|
| 15 | quite so sure. You know, economists have talked for a
|
| 16 | long time about the fact that perfect competition is
|
| 17 | describable as an outcome, and we don't have a very good
|
| 18 | story about how you get there. There's the infamous
|
| 19 | Walrasian auctioneer. That's obviously not a process that
|
| 20 | takes place in reality, let alone is protectable by
|
| 21 | antitrust.
|
| 22 | It seems to me that thinking about the coalition
|
| 23 | formation model gives you a stronger suggestion about what
|
| 24 | process to protect than thinking about perfect
|
| 25 | competition. |
73
| 1 | MR. EDLIN: I'll hazard a guess, which is, if
|
| 2 | you thought about things a little more the way that Joe
|
| 3 | and I think about things, then you would find that the
|
| 4 | Department of Justice would probably have won the American
|
| 5 | Airlines case; that entry would be easier in many
|
| 6 | industries because monopoly or dominant firms would have
|
| 7 | more limited ability to thwart entry; more attempts by
|
| 8 | monopolies to prevent entry by tying goods together would
|
| 9 | be illegal, but not all; and those would be the kinds of
|
| 10 | things that you would see in terms of substantive outcome
|
| 11 | differences.
|
| 12 | MR. SHELANSKI: I will just add that I think the
|
| 13 | process emphasis, while extremely important theoretically
|
| 14 | and at some level is absolutely correct economically does
|
| 15 | have some pragmatic difficulties.
|
| 16 | I actually really worry about instructing juries
|
| 17 | on the process as opposed to outcomes. And you can
|
| 18 | combine the two to halve their inquiry, but I think the
|
| 19 | confusion between competition and competitor is one very
|
| 20 | easily sown in juries.
|
| 21 | And connected to your question earlier about
|
| 22 | false positives, I think that as a firm, faced
|
| 23 | particularly with a private suit, knowing the instruction
|
| 24 | is going to the jury about process, you're worried about
|
| 25 | looking aggressive, worried about looking the bad guy, and |
74
| 1 | you get a lot of hidden false positives through
|
| 2 | settlement, particularly in the private cases.
|
| 3 | So, I do think it's worth thinking a lot more
|
| 4 | about the pragmatic implications of the process
|
| 5 | instruction of going forward.
|
| 6 | MR. COHEN: Finally, for Joe.
|
| 7 | The theory that you've explained depends on the
|
| 8 | formation of these blocking coalitions. There are
|
| 9 | obviously impediments to this. You recognize them and
|
| 10 | they may not always be formed, but at least there's an
|
| 11 | incentive to do them.
|
| 12 | Have you thought about how we should take into
|
| 13 | account the fact that not all of these coalitions will
|
| 14 | ever form in the first place, that there maybe information
|
| 15 | problems or the cost that prevents them from happening?
|
| 16 | How do we bridge from incentive to actual assumption that
|
| 17 | they're there and therefore that their losses are
|
| 18 | significant?
|
| 19 | MR. FARRELL: I don't. I mean, I think, as I
|
| 20 | think I mentioned, the way you prove that a competitive --
|
| 21 | that everything in the core is Pareto efficient, is by
|
| 22 | pointing to the so-called grand coalition of everybody, if
|
| 23 | it was prey to inefficient, then in theory this grand
|
| 24 | coalition could block. That's obviously not going to
|
| 25 | happen. |
75
| 1 | So, I think any policy, including antitrust, is
|
| 2 | not going to be able to get us all the way to Pareto
|
| 3 | efficiency, whether it thinks of it in terms of central
|
| 4 | planning, price-taking equilibrium or the core.
|
| 5 | Now, as related more directly on a practical
|
| 6 | point, which is, well, what happens if -- this is I think
|
| 7 | maybe what you were getting at with the bad act question.
|
| 8 | What happens if we have a not very good outcome in the
|
| 9 | status quo and the blocking coalition that, quote, ought
|
| 10 | unquote, to form doesn't form, not because of anything
|
| 11 | that the incumbent does, but just because it's really hard
|
| 12 | to form.
|
| 13 | Well, I think at some level that could be a
|
| 14 | competition policy question. There might be changes that
|
| 15 | could be made in the way the market works to make it more
|
| 16 | likely that such coalitions would form.
|
| 17 | If it were a competition policy question, it
|
| 18 | wouldn't necessarily be an antitrust question. I think
|
| 19 | they're potentially distinct areas. And it might be
|
| 20 | neither. It might just be, well, that's too bad, that's
|
| 21 | one of the imperfections of the world.
|
| 22 | MR. MATELIS: At the beginning of these
|
| 23 | hearings, both the Assistant Attorney General and the
|
| 24 | Chairman of the FTC stressed the importance of safe
|
| 25 | harbors for guiding businesses that are seeking to comply |
76
| 1 | with the antitrust laws.
|
| 2 | And, Joe, I have a question for you. The
|
| 3 | examples in your presentation were responses of a firm to
|
| 4 | new entry. Northeast's response to Sprite's entry and the
|
| 5 | A and B product potential responses at the new entry.
|
| 6 | Are there responses to new entry that, you know,
|
| 7 | looking at things through the core, should be within a
|
| 8 | safe harbor and something that firms should always feel
|
| 9 | comfortable doing?
|
| 10 | MR. FARRELL: Well, I'm sure there are, but just
|
| 11 | as I don't know exactly what the right rules for
|
| 12 | liabilities should be in a practical sense here, I also
|
| 13 | don't know what the right rules for safe harbor should be.
|
| 14 | I mean, one can give the following answer, which
|
| 15 | is sort of in the spirit of something Tim Bresnahan has
|
| 16 | said, and you will be hearing from him this afternoon,
|
| 17 | that the safe harbor is to make your money by being nice
|
| 18 | to consumers, not to make your money by being the other
|
| 19 | stuff you can be. That's not quite the way Tim put it,
|
| 20 | but he had a somewhat similar line which maybe you can get
|
| 21 | out of him if you ask him.
|
| 22 | MR. COHEN: Directing some questions to Howard
|
| 23 | Shelanski's presentation.
|
| 24 | You focused very much on intellectual property,
|
| 25 | the effects of possible changes in that area, bleeding |
77
| 1 | over into how we might look at Section 2 issues.
|
| 2 | If we're looking at Section 2 issues, we're not
|
| 3 | likely to have differential treatment of instances in
|
| 4 | which there are lateral refusals for intellectual
|
| 5 | properties versus others.
|
| 6 | Would your rule somehow -- are you envisioning
|
| 7 | somehow distinguishing between the two, or just a one size
|
| 8 | fits all modification?
|
| 9 | MR. SHELANSKI: One size fits all is what I'm
|
| 10 | looking at. I'm actually not so much proposing a
|
| 11 | particular rule, because I agree with you there should not
|
| 12 | be two rules. Obviously the precedent is a little choppy
|
| 13 | between the various circuit courts on the extent to which
|
| 14 | you get special Section 2 protections for intellectual
|
| 15 | property.
|
| 16 | But my view is you should not have a separate
|
| 17 | rule. And I was really looking at the macro level. If
|
| 18 | you take the total pool of goods that firms refuse to deal
|
| 19 | with, some of them are going to impose barriers because
|
| 20 | they're legally protected, legally blocked by IP.
|
| 21 | The smaller the pool of goods where there's an
|
| 22 | anticompetitive refusal to deal, the less enforcement
|
| 23 | minded you want to be against refusals to deal.
|
| 24 | So, for me it's really an adjustment mechanism
|
| 25 | about how permissive or strict a unitary rule you apply. |
78
| 1 | I mean, if you were to look and see, boy, a lot of these
|
| 2 | refusals to deal cases have at their core intellectual
|
| 3 | property. Then I think intellectual property would not,
|
| 4 | say, have a different rule for those cases versus others,
|
| 5 | but it would say we can have a more permissive rule
|
| 6 | towards refusals if we had intellectual property
|
| 7 | enforcement.
|
| 8 | MR. COHEN: One thing that you mentioned a
|
| 9 | number of times in your talk was issues about the degree
|
| 10 | to which imposing liability or not imposing liability for
|
| 11 | refusals to deal might affect innovation, might affect
|
| 12 | efforts invent around whatever problem there is.
|
| 13 | It's a little unfair, I know you gave a
|
| 14 | theoretical presentation, but of course we're very
|
| 15 | interested in anything empirical.
|
| 16 | Do you have any -- can you give any summary or
|
| 17 | are there any indications of what there is out there in
|
| 18 | the way of empirical evidence on this?
|
| 19 | MR. SHELANSKI: If I can cheat a little bit, I
|
| 20 | think I can. So, I did raise that issue of demand side
|
| 21 | innovation and competitive supply because I feel that in
|
| 22 | the discussion about duties to deals there's been
|
| 23 | overemphasis on deterring the initial innovation by the
|
| 24 | supplier. I think that's extremely important. And I
|
| 25 | wouldn't want to see a situation where we punished |
79
| 1 | innovation per se. So, I want to be very careful. But I
|
| 2 | wanted to build into the demand side there's innovation on
|
| 3 | both sides of the enforcement question.
|
| 4 | So, here's a possible place to look for some
|
| 5 | empirical support, and this is contentious. I would go to
|
| 6 | the regulatory arena and I would look at the unbundling
|
| 7 | obligations of the Telecommunications Act of 1996.
|
| 8 | There are allegations that overly permissive
|
| 9 | access for competitors to incumbent networks reduced the
|
| 10 | degree to which these new entrants built their own
|
| 11 | facilities and their own networks, therefore leading to
|
| 12 | less vigorous competitive entry.
|
| 13 | I think there's a lot of debate over the extent
|
| 14 | to which this is true, but there is some empirical
|
| 15 | evidence that after the FCC repealed a very permissive
|
| 16 | access to the incumbent platform under what some would
|
| 17 | argue were subsidized rates -- there is a legitimate
|
| 18 | dispute over that -- that after they repealed that access,
|
| 19 | there was a lot more facilities-based entry, a lot more
|
| 20 | actual building and installment of competitive facilities.
|
| 21 | This does suggest that a duty to deal, which
|
| 22 | would then include some kinds of terms of dealing, runs
|
| 23 | the risk of stopping entry of competitive assets into
|
| 24 | other markets. And the telecommunications market might be
|
| 25 | one place to look for such evidence. And there is some |
80
| 1 | literature out there with competing arguments about
|
| 2 | whether the essential facilities treatment or the duty to
|
| 3 | deal imposed by the Telecommunications Act of 1996 on
|
| 4 | incumbent networks deterred and chased out new competitive
|
| 5 | essence.
|
| 6 | MR. FARRELL: I think part of the reason why
|
| 7 | people have focused on incentives of the original
|
| 8 | invention or the original investment is that, of course,
|
| 9 | that innovation or investment directly leads to social
|
| 10 | benefits.
|
| 11 | Duplicative investment is -- I want to avoid
|
| 12 | taking too narrow a view here, but nevertheless, at some
|
| 13 | level duplicative investment is wasteful. And while
|
| 14 | having some of it may well be part of the process and
|
| 15 | negotiating for voluntary access in the shadow of the
|
| 16 | threat when you look at the investment is probably a
|
| 17 | bigger part of the process, I think it's actually wrong to
|
| 18 | treat reducing the incentive for duplicative investment as
|
| 19 | a policy downside in itself.
|
| 20 | Now, it might actually be a kind of shorthand or
|
| 21 | a proxy for some other harms that you think come out of
|
| 22 | more mandated sharing than other policies would give you.
|
| 23 | But I think one wants to be wary of that shorthand.
|
| 24 | MR. SHELANSKI: I'll disagree slightly. I think
|
| 25 | you're right that that's something to be taken into |
81
| 1 | account.
|
| 2 | I think the market conditions under which that
|
| 3 | duplicative entry would be welfare decreasing are fairly
|
| 4 | specialized. I don't know how common they are. I think
|
| 5 | it needs to be taken into account. But while it's a
|
| 6 | consideration, I am not sure that it's a big enough
|
| 7 | problem that I would discount -- I certainly wouldn't
|
| 8 | discount the value of at least some competitive investment
|
| 9 | or duplicative investment, especially where it's not
|
| 10 | economically blocked. There's not some kind of natural
|
| 11 | monopoly or scale kind of argument that would make that
|
| 12 | investment a not be beneficial end, but where there's
|
| 13 | simply a legal barrier to producing something that could
|
| 14 | be produced fairly cheaply. Software would be an example.
|
| 15 | MR. COHEN: Just one more. I'm going to return
|
| 16 | to something that Joe just mentioned a couple answers ago.
|
| 17 | You drew the distinction in a sense between a
|
| 18 | competition issue and an antitrust issue. Another way of
|
| 19 | phrasing some of the same points we've already been going
|
| 20 | over.
|
| 21 | To the panel just generally: Do you see a
|
| 22 | difference in your analysis between a competition issue in
|
| 23 | the sense of maximizing efficiency, and an antitrust issue
|
| 24 | in the sense of what should be a legal violation?
|
| 25 | MR. FARRELL: I'm certainly very open to that, I |
82
| 1 | think. First of all, I would not phrase a competition
|
| 2 | issue quite as maximizing efficiency, for all the reasons
|
| 3 | we spent all morning talking about.
|
| 4 | But I think it's perfectly possible for a
|
| 5 | competition agency, let's say, to discover that
|
| 6 | such-and-such a market would work a lot more competitively
|
| 7 | with these ground rules than with those ground rules. And
|
| 8 | to try to use its influence, perhaps even its legal
|
| 9 | authority, to have the better rules rather than the less
|
| 10 | good rules apply.
|
| 11 | And that doesn't necessarily involve anybody
|
| 12 | having, quote, done anything wrong. And so I think
|
| 13 | there's potentially a difference between competition would
|
| 14 | work better in such-and-such a way than with the status
|
| 15 | quo, and saying so-and-so has committed an antitrust
|
| 16 | offense.
|
| 17 | So, yes, I think there's probably a big area
|
| 18 | there, actually.
|
| 19 | MR. COHEN: Okay. Do any of the panelist have
|
| 20 | any final points they want to make?
|
| 21 | MR. EDLIN: I'm in favor of lunch.
|
| 22 | MR. COHEN: Okay, we vote for lunch here.
|
| 23 | I again want to thank all of our panelists for
|
| 24 | their thoughtful and insightful remarks. I ask the
|
| 25 | audience to please join me in a round of applause for our |
83
| 1 | speakers.
|
| 2 | (Applause.)
|
| 3 | MR. COHEN: And our afternoon session will begin
|
| 4 | promptly at 1:30.
|
| 5 | (Whereupon, at 11:59 a.m., a lunch recess was
|
| 6 | taken.)
|
| 7 |
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
84
| 1 | AFTERNOON SESSION
|
| 2 | (1:30 P.M.)
|
| 3 | MS. GRIMM: Good afternoon. I would like to
|
| 4 | welcome everyone to our afternoon session. And I'm glad
|
| 5 | that you all could be with us today.
|
| 6 | I am Karen Grimm. I am Assistant General
|
| 7 | Counsel for Policy Studies at the Federal Trade
|
| 8 | Commission. I am going to be moderating the session this
|
| 9 | afternoon, along with June Lee, who is an economist at the
|
| 10 | Antitrust Division of the U.S. Department of Justice.
|
| 11 | Before we start, I would like to just go through
|
| 12 | two housekeeping details. First of all, as a courtesy to
|
| 13 | our speakers, please turn off all your cell phones,
|
| 14 | Blackberries, and other devices
|
| 15 | And, secondly, because these are hearings, we
|
| 16 | request that the audience not make any comments or ask any
|
| 17 | questions during the presentation.
|
| 18 | This afternoon we are honored to have another
|
| 19 | group of distinguished economists from the University of
|
| 20 | California at Berkeley and Stanford University to offer
|
| 21 | their testimony in these series of Section 2 hearings.
|
| 22 | Our afternoon panelists, like those this
|
| 23 | morning, will provide their perspectives on various issues
|
| 24 | related to the complex area of Section 2 jurisprudence and
|
| 25 | enforcement. |
85
| 1 | Our panelists this afternoon are Timothy
|
| 2 | Bresnahan, who is the Landau Professor of Technology and
|
| 3 | the Economy in the economics department at Stanford
|
| 4 | University; Richard Gilbert, who is a professor of
|
| 5 | economics at the University of California Berkeley and the
|
| 6 | chair of the Berkeley Competition Policy Center; Daniel
|
| 7 | Rubinfeld, who is the Robert L. Bridges Professor of Law
|
| 8 | and Professor of Economics at the University of California
|
| 9 | Berkeley; and Carl Shapiro, who is the TransAmerica
|
| 10 | Professor of Business Strategy and Professor of Economics
|
| 11 | and the Director of the Institute of Business and Economic
|
| 12 | Research at the University of California Berkeley.
|
| 13 | Our first three panelists will make
|
| 14 | presentations, and Professor Shapiro will be participating
|
| 15 | in the discussion with his fellow panelists.
|
| 16 | Our format this afternoon is as follows: Each
|
| 17 | speaker will make a 20 to 30 minute presentation. After
|
| 18 | all the presentations have been completed, we will take
|
| 19 | about a 15 minute break. And after that break we will
|
| 20 | reconvene for a round-table discussion. We are scheduled
|
| 21 | to conclude this session about 4:30.
|
| 22 | I would like to thank all of you for being with
|
| 23 | us here today. I want to thank all of our panelists for
|
| 24 | coming and for their participation. We very much
|
| 25 | appreciate the time and effort all of them have put into |
86
| 1 | preparing their presentations and their willingness to
|
| 2 | share their insights with us.
|
| 3 | I would now like to turn the podium over to my
|
| 4 | DOJ colleague and co-moderator, June Lee, for any remarks
|
| 5 | she would like to make
|
| 6 | Ms. Lee: The Antitrust Division of the
|
| 7 | Department of Justice is pleased to co-sponsor today's
|
| 8 | single-firm conduct hearing. As noted by Joe Matelis this
|
| 9 | morning, five of today's panelists were Deputy Assistant
|
| 10 | Attorneys General in the Antitrust Division. Four of the
|
| 11 | five are in the panel. I thank them for participating
|
| 12 | and, like Karen, for sharing their insights. I look
|
| 13 | forward to their presentations in what I'm sure will be a
|
| 14 | lively discussion.
|
| 15 | I join Joe in thanking the Competition Policy
|
| 16 | Center and the Berkeley Center For Law And Technology at
|
| 17 | the University of California Berkeley for hosting these
|
| 18 | hearings. And I thank Karen and her colleagues at the FTC
|
| 19 | for their work in organizing today's hearing and
|
| 20 | assembling the august panel we have today.
|
| 21 | Karen.
|
| 22 | MS. GRIMM: Our first speaker this afternoon is
|
| 23 | Timothy Bresnahan, who is Landau Professor of Technology
|
| 24 | and the Economy at Stanford University and Chair of the
|
| 25 | department of economics. |
87
| 1 | He is Director of the Center for Research in
|
| 2 | Employment and Economic Growth in the Stanford Institute
|
| 3 | for Economic Policy Research. He also has served as Chief
|
| 4 | Economist of the Antitrust Division of the U.S. Department
|
| 5 | of Justice.
|
| 6 | His research interests lie in the economic of
|
| 7 | industry, especially of high technology industry.
|
| 8 | Professor Bresnahan received his B.A. from
|
| 9 | Haverford College and his master's degree and Ph.D. in
|
| 10 | economics from Princeton University.
|
| 11 | Tim.
|
| 12 | MR. BRESNAHAN: Thanks for that very nice
|
| 13 | introduction. Let me see if I can find my slides.
|
| 14 | While I'm finding my slides, let me confess that
|
| 15 | in my role as department chair, I worked with the agencies
|
| 16 | in a failed effort to bring these hearings to Stanford
|
| 17 | rather than Berkeley. If you think of the reputations of
|
| 18 | those two great universities, you might infer that signals
|
| 19 | a leftward shift in the antitrust enforcement effort.
|
| 20 | But I don't think that's what it signals. If
|
| 21 | you either look over here to my left or at the brochure
|
| 22 | from the Competition Policy Center, you can see why
|
| 23 | Berkeley is an enormous center of academic influence in
|
| 24 | this area. This was the right place to put it.
|
| 25 | I want to talk about monopolization (Section 2) |
88
| 1 | cases. And my real agenda is to normalize them, to
|
| 2 | regularize them within antitrust analysis.
|
| 3 | We have a tendency in talking about Section 2
|
| 4 | matters to immediately leap to the most difficult part,
|
| 5 | which is the part that's about alternative efficiency
|
| 6 | theories of whatever business practice it is that's
|
| 7 | challenged in the Section 2 matter.
|
| 8 | I think that that makes Section 2 matters more
|
| 9 | difficult than they need to be, and I'm going to propose a
|
| 10 | different approach, not inconsistent with what we've
|
| 11 | done in the past, and which we'll see in a minute, not
|
| 12 | inconsistent with recent court decisions.
|
| 13 | I'm going to suggest a different approach where
|
| 14 | we look at competitive effects first. It's not very
|
| 15 | surprising that I want to look at competitive effects
|
| 16 | first since I'm an economist.
|
| 17 | And then I think I'm going to argue it's going
|
| 18 | to make thinking about whether a Section 2 case is
|
| 19 | procompetitive much easier than starting from that very
|
| 20 | difficult question of whether the challenged practices are
|
| 21 | an act of competing rather than anticompetitive act. So,
|
| 22 | I'm going to start with competitive effects.
|
| 23 | There's been a good bit of action in the courts
|
| 24 | in Section 2 lately. You know, I see three big topics
|
| 25 | here: boundaries with other parts of the law, notably with |
89
| 1 | patent and copyright law; predatory pricing is another area.
|
| 2 | What I want to talk about are bundling and
|
| 3 | related practices. So, vertical Section 2 cases where a
|
| 4 | monopolist commits monopolization or is alleged to
|
| 5 | commit monopolization through bundling its monopoly
|
| 6 | product with something else, or through contractual
|
| 7 | restrictions that amount to de facto bundling.
|
| 8 | I'm also going to talk about Microsoft and
|
| 9 | Dentsply in some detail, but Dentsply first. This partly
|
| 10 | reflects the idea that I think that the folks who do
|
| 11 | judicial decisions have the same economics in mind that
|
| 12 | I'm going to talk about this afternoon. And it's partly
|
| 13 | that there are three cases, two recent cases in this area.
|
| 14 | And I found those two, again another confession, much
|
| 15 | easier to read than I found the LePage's case, which was a
|
| 16 | struggle for me, although I am not sure it's inconsistent
|
| 17 | with what I'm going to say.
|
| 18 | So, any Section 2 inquiry I think has at its
|
| 19 | heart an economic structure if it's a rule of reason
|
| 20 | inquiry. Any rule of reasoning inquiry has economics in
|
| 21 | it. I think the economics enters at two distinct places.
|
| 22 | It has to enter in market power. You need economists to
|
| 23 | figure out market power. And I want to say, as I've been
|
| 24 | saying for a quarter of a century, the thing about market
|
| 25 | power is sometimes it's a useful shortcut in antitrust |
90
| 1 | enforcement. We should be thinking about competitive
|
| 2 | effects when we're thinking about market power, particularly
|
| 3 | I would encourage the agencies, when picking cases in the
|
| 4 | merger area or in the Section 2 area, to pick cases where
|
| 5 | there's potentially a substantial change in the conditions
|
| 6 | of competition in the market and significant impact on the
|
| 7 | economy. That's not the same as market power. That's a
|
| 8 | change in market power.
|
| 9 | The other place where economics matters is in
|
| 10 | thinking about the causal flow from the acts which are
|
| 11 | alleged to be anticompetitive in a Section 2 case to the
|
| 12 | changes in market power. And I'm going to argue, this is
|
| 13 | my theme for the afternoon, you can gain a lot of clarity
|
| 14 | about a Section 2 case by bringing the competitive effects
|
| 15 | and causation arguments to the forefront. And I think that's
|
| 16 | consistent with the three bundling cases I cited, bundling
|
| 17 | or tying cases, I cited on the previous page.
|
| 18 | Section 2 cases are never going to be easy.
|
| 19 | Let's be real. There's a reason for that. This is I
|
| 20 | think the hardest part. Almost all conduct which would be
|
| 21 | exclusionary in some context would be an ordinary and
|
| 22 | competitive business practice in some other industry. So,
|
| 23 | it's necessarily context specific. That makes it
|
| 24 | difficult I think for attorneys to get their heads around
|
| 25 | Section 2 matters all the time because it seems like |
91
| 1 | there's a fairly unstructured rule of reason analysis in a
|
| 2 | Section 2 case.
|
| 3 | I'm going to argue again that monopolization can
|
| 4 | lead you to a fairly structured economic competitive
|
| 5 | effects decision. Let me do that right away. I'll do it
|
| 6 | in Dentsply first.
|
| 7 | This is a Department of Justice case. I know a
|
| 8 | part of the history of it. I believe it was brought when
|
| 9 | Dan Rubinfeld was Chief Economist. It was litigated when
|
| 10 | I was Chief Economist. And I just learned from Professor
|
| 11 | Shapiro that it was under investigation on his watch.
|
| 12 | MR. GILBERT: It was under investigation at the
|
| 13 | FTC before I was at DOJ.
|
| 14 | MR. BRESNAHAN: Exactly. We are lucky that
|
| 15 | prefabricated artificial teeth is not a market which
|
| 16 | changed quite so quickly as computer software. But I note
|
| 17 | that the other case I am going to talk about, Microsoft,
|
| 18 | has a similarly long, long series of investigations before
|
| 19 | there was a serious enforcement action.
|
| 20 | So, what's the story of Dentsply? Why did the
|
| 21 | Department of Justice bring a Section 2 action?
|
| 22 | So, part of it, there is a market definition,
|
| 23 | there is monopoly power, and there is, in the current
|
| 24 | market, a monopoly in prefabricated artificial teeth.
|
| 25 | There are some small sellers, but there is one great big |
92
| 1 | seller named Dentsply.
|
| 2 | Now, here's the competitive effects part. And
|
| 3 | this is something I think that's a reason that's going to
|
| 4 | make cases fairly rare in monopolization. While there is
|
| 5 | a monopoly in prefabricated artificial teeth, there could
|
| 6 | be substantially more competition in the market from a
|
| 7 | number of non-Dentsply like artificial teeth -- prefab
|
| 8 | artificial teeth providers who are smaller, very small at
|
| 9 | the time the case was brought, and typically lower priced.
|
| 10 | And it's the difference between the competitive
|
| 11 | regime there is, monopoly, and the competitive regime
|
| 12 | there could be, much less monopoly, which is the
|
| 13 | competitive effect that I think we should bring to the
|
| 14 | forefront.
|
| 15 | If it's inevitable, if Dentsply has a
|
| 16 | monopoly that cannot be changed, if there is some barrier to
|
| 17 | entry which cannot be lowered by any earthly force, there
|
| 18 | can still be a monopoly but how can there be
|
| 19 | monopolization? Monopolization I think needs to be
|
| 20 | cause of a change in the competitive regime or prevention of
|
| 21 | the change to a competitive regime that otherwise might arise.
|
| 22 | Now, in this case, the mechanism, you need a bad
|
| 23 | act as well as a competitive effect to have a Section 2
|
| 24 | case. The mechanism by which Dentsply prevented the
|
| 25 | emergence of competition from these other firms was |
93
| 1 | exclusive contracts with dealers. They were dealers who
|
| 2 | supply dental laboratories with all kinds of things, but
|
| 3 | in particular with prefabricated artificial teeth. And
|
| 4 | those contracts block the laboratory from sourcing another
|
| 5 | firm's teeth, preventing the American consumer from
|
| 6 | having an effective prefabricated tooth choice.
|
| 7 | You know, there's a market in everything. Some
|
| 8 | of it might be competitive. As you get older, you get
|
| 9 | more serious about the importance of health care markets
|
| 10 | for having a competitive organization. And, Lord knows,
|
| 11 | there is not enough competition in most health care markets.
|
| 12 | So, I want to bring to the forefront, the
|
| 13 | horizontal competitive effects. Impact, if there's a
|
| 14 | Section 2 case, the impact of the bad acts, the contracts
|
| 15 | in this case, is to reduce competition in the market for
|
| 16 | prefab artificial teeth. So, it's possible that there are
|
| 17 | two competitive regimes, one with monopoly and the other
|
| 18 | with competition.
|
| 19 | And I want to push to the second, the vertical
|
| 20 | restraints logic, that the economic effects of these
|
| 21 | contracts, these exclusive contacts, is to change that
|
| 22 | competitive regime.
|
| 23 | You know, it seems to me that you can, in the
|
| 24 | course of investigating an alleged Section 2 violation,
|
| 25 | discard an enormous number of cases just by thinking about |
94
| 1 | -- not about the efficiency theory of the supposed bad
|
| 2 | act, but rather just thinking about the anticompetitive
|
| 3 | theory. The inquiry would ask: is it possible that there
|
| 4 | could be less competition and also there could be more
|
| 5 | competition in this industry? Is it possible that if the
|
| 6 | dealer contracts weren't exclusive that then there
|
| 7 | could be competition? Without a "yes" to both, further
|
| 8 | inquiry is not going to lead a Section 2 case. The second
|
| 9 | question, the exclusivity of the dealer contracts having
|
| 10 | sufficient impact to change the compeitive regime, that is
|
| 11 | not a small inquiry. There is a lot of assumptions under
|
| 12 | there.
|
| 13 | There are at least two base assumptions. The
|
| 14 | monopolist, Dentsply, is in a position to compel the
|
| 15 | dealers to accept these exclusive contracts. That's not
|
| 16 | going to be true in all industries. There can't, for example,
|
| 17 | be the possibility of some other parallel distribution segment
|
| 18 | which can grow up and distribute the competitive prefab
|
| 19 | teeth. Furthermore, while the distribution channel firms must
|
| 20 | not be in a position to resist Dentsply, Dentsply's competitors
|
| 21 | must need the distribution channel. Thus, the distribution
|
| 22 | channel must be dependant upon Dentsply but depended upon by
|
| 23 | the competitors. Not all distribution channels will satisfy
|
| 24 | both conditions. So, there's a reason that these exclusive
|
| 25 | dealership contractors have bite. Bite, it was entirely |
95
| 1 | accidental pun. I think if we could go down the path of the
|
| 2 | Dentsply puns, they would be very unhappy for us.
|
| 3 | But I mean to emphasize that there are two
|
| 4 | dualities just in the competitive effects part of a
|
| 5 | Section 2 case, which means, before you get to the hard thing
|
| 6 | about efficiencies, you could throw a lot of cases out. It
|
| 7 | has to be possible that there's two competitive regimes,
|
| 8 | monopoly and more competitive, and it has to be possible
|
| 9 | that the bad act works to move the market between them,
|
| 10 | and that itself has two steps. The little guys, the
|
| 11 | potential competitive providers of these competitive teeth,
|
| 12 | have to need the distributors. The distributors need to be a
|
| 13 | powerful hard-to-replace force. And the existing monopolist,
|
| 14 | Dentsply, has to be able to kick around the distributors.
|
| 15 | So, you've got two dualities, it's monopoly, but
|
| 16 | it might be more competitive. And the distributors are
|
| 17 | important, but the monopolist is in a position to either
|
| 18 | bribe them or compel them to prevent the outbreak of
|
| 19 | competition, competition which would be plausibly in their
|
| 20 | interests.
|
| 21 | Those two dual tests I think will weed out a lot
|
| 22 | of cases before you begin this open-ended discussion of
|
| 23 | whether these particular contracts are efficient. So,
|
| 24 | here is how I graph it. You've got -- your centerpiece
|
| 25 | should be the anticompetitive effects. So, in |
96
| 1 | monopolization case, the effects are anticompetitive.
|
| 2 | There is an exclusionary act, in this case the contracts,
|
| 3 | which is keeping us in a higher market power monopoly, in
|
| 4 | this case industry regime rather than a lesser market
|
| 5 | power.
|
| 6 | And, as I said, that's a lot for the plaintiff
|
| 7 | to show. In the case of the agencies, that's a lot for
|
| 8 | them to show. And I want to urge a review of whether we
|
| 9 | can show these things early in a case. When I said to
|
| 10 | kind of regularize Section 2 review, you know, it's just
|
| 11 | like merger review, is there a competitive effect this merger
|
| 12 | is going to do? Is there a competitive effect these are bad
|
| 13 | practices are going to have, too? Is it really true that
|
| 14 | there is more market power in the current regime but there
|
| 15 | could be less market power? And that is the centerpiece,
|
| 16 | that there is this causation, there's these
|
| 17 | exclusive contracts, which exist because the existing
|
| 18 | monopolist wants to maintain a monopoly, or what's keeping
|
| 19 | us in the less competitive regime rather than the more
|
| 20 | competitive regime.
|
| 21 | And I think if you do both that causation
|
| 22 | carefully and that competitive effects carefully that
|
| 23 | would make Section 2 cases look a lot more like ordinary
|
| 24 | antitrust analysis.
|
| 25 | So, I said a number of times that that's a lot |
97
| 1 | to show. It has to be possible that the competitive
|
| 2 | regime could change; it has to be possible that the bad
|
| 3 | acts are what's preventing the competitive regime from
|
| 4 | changing; there has to not be another explanation of why
|
| 5 | the competitive regime is not changing.
|
| 6 | We spend so much time in Section 2. Here's my
|
| 7 | one slide. I think I only have one slide and it's sort of
|
| 8 | ordinary analysis. We spend so much time thinking about
|
| 9 | whether there's an efficiency theory of the
|
| 10 | anticompetitive acts. And that is important. But, you
|
| 11 | know, I guess I would say, solve the problem with whether
|
| 12 | there's a harm to competition first and then worry about
|
| 13 | if there's an efficiency theory.
|
| 14 | A lot of this efficiency discussion -- and here
|
| 15 | I'm echoing Professor Farrell's earlier remarks in these
|
| 16 | hearings -- we're driving in the direction of that world
|
| 17 | of pure economic theory where we can figure out in a
|
| 18 | quantitatively precise and reliable way whether
|
| 19 | the consumer of the industry is better off with the
|
| 20 | existing industry structure, including its contracts,
|
| 21 | versus some counterfactual regime where the contracts
|
| 22 | would be gone and there would be less efficiency
|
| 23 | presumably from the contracts, but also more competition.
|
| 24 | In economic theory, the author of the model knows
|
| 25 | everything and could calculate how well off consumers are in |
98
| 1 | another world. In the real world, the ability of
|
| 2 | empirical economics, even with the very high level of
|
| 3 | inquisitory abilities of the enforcement agencies to figure
|
| 4 | out what would happen in that but-for world in enough detail
|
| 5 | to calculate social welfare seems to me to be a waste of
|
| 6 | time.
|
| 7 | So, I would say, plaintiff has to show that
|
| 8 | there is an anticompetitive effect and that it's causal.
|
| 9 | And defendant gets to rebut that. Defendant has to show
|
| 10 | that their practices are efficient. Plaintiff gets to
|
| 11 | rebut that.
|
| 12 | If the world is not tired of hearing from me
|
| 13 | about the Microsoft case, let me talk about that one too.
|
| 14 | I mostly want to emphasize its parallels to Dentsply.
|
| 15 | Again, my competitive effects story is in the
|
| 16 | graph here, I think I'm very close to the D.C. Circuit's
|
| 17 | logic here. The competitive story is slightly different
|
| 18 | because the industries are slightly different. And this is
|
| 19 | one of the inevitable costs of Section 2. Section 2 cases
|
| 20 | are rare. They arise in those industries where there is the
|
| 21 | possibility of a big change in competitive circumstances.
|
| 22 | That's not most industries and that's probably
|
| 23 | idiosyncratic industries. Certainly these two, the teeth
|
| 24 | and the software, are both idiosyncratic.
|
| 25 | So, what's the state of the market? There is a |
99
| 1 | Windows monopoly in operating systems on PCs. That was
|
| 2 | true when the case was brought. I got the year wrong. It
|
| 3 | was tendered to the Department of Justice in 1997 or so.
|
| 4 | There could have been dynamic competition for the operating
|
| 5 | system market if the mass use of the Internet led to new
|
| 6 | standards in new markets.
|
| 7 | So, here -- well, in the case of Dentsply, there
|
| 8 | was a monopoly and could have been competition in the
|
| 9 | market for prefab artificial teeth. In the case of
|
| 10 | operating system software, there is a monopoly and the
|
| 11 | industry in the past had had dynamic competition where
|
| 12 | entrants in many important software products had replaced
|
| 13 | incumbents. And in other important software markets, they
|
| 14 | had given incumbents a terrible scare and created
|
| 15 | incentives to get some real innovation out of them. In
|
| 16 | these software markets, there is persistent static
|
| 17 | monopoly, but there could be the prospect of
|
| 18 | Schumpeterian competition. So, that's the two competitive
|
| 19 | regimes that you get the competitive effects on.
|
| 20 | The other part of Microsoft is really quite
|
| 21 | similar to Dentsply. What kept the world in the monopoly
|
| 22 | regime rather than in the potentially more competitive
|
| 23 | regime, a regime where say a Linux might have taken a run
|
| 24 | at the position of Microsoft Windows on the desktop?
|
| 25 | It was a distribution case just like Dentsply, |
100
| 1 | how could actual distributors, and a wide number of
|
| 2 | different kinds of complementors, with other third parties
|
| 3 | that would have worked with something like Linux on the
|
| 4 | desktop prevented a market test for the Internet entrepreneurs,
|
| 5 | and thereby ultimately prevented Schumpeterian competition in
|
| 6 | the operating systems market.
|
| 7 | So, again, this is the stuff that the Antitrust
|
| 8 | Division had to prove in Microsoft. That's why it's such a
|
| 9 | long case. Two potential competitive regimes. One, the
|
| 10 | present one in operating systems and other infrastructure
|
| 11 | software on the PC, which is about ten years you've had
|
| 12 | very little competition in those industries, but in the
|
| 13 | same industry in the previous twenty years before that you had
|
| 14 | it all the time. Maybe there could have been, certainly the
|
| 15 | Microsoft guys thought there could have been, dynamic
|
| 16 | competition against some of those valuable position if the
|
| 17 | Internet entrepreneurs had succeeded.
|
| 18 | Some of this was more complicated and it's vertical
|
| 19 | in more senses. The Internet entrepreneurs wVere not
|
| 20 | horizontal competitors for Windows. The browser
|
| 21 | was a complement. So, this was vertical restrictions to
|
| 22 | prevent vertical disintegration. The vertical
|
| 23 | disintegration would have permitted horizontal (dynamic)
|
| 24 | competition in the operating systems market. So, it's a
|
| 25 | good thing that the history of the industry had so much |
101
| 1 | vertical disintegration causing horizontal competition for
|
| 2 | the market, and that the Microsoft guys in their internal
|
| 3 | documents were so clear about that that such a complex
|
| 4 | case could be argued.
|
| 5 | So, there's Andy Grove. Everybody has seen
|
| 6 | Andy's slide a hundred times. The way you get competition
|
| 7 | is you get a vertical disintegration. Andy was, when he
|
| 8 | wrote this, the CEO of Intel. Mr. Gates of Microsoft has
|
| 9 | said this many times as well.
|
| 10 | This was the essence of the antitrust case,
|
| 11 | that the internal documents, used that model of
|
| 12 | vertical disintegration leading to horizontal competition,
|
| 13 | provided evidence for the potential change in the competitive
|
| 14 | regime.
|
| 15 | Now, again, I want to say, these cases are going
|
| 16 | to be rare. There's not a lot of industries where
|
| 17 | vertical disintegration is the key trigger for horizontal
|
| 18 | competition. It happens to be in infrastructural or mass
|
| 19 | market software on your personal computer that that's
|
| 20 | true, and it's been true since the industry was founded.
|
| 21 | But, the cases where there can be causation from a
|
| 22 | vertical restriction to horizontal competition are going
|
| 23 | to be reasonably rare. This was one.
|
| 24 | I would emphasize again, look for evidence of
|
| 25 | that causal change before you go worrying about |
102
| 1 | efficiencies.
|
| 2 | This part is pretty much the same as
|
| 3 | Dentsply in many ways. Microsoft is more complicated
|
| 4 | because it's vertical in two senses: vertical
|
| 5 | restrictions to prevent vertical disintegration, and
|
| 6 | vertical disintegration in turn preventing horizontal
|
| 7 | competition.
|
| 8 | But what was really important in the competitive
|
| 9 | effects in the case was that chain of causation did lead
|
| 10 | to blocking of a threat which could have led to the kind
|
| 11 | of dynamic and very valuable competition we had seen over
|
| 12 | the previous twenty years in this industry.
|
| 13 | Microsoft -- this other pragmatic, question about
|
| 14 | when to bring a Section 2 case, it's helpful to have a
|
| 15 | defendant that tries to prove entirely implausible things
|
| 16 | like, there's no market power in Windows. It was a bad moment
|
| 17 | for their economics expert witness, I think.
|
| 18 | The other very unwise thing
|
| 19 | that Microsoft chose to prove was that their reaction to
|
| 20 | the widespread mass market use of the Internet wasn't
|
| 21 | strategic, even though there were hundreds and hundreds
|
| 22 | and hundreds of internal documents saying that it was
|
| 23 | strategic. The CEO, whose memo I just quoted saying, this
|
| 24 | is a terrible threat to us, chose to testify that he had
|
| 25 | no idea what the threatening firm was doing at the time. |
103
| 1 | So, defendent's trying to prove that it wasn't
|
| 2 | strategic, trying to prove that there was market power,
|
| 3 | made it somewhat easier for the government to prevail.
|
| 4 | These are complicated cases. The agencies are not always
|
| 5 | going to prove both dualities, that there could be a change
|
| 6 | in market conditions and that the distribution system is
|
| 7 | essential causally to keeping an out.
|
| 8 | So, here's another one with a slide. The ultimate
|
| 9 | remedy chosen in Microsoft was to require divestiture of
|
| 10 | all applications, including the browser and Microsoft office.
|
| 11 | This was not on Richard's, Carl's or Dan's watch.
|
| 12 | This one is on my watch. And I have to say, I had to put
|
| 13 | up this slide. There slide -- actually there is a long
|
| 14 | history of this particular slide. When Dennis Yao, who
|
| 15 | was my roommate in high school, was a Commissioner in the
|
| 16 | FTC in 1989 or 1990, called me and said, you know, we
|
| 17 | figured out we don't want to go after IBM and Microsoft
|
| 18 | together, should we go after Microsoft. And the metaphor
|
| 19 | immediately leapt to my mind, you're going to be like a
|
| 20 | dog that's chasing a fire truck, you know, they're rolling
|
| 21 | down a little street, noisy, illegal as hell,
|
| 22 | anticompetitive as hell, but what are you going to do with
|
| 23 | it when you catch it?
|
| 24 | As it worked out, they didn't catch Microsoft.
|
| 25 | I did. And the dog in this picture turned out in actual |
104
| 1 | history to be me. What did we get? Not any remedy which
|
| 2 | changed the conditions of competition. Ultimately, there
|
| 3 | was an entirely ineffectual settlement in the United States
|
| 4 | and a mildly effectual settlement in the EU. Certainly not
|
| 5 | enough remotely to have the kind of competitive conditions
|
| 6 | change that was possible from the widespread use of the
|
| 7 | Internet.
|
| 8 | So, there's another problem with the agencies,
|
| 9 | bringing large, complicated antitrust cases. The
|
| 10 | counter example here would be, of course, U.S. v.
|
| 11 | AT&T. The United States was incredibly well served by
|
| 12 | that case. During the long interval between the AT&T
|
| 13 | breakup and the soon-to-happen reestablishment of the
|
| 14 | Bell System, we were incredibly well served to have
|
| 15 | vertical disintegration in telephony. The fact that we
|
| 16 | had vertical disintegration in telephony at the moment in
|
| 17 | history when, for example, technologists finally figured
|
| 18 | out how to have mass market use of online services. That
|
| 19 | was incredibly fortunate and that resulted from the antitrust
|
| 20 | case. But they can also fizzle. And even if you win a
|
| 21 | case, there can be severe problems in finding a remedy
|
| 22 | that the antitrust system will undertake.
|
| 23 | So, let me go to my bottom line. I really want us
|
| 24 | to turn around. These cases are going to be hard to prove and
|
| 25 | I want us to turn around and think about both the potential |
105
| 1 | for a competitive effect, meaning there could be change in
|
| 2 | the conditions of competition. The form of that change was
|
| 3 | different with the two cases I talked about. Second, think
|
| 4 | about a causal link between the alleged act and monopoly. I
|
| 5 | would bring those to the fore. Those would be my framework
|
| 6 | for thinking about a Section 2 case.
|
| 7 | But of course that discussion is only about the
|
| 8 | question of whether there is an antitrust case. This doesn't
|
| 9 | remove from the agencies or any other plaintiff, but particularly
|
| 10 | not for the agencies, the problem of thinking about whether
|
| 11 | there's enough of a harm to competition at stake to justify
|
| 12 | any intervention. I guess I would say that in an cases like
|
| 13 | AT&T or Microsoft, where you've got a substantial impediment
|
| 14 | to technical progress in an infrastructure industry, that matters
|
| 15 | to the whole economy, arising from the lack of competition.
|
| 16 | That one might get you over the hump. But there are other
|
| 17 | metrics that can be used, such as the size of the differnce
|
| 18 | between the two competitive regimes and the importance to
|
| 19 | consumers.
|
| 20 | And also to think through whether there might be
|
| 21 | an efficiency defense, whether there might be more harm
|
| 22 | than good done by the antitrust intervention. I don't
|
| 23 | want to take that away, but I do want to say that I would
|
| 24 | emphasize -- I would emphasize thinking through whether
|
| 25 | there is an antitrust case in a perfectly ordinary |
106
| 1 | antitrust analytical way, competitive effects and
|
| 2 | causation.
|
| 3 | Thank you very much.
|
| 4 | MS. GRIMM: Thank you very much.
|
| 5 | Our next speaker is Professor Rich Gilbert, who
|
| 6 | is Professor of Economics of the University of California
|
| 7 | at Berkeley.
|
| 8 | From 1993 to 1995, he was Deputy Assistant
|
| 9 | Attorney General in the Antitrust Division of the U.S.
|
| 10 | Department of Justice, where he led the efforts that
|
| 11 | developed joint Department of Justice and Federal Trade
|
| 12 | Commission "Antitrust Guidelines for the Licensing of
|
| 13 | Intellectual Property."
|
| 14 | Professor Gilbert has served as an Associate
|
| 15 | Editor of the "The Journal of Industrial Economics," "The
|
| 16 | Journal of Economic Theory," and "The Review of Industrial
|
| 17 | Organization."
|
| 18 | Professor Gilbert research specialties include
|
| 19 | antitrust economics, intellectual property, and research
|
| 20 | and development.
|
| 21 | He earned his Ph.D. from Stanford University in
|
| 22 | 1976. He received a Bachelor of Science degree in
|
| 23 | Electrical Engineering in 1966 and a Master of Science
|
| 24 | degree in 1967 both, from Cornell university.
|
| 25 | Professor Gilbert. |
107
| 1 | MR. GILBERT: Thank you very much, Karen.
|
| 2 | While I figure out how to find my talk here, I
|
| 3 | will thank you for bringing these hearings to Berkeley.
|
| 4 | We're very glad we could be able to host these hearings.
|
| 5 | And here we go.
|
| 6 | I'm going to talk about a very narrow slice of
|
| 7 | conduct that could invoke Section 2 liability, namely
|
| 8 | innovation or product design, and ask the question of
|
| 9 | whether innovation, certain types of innovations can be a
|
| 10 | source of Section 2 or contribute to Section 2 liability.
|
| 11 | Now, I don't think many people would argue that
|
| 12 | innovation is great for the economy. Nevertheless, there
|
| 13 | are quite a number of cases that have alleged that
|
| 14 | innovation or product design has contributed to
|
| 15 | monopolization. Of course, Microsoft, as we just heard,
|
| 16 | is one. A slew of cases involving IBM and standardization
|
| 17 | for complimentary products, the use of complimentary
|
| 18 | products. There are some interesting cases on the horizon
|
| 19 | in the prescription drug industry that raise innovation
|
| 20 | issues in a Section 2 sort of context.
|
| 21 | So, I'm going to be reviewing some of these
|
| 22 | cases and asking whether we could have a standard, we've
|
| 23 | heard a lot about standards this morning to evaluate
|
| 24 | Section 2 type conduct, whether any of these standards is
|
| 25 | useful for evaluating innovation. Maybe I will give you |
108
| 1 | my punch line right away. I think the answer is no, and
|
| 2 | try to tell you why.
|
| 3 | I'll begin -- let's see. I'm going to begin
|
| 4 | with a very simple model. I hope not to raise the fear
|
| 5 | factor too much and talk about letters here. If you are
|
| 6 | worried about this, you can replace any letters with
|
| 7 | numbers. So, I want to talk about a very simple model of
|
| 8 | innovation.
|
| 9 | I have here an old technology. It has a social
|
| 10 | value, v, zero, for each use. You could use, say, fifty
|
| 11 | dollars for v, zero. A new technology could come along
|
| 12 | with a higher social value, maybe a hundred dollars, for
|
| 13 | each use. I'm going to strip away marginal cost to keep
|
| 14 | things as simple as possible. There are a bunch of users,
|
| 15 | say there's a thousand users, if you want. And there's
|
| 16 | some R&D costs.
|
| 17 | Now, in this simple model, the innovation is
|
| 18 | socially desirable, I mean, it's still the small one can
|
| 19 | be as simple as possible if the total incremental social
|
| 20 | value exceeds the cost of the innovation.
|
| 21 | So, we have our thousand consumers and they each
|
| 22 | use this technology in one application, the extra value of
|
| 23 | the innovation is fifty dollars, so that would be fifty
|
| 24 | thousand dollars. The question is: Does that cover the
|
| 25 | cost? |
109
| 1 | Now, in terms of whether the innovation is
|
| 2 | privately profitable, there's a price that the innovator
|
| 3 | can collect for the new technology and it's profitable if
|
| 4 | the price it can collect times the number of people who
|
| 5 | buy it, assuming they all buy it, in fact covers the cost.
|
| 6 | So, the first that I want to make, and there is
|
| 7 | a paper that should be coming out in "Competition Policy
|
| 8 | International" on this topic, the first point is to say,
|
| 9 | innovations can be socially desirable but not privately
|
| 10 | profitable, or you can have innovations that are privately
|
| 11 | profitable but not socially desirable.
|
| 12 | So, the first point is a very simple point:
|
| 13 | That innovation can go any way -- there can be any order
|
| 14 | in evaluating social and private profitableness. It's not
|
| 15 | like a price -- innovation is like a price change in some
|
| 16 | respects. If you come out with an innovation for a
|
| 17 | product, it's like reducing its quality-adjusted price,
|
| 18 | and you can make an analogy between innovation and, say,
|
| 19 | predatory pricing. If you reduce the quality-adjusted
|
| 20 | price, that leads to the exit of competitor, and then you
|
| 21 | raise your price again, that has a sort of predatory
|
| 22 | flavor to it.
|
| 23 | But unlike pricing, where lower price certainly
|
| 24 | lowers the price above marginal cost is a good thing, we
|
| 25 | really don't know if more or less innovation is a good |
110
| 1 | thing unless you do the whole analysis.
|
| 2 | So, the standards I want to talk about, these
|
| 3 | came up this morning, I want to talk about different rules
|
| 4 | of reason which I interpret as either a total rule of
|
| 5 | reason, which looks at all of the economic value
|
| 6 | associated with some conduct, whether it's value to
|
| 7 | consumers or value to producers.
|
| 8 | And then there's probably the more popular
|
| 9 | consumer rule of reason analysis which focuses on
|
| 10 | consumers, and some people would say is at the heart of
|
| 11 | antitrust analysis, at least according to, say, Steve
|
| 12 | Sala, although others such as Joe Farrell and Mike Katz,
|
| 13 | and Ken Hirers from the antitrust division, have advocated
|
| 14 | a total rule of reason standard.
|
| 15 | Then there's the profit sacrifice test in one of
|
| 16 | its many forms. There's the no economic sense test.
|
| 17 | We've heard a little bit about that this morning. And
|
| 18 | then I'll talk a little bit about sham innovation.
|
| 19 | So, a total real of reason analysis, in a sense
|
| 20 | it's the right thing to do if you are, sort of by
|
| 21 | definition, an economist, it's the right thing to do
|
| 22 | because it ask whether total surplus is increased from
|
| 23 | some activity. And even if that makes producers
|
| 24 | relatively better off than consumers, at least there's the
|
| 25 | possibility that those producer profits will flow |
111
| 1 | eventually to consumer benefit, or that somehow producers
|
| 2 | can bribe consumers to get it all right.
|
| 3 | But the problem of course is that you can have
|
| 4 | the price being either larger or smaller than the
|
| 5 | incremental social benefit. And all of the analysis would
|
| 6 | have to be done when the innovation decisions from the
|
| 7 | perspective of the decisions that are actually made, which
|
| 8 | means what we call an ex ante analysis. And this really I
|
| 9 | think sets up innovation as being distinctly different
|
| 10 | from other conduct. Because when you talk about
|
| 11 | innovation, it's absolutely necessary to keep going
|
| 12 | backwards and backwards to what are the incentive effects
|
| 13 | of whatever rules or policies you have in place, what are
|
| 14 | their incentive effects for innovation in the first place.
|
| 15 | And now it's easy to say, well, of course that's
|
| 16 | right, of course we're going to take that into account.
|
| 17 | But I want to ask you, if you have been in these hearings,
|
| 18 | how many times have people really gone backwards and said,
|
| 19 | what are the implications of what we're doing for the
|
| 20 | kinds of decisions that people are make that could have
|
| 21 | developed and could develop new products or new processes
|
| 22 | or whatever ten years from now. And I would say you
|
| 23 | haven't heard it very many times.
|
| 24 | So, it very easy to lose sight of these
|
| 25 | incentive effects. And on top of that, if you did a total |
112
| 1 | rule of reason analysis, the analysis that you would have
|
| 2 | to do is hugely complex. You have to really take into
|
| 3 | account all spillovers, how innovation affects consumers
|
| 4 | and firms in other industries, and those we know can be
|
| 5 | very, very large. And with the complexity, you can lead
|
| 6 | easily to false positive and false negatives. I'm not
|
| 7 | going to say Type 1 and Type 2 because I always forget
|
| 8 | which one is which, so I will just say false positives and
|
| 9 | false negatives, and you can figure out which one is a
|
| 10 | positive and which one is a negative on your own.
|
| 11 | Too much enforcement or too little enforcement.
|
| 12 | Portion. It can go either way.
|
| 13 | A consumer rule of reason analysis. Again, it's
|
| 14 | very complex. The problems are similar to those that
|
| 15 | arise in a total rule of reason analysis. Again, the
|
| 16 | ex ante problems, the uncertainties, the spillover
|
| 17 | effects, etc. And as well can lead to conclusions that
|
| 18 | just simply don't make sense. This is particularly a
|
| 19 | problem in innovation. You could have an innovation that
|
| 20 | just saves millions of dollars in production cost, but
|
| 21 | maybe it leads to a nickel increase in price, which
|
| 22 | certainly could happen. And would you want to say that
|
| 23 | this is an anticompetitive innovation because consumers
|
| 24 | are slightly worse off, despite the fact that it's
|
| 25 | generated enormous savings and efficiencies on the |
113
| 1 | producer's side.
|
| 2 | Well, I know that people can differ on that, but
|
| 3 | my view is that it just doesn't make any sense to discount
|
| 4 | all of those efficiencies. Now, you can say that you're
|
| 5 | looking at a merger case or you're looking at other
|
| 6 | conduct that doesn't involve product design, that those
|
| 7 | kinds of efficiencies are not likely to be huge or have
|
| 8 | not been demonstrated to be huge, but when you're talking
|
| 9 | directly about innovations these efficiencies exist as
|
| 10 | part of the innovation. So, you can't discount them.
|
| 11 | A profit sacrifice test. There are, of course,
|
| 12 | different versions of a profit sacrifice test. And I'm
|
| 13 | going to quote Janusz Ordover's and Bobby Willig's
|
| 14 | definition: "Predatory intentions are present if a
|
| 15 | practice would be unprofitable without the exit that it
|
| 16 | causes but profitable with the exit." Now, Ordover and
|
| 17 | Willig also say this is just talking about predatory
|
| 18 | intent not facts, they add a lot of other conditions in
|
| 19 | their analysis that make this analysis considerably more
|
| 20 | elaborate, and in many ways closer to a total rule of
|
| 21 | reason analysis. So, this is just the basic idea of a
|
| 22 | profit sacrifice test.
|
| 23 | Now, the profit sacrifice test, I am not the
|
| 24 | first to say this, it doesn't seem to me to make any sense
|
| 25 | to innovation, even though it was in fact developed |
114
| 1 | originally to talk about innovation as well as price --
|
| 2 | predatory pricing. The problem of course first of all is
|
| 3 | that innovation almost always involves a profit sacrifice.
|
| 4 | It's called investing in research and development. That's
|
| 5 | what you do.
|
| 6 | It's also the case that innovation, if it really
|
| 7 | works, probably excludes competitors. So, exclusion is
|
| 8 | sometimes a direct result of producing a really good
|
| 9 | mousetrap. The other mousetraps can't compete.
|
| 10 | Now -- and furthermore, and this is absolutely
|
| 11 | crucial, is that we need to know how much market power
|
| 12 | after the innovation occurs is necessary to justify the
|
| 13 | investment in innovation in the first place. And you can
|
| 14 | make statements about whether innovation creates too much
|
| 15 | or too little market power relative to its social value.
|
| 16 | But the social value is very hard to calculate. And the
|
| 17 | amount of power or pricing power that is necessary to
|
| 18 | evoke the right amount of investment in research and
|
| 19 | development is simply a very hard question. So, I
|
| 20 | conclude, based on this, that a profit sacrifice test
|
| 21 | really doesn't do very much to inform this analysis.
|
| 22 | What about a no economic sense test. I am going
|
| 23 | to use Greg Werden's version of this. He says: "Conduct
|
| 24 | is not exclusionary or predatory unless it would make no
|
| 25 | economic sense for the defendant but for the tendency to |
115
| 1 | eliminate or lessen competition."
|
| 2 | Now, you can see that, with all the negatives
|
| 3 | again, the no economic sense test is really a test of the
|
| 4 | absence of predation. So, if it makes sense to do this
|
| 5 | activity, then it's not predatory.
|
| 6 | Now, although it's not really clear in the no
|
| 7 | economic sense test what no economic sense means, there
|
| 8 | are two interpretations of this, certainly as applied to
|
| 9 | innovation. One is that it's not profitable. No
|
| 10 | reasonable firm would have dumped all of this money into a
|
| 11 | new product design unless it had a purpose of excluding
|
| 12 | competition. A second interpretation is that innovation
|
| 13 | really always makes economic sense because it's just a
|
| 14 | good thing that firms do.
|
| 15 | Depending upon which one of these
|
| 16 | interpretations you have, if it's the first one, then the
|
| 17 | no economic sense test is very similar to the profit
|
| 18 | sacrifice test. Now, if it's the second one, the no
|
| 19 | economic sense test is similar to really whether
|
| 20 | innovation is a sham, meaning whether it's a fraud or not.
|
| 21 | I think it's the case, and I know that Werden has said
|
| 22 | that his view of the no economic sense test as applied to
|
| 23 | innovation is the second version, not the first version.
|
| 24 | And I also know that he has views of conduct that do not
|
| 25 | in fact involve a profit sacrifice, even though there was |
116
| 1 | some discussion this morning that they're the same. His
|
| 2 | example was a world with no arson laws and flush with
|
| 3 | matches. So, you can go out there and burn down anybody
|
| 4 | you want, including your competitors.
|
| 5 | So, let me review a little bit of some cases
|
| 6 | involving predatory innovation, particularly with respect
|
| 7 | to complimentary products, products that interact with
|
| 8 | other products. Those are almost totally -- well, they're
|
| 9 | not entirely, but to a great extent they have to do with
|
| 10 | changes to the interface stands. That was certainly the
|
| 11 | case with the IBM peripherals litigation, a bunch of these
|
| 12 | in the late 1970s, whether it's other people's disk drives
|
| 13 | would hook into and work with IBM mainframe computers.
|
| 14 | And the Microsoft case. And there's been a few others.
|
| 15 | As a general conclusion in looking through these
|
| 16 | cases, well, you can find a lot of lower court decisions,
|
| 17 | a general conclusion is that in nearly all of these cases,
|
| 18 | weak evidence of efficiencies was sufficient to avoid
|
| 19 | liability for predatory innovation.
|
| 20 | So, after there was lots of talk about whether
|
| 21 | there was monopoly power or not, or whether or not there
|
| 22 | was a monopoly of market effect, competitive effect. The
|
| 23 | final analysis, they said -- these courts generally said,
|
| 24 | well, we can think of it as an efficiency reason for this
|
| 25 | conduct, therefore it's okay. |
117
| 1 | To my knowledge, only the Microsoft case,
|
| 2 | Microsoft 4 as it is sometimes affectionately called,
|
| 3 | purported to apply a rule of reason analysis to
|
| 4 | innovation. So, let's talk about Microsoft a little bit.
|
| 5 | The Microsoft case actually came up with a road
|
| 6 | map to kind of evaluate innovation. There actually five
|
| 7 | steps to the road map. I'm going to condense them to
|
| 8 | three.
|
| 9 | The plaintiff first must demonstrate that the
|
| 10 | conduct that harmed consumers had an economic
|
| 11 | anticompetitive effect. Second, if a plaintiff
|
| 12 | successfully demonstrates anticompetitive effect, then the
|
| 13 | monopolist may prefer a procompetitive justification for
|
| 14 | its conduct. So, the second step is the monopolist,
|
| 15 | alleged monopolist can talk facts and say, we have a
|
| 16 | reason for doing this. And then the third step says,
|
| 17 | well, the plaintiff can now come back and rebut the
|
| 18 | monopolist's justification. Or, if it can't actually
|
| 19 | justifiably rebut it, it can demonstrate that the
|
| 20 | anticompetitive effect was bigger than the procompetitive
|
| 21 | benefit and outweighs it. So, it can do a rule of reason
|
| 22 | analysis is what it says.
|
| 23 | Well, let me just review what happened in the
|
| 24 | Microsoft case. There were many allegations having to do
|
| 25 | with Java standards and with various contracting policies |
118
| 1 | with lots of different players in the industry.
|
| 2 | There were really three design elements that
|
| 3 | were challenged in the Microsoft case. One was not having
|
| 4 | Internet Explorer in the Add/Remove programs utility. The
|
| 5 | other was designing Windows so as in certain circumstances
|
| 6 | to override the user's choice of a default browser other
|
| 7 | than Internet Explorer. And the third one was commingling
|
| 8 | browser and operating system code.
|
| 9 | Now, interestingly, the court concluded that
|
| 10 | Microsoft offered no procompetitive justifications for the
|
| 11 | first and the third, and these were held by the court to
|
| 12 | contribute to the Section 2 violation. But then the court
|
| 13 | also concluded that plaintiffs -- that Microsoft did offer
|
| 14 | a justification for the second element of its conduct,
|
| 15 | that is, the overriding of user's choice of the browser,
|
| 16 | which the plaintiff did not rebut, and therefore in fact
|
| 17 | the Microsoft court never got to the third step. So, the
|
| 18 | court never got to the rule of reason balancing in the
|
| 19 | third step because either it was anticompetitive with no
|
| 20 | efficiencies or there were efficiencies and the plaintiff
|
| 21 | didn't come back. So, maybe Tim will explain or Dan will
|
| 22 | elaborate on this, but this is my reading of what happened
|
| 23 | with the court.
|
| 24 | So, the practical effect of what happened in the
|
| 25 | Microsoft court's analysis was really, I think, similar to |
119
| 1 | the no economic sense test of the first variety. That is,
|
| 2 | was there some reason for this conduct. If there was,
|
| 3 | it's okay.
|
| 4 | Now I want to turn to another area that I find
|
| 5 | quite interesting. As they say, this is emerging
|
| 6 | antitrust. This is that drug patents may delay generic
|
| 7 | competition. So, the innovation that contributes to these
|
| 8 | drug patents can have competitive effect. It can have
|
| 9 | competitive effect both through the nature of generic
|
| 10 | substitution and also because of the specific elements of
|
| 11 | the Hatch-Waxman Act, which impose a 30-month stay on
|
| 12 | generic competition if you have a patent.
|
| 13 | So, one of these cases is called Tricor, which
|
| 14 | is actually a drug called phenofibrate. It's used to
|
| 15 | control triglyceride and cholesterol levels. And I should
|
| 16 | acknowledge I have been a consultant in this case. A
|
| 17 | second case is Prilosec and Nexium, which Prilosec is a
|
| 18 | common drug prescribed for heartburn, gastric reflux, and
|
| 19 | then your more serious conditions like esophageal and
|
| 20 | duodenal ulcers. It turns out that Nexium is what is
|
| 21 | called an isomer of the chemical that's in Prilosec. It's
|
| 22 | basically the same molecules. It's been rearranged a
|
| 23 | little bit. And it's supposed to have some advantages for
|
| 24 | the esophageal and duodenal ulcers, but not for heartburn.
|
| 25 | The allegations that came up in both of these |
120
| 1 | cases is that the innovations are costly but minor
|
| 2 | improvements, that they're contrary to the intent of the
|
| 3 | Hatch-Waxman legislation to promote generic competition,
|
| 4 | and they have large adverse competitive effects by
|
| 5 | delaying generic competition.
|
| 6 | Now, I think certainly if you just take a
|
| 7 | snapshot of competition, once these drugs exist, anything
|
| 8 | that delays generic competition has at lease the
|
| 9 | possibility of a competitive effect. But it's important
|
| 10 | to recognize that the Hatch-Waxman legislation was a trade
|
| 11 | off between more generic competition and more protection
|
| 12 | for patented drugs. In fact, the first three letters of
|
| 13 | the Hatch-Waxman Act are patent term restorations. I
|
| 14 | think it was designed to protect pioneer drugs, as well as
|
| 15 | promote generic competition.
|
| 16 | Product line extensions certainly increase
|
| 17 | incentives for drug innovation. If you actually look at
|
| 18 | the respective patent terms for prescription drugs,
|
| 19 | patented prescription drugs, it's actually quite short.
|
| 20 | It's one of the shortest of all industries because of all
|
| 21 | the FDA delays and regulations required to actually
|
| 22 | produce the drugs. And it's very hard to assess these
|
| 23 | benefits from these innovations.
|
| 24 | So, I think instead of looking at any of these
|
| 25 | standards to inform a Section 2 analysis for innovation, I |
121
| 1 | find all of them seriously lacking. I think instead you
|
| 2 | can turn to consistency with other rules.
|
| 3 | And let's talk about something we've heard
|
| 4 | before, talk about the process rather than the outcome.
|
| 5 | That was discussion was featured in this morning's session
|
| 6 | to great extent by members of the panel talking about the
|
| 7 | process rather than the outcome.
|
| 8 | So, the quote that I'm quoting here is by a
|
| 9 | distinguished economist, but not anyone from our group.
|
| 10 | It's from an economist who works for the Oakland Athletics
|
| 11 | who was quoted by Michael Lewis in "Moneyball," and he was
|
| 12 | actually talking about how to hire baseball players, but I
|
| 13 | think his insight here is equally applicable to antitrust
|
| 14 | policy, "We have to look at process, not outcomes."
|
| 15 | So, if we think about making an analogy between
|
| 16 | innovation effects, and the effects and rules that are
|
| 17 | applied to other conduct, I want to argue that, in many
|
| 18 | innovation cases, the effects of the innovation are very
|
| 19 | similar to the effects of a unilateral refusal to deal.
|
| 20 | When you're talking about, say, if IBM refuses to make
|
| 21 | mainframes compatible able with third parties' components,
|
| 22 | it's a lot like saying, well, one day Microsoft gets up
|
| 23 | and says, I don't want to work with these third party
|
| 24 | people anymore, I want to build computers just for myself.
|
| 25 | Microsoft refuses to make Windows compatible with other |
122
| 1 | browsers. Or a generic drug manufacturer refuses to
|
| 2 | supply a drug that generics can copy.
|
| 3 | In effect, this conduct looks a lot like a
|
| 4 | unilateral refusal to deal. Now, these days, after
|
| 5 | "Verizon v. Trinko", seems like unilateral refusals to
|
| 6 | deal have a long way to go before they can generate
|
| 7 | antitrust liability.
|
| 8 | Now, I don't want to state that as a categorical
|
| 9 | fact, or that "Verizon v. Trinko," that all the words in
|
| 10 | "Verizon v. Trinko" were necessarily the greatest words
|
| 11 | that have ever been uttered in all of antitrust policy. I
|
| 12 | am not sure it's the greatest policy.
|
| 13 | But my only point is that if you are going to
|
| 14 | have a policy that gives considerable deference to a
|
| 15 | decision by a single firm about who that firm will deal
|
| 16 | with or supply, it just seems odd that one wouldn't have a
|
| 17 | more strict policy, more intervention policy with respect
|
| 18 | to innovations that have very similar effects.
|
| 19 | So, I'm not saying -- again I want to emphasize
|
| 20 | that I'm not saying that we should have policies that say
|
| 21 | that unilateral refusals to deal with per se legal, I
|
| 22 | don't think that's necessarily the right thing. But if we
|
| 23 | are going to have such a policy, then consistency seems to
|
| 24 | say that if you unilateral innovations that have similar
|
| 25 | effects should not be treated more severely. |
123
| 1 | So, one of my conclusions here is that all of
|
| 2 | the rule of reason and profit sacrifice tests have limited
|
| 3 | value to evaluate what is sometimes called predatory
|
| 4 | innovation. It's hard to do; likely to get the wrong
|
| 5 | answer; very hard to look al at the incentive effects that
|
| 6 | are necessary to really thinking about innovation.
|
| 7 | The no economic sense test is better, but only
|
| 8 | if it's interpreted as a test of sham innovation because
|
| 9 | otherwise it comes out just like or very similar to a
|
| 10 | profit sacrifice test.
|
| 11 | And my other conclusion is that this is what
|
| 12 | courts in fact almost always have done with very few
|
| 13 | exceptions in the way they've treated these cases and it's
|
| 14 | probably as reasonable an approach as any.
|
| 15 | MS. GRIMM: Our third presenter this afternoon
|
| 16 | is Daniel Rubinfeld, who is the Robert L. Bridges
|
| 17 | Professor of Law and Professor of Economics at the
|
| 18 | University of California at Berkeley, where he has taught
|
| 19 | since 1983
|
| 20 | He has also served as Deputy Assistant Attorney
|
| 21 | General for Antitrust in the U.S. Department of Justice,
|
| 22 | as well as in various capacities with the President's
|
| 23 | Council of Economic Advisors, the National Academy of
|
| 24 | Sciences, the Urban Institute, and the National Bureau of
|
| 25 | Economic Research. |
124
| 1 | Professor Rubinfeld's major books include
|
| 2 | "Econometric Models and Economic Forecasts" and
|
| 3 | "Microeconomics." Recent publications include, "Antitrust
|
| 4 | Enforcement in Dynamic Network Industries" in "The
|
| 5 | Antitrust Bulletin," 1998; and "Empirical Methods in
|
| 6 | Antitrust: Review and Evidence" in "American Law and
|
| 7 | Economics Review."
|
| 8 | He is President of the American Law and
|
| 9 | Economics Association.
|
| 10 | Professor Rubinfeld received his B.A. from
|
| 11 | Princeton University in 1967; his M.S. and Ph.D. from the
|
| 12 | Massachusetts Institute of Technology.
|
| 13 | Dan.
|
| 14 | MR. RUBINFELD: Thanks very much. I really,
|
| 15 | like everyone else, appreciate the opportunity to appear
|
| 16 | before you today. It's been about eight or nine years
|
| 17 | since I left the Antitrust Division and I guess,
|
| 18 | understandably I've aged about eight or nine years during
|
| 19 | that time, and I find as one gets older one tends to
|
| 20 | reflect back on the past, perhaps more than one should.
|
| 21 | But what I'm going to do in my comments today is to really
|
| 22 | do some reflection on what happened, and I might hit on
|
| 23 | some of the previous commentators' issues, but see I can do it in
|
| 24 | a way that will be constructive for the agencies as you
|
| 25 | think about forming your policies. |
125
| 1 | So, the first point I want to make is why I
|
| 2 | think it's really important to have an active Section 2
|
| 3 | jurisprudence. And I want to look back and talk about the
|
| 4 | legacy of "U.S. vs. Microsoft" for antitrust enforcement.
|
| 5 | And, finally, I want to look at bundling and talk about
|
| 6 | the legacy of "LePage's vs. 3M".
|
| 7 | I should say, to make it clear, that I had an
|
| 8 | interest in both of those cases. I helped to prosecute
|
| 9 | the Microsoft case. And I have consulted for 3M with
|
| 10 | respect to some of the issues that arose in its appellate
|
| 11 | case. I was not involved in the LePage's case itself, but
|
| 12 | I was involved in thinking about some of the appellate
|
| 13 | issues. So, I have taken a pretty close look at the Third
|
| 14 | Circuit opinion in that case.
|
| 15 | If you're interested in some of the deeper
|
| 16 | comments I am going to give today, they will appear in
|
| 17 | two articles. One is an article that Doug Melamed and
|
| 18 | myself are completing for our forthcoming volume in
|
| 19 | which we are looking at the lessons of the Microsoft case.
|
| 20 | And the second is an article I published a year or so ago,
|
| 21 | looking at the bundling in the "LePaige's vs. 3M" case.
|
| 22 | Before I go on to the cases, as far as the active
|
| 23 | Section 2 jurisprudence is concerned, I guess history
|
| 24 | affects how one views things, and I can be very quick, I
|
| 25 | can just say, having been involved in actually bringing |
126
| 1 | both Microsoft and Dentsply, both of which I thought was
|
| 2 | the right thing to do, and the D.C. Circuit and the Third
|
| 3 | Circuit in both cases have written opinions that were
|
| 4 | supportive of that decision, I'm proud to have been
|
| 5 | involved in both of those cases, and I think that shows,
|
| 6 | consistent with what Tim Bresnahan said, it shows the kind
|
| 7 | of active Section 2 jurisprudence that I think makes
|
| 8 | sense.
|
| 9 | Both cases had a particular set of facts
|
| 10 | associated with them that told a story that made them the
|
| 11 | right cases to bring, viable cases. And I think the
|
| 12 | agencies need to be careful because there is not going to
|
| 13 | be a lot of good Section 2 cases. So, you need to be
|
| 14 | careful and active and watchful for the appropriate
|
| 15 | opportunities in the future.
|
| 16 | So, having said that, let me go on and take a
|
| 17 | look at "U.S. vs. Microsoft". And I am going focus now
|
| 18 | really on sort of what we've learned from the case in a
|
| 19 | very broad perspective. I'm not going to try to go into
|
| 20 | some of the technical details unless we have discussion
|
| 21 | later.
|
| 22 | It's sometimes easy to forget, since this is
|
| 23 | almost ten years ago when at least my version of Microsoft
|
| 24 | was brought, that people were barely talking about network
|
| 25 | effects. Now it's taken for granted that in high tech |
127
| 1 | it's common to face industries in which network effects
|
| 2 | matters and that enters into the economics and to the law,
|
| 3 | legal thinking about the cases.
|
| 4 | I see one of the legacies of Microsoft is sort
|
| 5 | of helping to bring us from the pre-network effect world
|
| 6 | to a world where network effects are often the core of the
|
| 7 | analysis.
|
| 8 | Next important is people are thinking somewhat
|
| 9 | differently now than they were before about barriers to
|
| 10 | entry. When we originally think about investigating the
|
| 11 | Microsoft case, obviously barriers to entry was something
|
| 12 | that I paid a lot of attention to. We became convinced
|
| 13 | that there was a significant barrier to entry, but it's
|
| 14 | not the usual one you might imagine. It had to do with
|
| 15 | the fact that in order to have a successful operating
|
| 16 | system, you really needed to have successful applications.
|
| 17 | There was what we called a two-level entry problem. And
|
| 18 | we spent a lot of time developing the underlying economics
|
| 19 | that describe this applications barrier to entry.
|
| 20 | One of the things that people forget, actually I
|
| 21 | almost forget myself, is that the term "application
|
| 22 | barrier to entry" did not exist, at least to my
|
| 23 | knowledge, prior to our work. We coined and reiterated it
|
| 24 | every time we could at trial until the judge finally got it
|
| 25 | into his mind. |
128
| 1 | And it was fun to watch the trial, by the way,
|
| 2 | because at the beginning of the trial, Microsoft disavowed
|
| 3 | the application "barrier to entry." By the end of the
|
| 4 | trial it was being discussed by them as if it were a
|
| 5 | common coin of the realm.
|
| 6 | So, let's remember that that was one, for better
|
| 7 | or worse, I think for better, one of the legacies of the
|
| 8 | Microsoft case.
|
| 9 | The other thing is, as you all know, the case
|
| 10 | involved tying, but it was different than the classic kind
|
| 11 | of tying case, which is usually thought of leveraging
|
| 12 | market power from a market where a firm has substantial
|
| 13 | market power to use some related power where it does not
|
| 14 | necessarily have significant market power.
|
| 15 | But this case did involve tying as well as
|
| 16 | bundling. And it was a non-leveraged form of tying. And
|
| 17 | now it's not, I think unusual to think about bundling in
|
| 18 | that context in certain cases where it was probably quite
|
| 19 | radical at the time.
|
| 20 | The other thing is that the case brought to our
|
| 21 | mind a different way, a different perspective of thinking
|
| 22 | about market definitions. As Tim suggested earlier today,
|
| 23 | there's always been a lot of talk about Schumpeterian
|
| 24 | competition and certainly the agencies have been aware of
|
| 25 | it for a long time. |
129
| 1 | In this case, to one degree or another,
|
| 2 | Schumpeterian competition really came to the forefront
|
| 3 | because, in the debate about market definition and market
|
| 4 | power, Microsoft took the position that it was the threat
|
| 5 | of entry by competitors that really not only restrained
|
| 6 | this market definition, this market power, but also in
|
| 7 | fact meant that the market should be defined very broadly.
|
| 8 | Microsoft argued for an extremely broad market definition
|
| 9 | that included almost all operating systems, from
|
| 10 | hand-helds pretty much up through mainframe computers, and
|
| 11 | argued that it had no market power over that relevant
|
| 12 | market.
|
| 13 | I still remember one particular trial exhibit
|
| 14 | which Microsoft presented which sort of brought this issue
|
| 15 | to the front. And the exhibit said that Microsoft faces
|
| 16 | substantial competition from known and unknown
|
| 17 | competition. And my view, which was borne out, by the
|
| 18 | way, by the Circuit Court opinion, is that when you have
|
| 19 | to defend your market power or lack of it by describing
|
| 20 | competition that no one knows about yet, you really have a
|
| 21 | fairly weak position.
|
| 22 | And if you read the D.C. Circuit opinion, I
|
| 23 | think the D.C. Circuit got it right, as they did in most
|
| 24 | areas, they said, the nascent competition really could be
|
| 25 | important but it really has to be competition which is |
130
| 1 | expected with reasonable certainty to actually be there in
|
| 2 | the marketplace at some period in the future, thinking
|
| 3 | about two years would be the relevant time period.
|
| 4 | But the fact that someone might come along and
|
| 5 | take away your market power isn't sufficient. I think the
|
| 6 | court was pretty clear about that. And it's basically the
|
| 7 | right place to be.
|
| 8 | As far as legal issues I see coming out of the
|
| 9 | case, there are about five. I'd like to highlight, again,
|
| 10 | without getting into the technical/legal side of the case,
|
| 11 | the first thing which I think we now take for granted, or
|
| 12 | at least I hope we do, which is that the same antitrust
|
| 13 | principles apply in dynamic high tech industries as apply
|
| 14 | in the other industries. The application of course might
|
| 15 | be somewhat different, but the principals are the same.
|
| 16 | And I quote Judge Posner, who really says what I
|
| 17 | have in mind, which is that antitrust doctrine really is
|
| 18 | pretty well situated to allow us to handle high tech
|
| 19 | industries. We don't need to rewrite Section 2, in my
|
| 20 | view.
|
| 21 | Up until Rich started speaking earlier, I would
|
| 22 | have said hardly anyone remembers that there are IP issues
|
| 23 | raised in Microsoft. Rich laid them out pretty well.
|
| 24 | And so, what I wanted to say is that the court
|
| 25 | makes it pretty clear that the same general antitrust |
131
| 1 | principles that apply to conduct involving intellectual
|
| 2 | property that apply to any other form of property underc
|
| 3 | the antitrust laws.
|
| 4 | Originally, at one point in the case, Microsoft
|
| 5 | actually claimed that their IP rights covered the entire
|
| 6 | desktop, at least with respect to the first boot up of
|
| 7 | their operating system. The court made it very clear that
|
| 8 | (a) that was too expansive an interpretation, and (b) that
|
| 9 | it was appropriate for the Sherman Act and the courts to
|
| 10 | really look at the IP issues. You did not get a free ride
|
| 11 | just because you did in fact have some legitimate
|
| 12 | intellectual property.
|
| 13 | And Rich described in detail and correctly where
|
| 14 | the court finally came out about these specific IP issues.
|
| 15 | With respect to product design, as I interpret
|
| 16 | the court opinion, it makes clear that the court is going
|
| 17 | to give pretty wide deference to firms that are designing
|
| 18 | new products, along the lines Rich described. But the
|
| 19 | court also said this is an area that's open for viable
|
| 20 | investigation. And where particular aspects of
|
| 21 | Microsoft's product design excluded rivals, the court did
|
| 22 | shift the burden to Microsoft to establish a
|
| 23 | procompetitive justification for the design. There is no
|
| 24 | safe harbor just because you're involved in innovation or
|
| 25 | product design. And the removal of the Add/Remove utility |
132
| 1 | which Rich described was one good example of that. The
|
| 2 | court was very clear that was problematic and there was no
|
| 3 | procompetitive justification given that I can see in the
|
| 4 | case.
|
| 5 | There's also an issue in this kind of Section 2
|
| 6 | case as to whether you ought to kind of just describe the
|
| 7 | case with kind of a broad brush or kind of go into the
|
| 8 | practices with fine detail. My sense, my personal sense
|
| 9 | during the trial was that there were times when the
|
| 10 | defense seemed to say, we want to just talk very broadly
|
| 11 | about the rights of a dominant firm to engage in certain
|
| 12 | kinds of potentially procompetitive activities. And the
|
| 13 | government, as I saw it, focused really in with apparent
|
| 14 | detail about the details surrounding each of these kinds
|
| 15 | of conduct.
|
| 16 | And I read the D.C. Circuit as basically saying
|
| 17 | that any aspect, the explicit, discrete aspect of
|
| 18 | monopolist conduct that tends to exclude rivals may be
|
| 19 | illegal, unless there's a legitimate procompetitive
|
| 20 | justification for that particular conduct.
|
| 21 | So, there is at least a burden-shifting aspect
|
| 22 | to some of the illegal rules that flow from the Microsoft
|
| 23 | case, which I think is appropriate.
|
| 24 | There is an issue about whether you ought to
|
| 25 | focus on rules or cases, specific facts. Here, as you |
133
| 1 | know, the court, the appellate court, on the time claims,
|
| 2 | suggested that the per se rule didn't apply because of the
|
| 3 | particular attributes of platform software. So, we're now
|
| 4 | left in a somewhat unclear world that may apply mostly to
|
| 5 | Section 1, but also has Section 2 implications as to how
|
| 6 | to treat tying.
|
| 7 | And I have to say here, as an economist, you may
|
| 8 | not be surprised to hear that I'm pretty sympathetic with
|
| 9 | the comments of the court. I think it's really hard to,
|
| 10 | as an economist, come up with per se rules that would
|
| 11 | apply in this kind of high tech context.
|
| 12 | Of course we don't know quite where that would
|
| 13 | have ended up because the Department of Justice chose not
|
| 14 | to appeal that part of the D.C. Circuit's ruling.
|
| 15 | With respect to causation, I see the case telling
|
| 16 | us conduct that violates the antitrust laws only if it
|
| 17 | injures competition. Causation can be inferred when
|
| 18 | exclusionary conduct is aimed at producers of nascent
|
| 19 | competitive technologies, as well as when it's aimed at
|
| 20 | producers of established substitutes.
|
| 21 | So, basically the court spelled out causation along
|
| 22 | the lines Tim suggested, and I think the court makes it
|
| 23 | pretty clear that that's necessary and that the government
|
| 24 | succeeded in that effort.
|
| 25 | What about profit sacrifice? Here we could |
134
| 1 | debate exactly how to characterize the case. I would say
|
| 2 | that the case we put forward did really involve a profit
|
| 3 | sacrifice test. My definition would be that conduct is
|
| 4 | anticompetitive when it would not make business sense for
|
| 5 | the defendant but for its tendency to exclude rivals and
|
| 6 | create or maintain market power for the defendant.
|
| 7 | This is kind of a crude paraphrase. If you go
|
| 8 | back and read the details of the case, you'll see a more
|
| 9 | formal definition. It is a variant on a profit sacrifice
|
| 10 | test. I wouldn't say it's quite a no nonsense test, but
|
| 11 | it's pretty close.
|
| 12 | Now, that's not what the D.C. Circuit said.
|
| 13 | What the D.C. Circuit said was quite close to what Rich
|
| 14 | Gilbert said earlier. The court said that the conduct is
|
| 15 | anticompetitive if it harms the competitive process and
|
| 16 | either it's not shown to further efficiency or to have
|
| 17 | some other procompetitive justification or the
|
| 18 | anticompetitive harm outweighs its procompetitive benefit.
|
| 19 | So, the D.C. Circuit was suggesting more of a balancing
|
| 20 | test than a profit sacrifice test.
|
| 21 | And this leaves us with the question of what we
|
| 22 | should do if we find Section 2 type conduct that harms
|
| 23 | competition and furthers a legitimate purpose should we
|
| 24 | have a balancing test.
|
| 25 | Now, I should say here, I am not entirely sure |
135
| 1 | of where I would end up, but I lean strongly towards the
|
| 2 | profit sacrifice test, at least in most cases, because I
|
| 3 | think it's easier to operationalize. We could debate
|
| 4 | about how to exactly operationalize it, but I think Tim
|
| 5 | suggested that, in most of these cases, it's just not
|
| 6 | possible to sit down and do a fully complete balancing
|
| 7 | rule of reason analysis. We don't have the time or the
|
| 8 | information available. And the cost, by the way,
|
| 9 | including the cost to the parties, would be tremendous.
|
| 10 | And I think in most situations, a profit sacrifice test
|
| 11 | would get us to the right place. I think you can try to
|
| 12 | find some counter-examples, but I think you have to work
|
| 13 | hard to do it. So, I am on the side of the folks who
|
| 14 | think we ought to just refine the profit sacrifice test.
|
| 15 | Okay, let me switch to my other case of
|
| 16 | interest, "LePage's vs. 3M". You have heard about it a
|
| 17 | little bit already. This was the case involving bundled
|
| 18 | rebates offered by 3M in the market for transparent tape.
|
| 19 | 3M was facing substantial competition from LePage's, not a
|
| 20 | new entrant, but an entrant that had become very
|
| 21 | successful in the production and sale of private label
|
| 22 | tape.
|
| 23 | And the question was: Were 3M's programs,
|
| 24 | specific bundling programs, anticompetitive and a
|
| 25 | violation of Section 2. |
136
| 1 | Now, here I'm very critical of the Third Circuit
|
| 2 | opinion generally for two reasons. One is that the
|
| 3 | opinion itself does not, in my mind, in any way provide
|
| 4 | any clear guidance as to how firms ought to behalf when
|
| 5 | they do have a dominant position and they are deciding
|
| 6 | what kind of business practice to engage in. And I think
|
| 7 | any clear legal rule ought to do so.
|
| 8 | And, secondly, I actually think that I have been
|
| 9 | unable to come up with what I think is any coherent theory
|
| 10 | of predation or any Section 2 theory which fits the facts
|
| 11 | of the 3M case. In my view, the Third Circuit was a
|
| 12 | little bit loose in how they actually borrowed and used
|
| 13 | facts of the case. I actually went back and read most of
|
| 14 | the record in the LePage's case and I cannot find a theory
|
| 15 | that I find coherent that actually fits the facts of the
|
| 16 | case.
|
| 17 | And the thing to remember is that bundling
|
| 18 | itself of course is quite ubiquitous and often is
|
| 19 | procompetitive. So, if we generate a legal rule, we want
|
| 20 | someone else to define those relatively few cases where
|
| 21 | bundling is a problem and distinguish it from the majority
|
| 22 | of cases where bundling is procompetitive. So, we're
|
| 23 | looking for those particular situations. Lack of clarity
|
| 24 | is a problem.
|
| 25 | Let me briefly take a few minutes and just very |
137
| 1 | quickly tell you about 3M's programs. There were a whole
|
| 2 | bunch of programs being attacked, but the two that
|
| 3 | involved bundled rebates were, first, the executive growth
|
| 4 | fund program. And the thing that's key about this program
|
| 5 | was it was actually I think a one-year program and it was
|
| 6 | a pilot program for a small number of customers.
|
| 7 | Now, what it did do was it set up growth targets
|
| 8 | for six different errant divisions of 3M, which would
|
| 9 | cover a lot of office supply products. And firms actually
|
| 10 | had to meet target goals in each of these divisions.
|
| 11 | Now, my view is that the executive growth fund
|
| 12 | program -- let me be clear that this is my view and not
|
| 13 | 3M's view. My view is that, had this program been
|
| 14 | expansive and had it covered all customers rather than
|
| 15 | just a few, and had it continued for a number of years, it
|
| 16 | could well have been an anticompetitive program. I don't
|
| 17 | think it was because it was too narrow. It had no ability
|
| 18 | really to substantially exclude competitors because many
|
| 19 | of the key competitors, Walmart being the most important,
|
| 20 | were not covered by this program. But it had the
|
| 21 | potential if it continued to actually be restrictive
|
| 22 | because of the specific design of the program.
|
| 23 | But for various reasons, which I think relate
|
| 24 | partly to the demands of some customers, including
|
| 25 | Walmart, 3M changed its program to a partnership growth |
138
| 1 | program, and this program did involve discounts in six
|
| 2 | different areas, but there were no specific targets to
|
| 3 | reach in each of the areas. Basically you got a rebate
|
| 4 | based on the aggregate of all your purchases in all six
|
| 5 | categories. So, this amounted to a somewhat complex
|
| 6 | discount program, volume discount program.
|
| 7 | And my view is that the PGF program, as it's
|
| 8 | called, was not anticompetitive, even though the court
|
| 9 | felt otherwise.
|
| 10 | So, if you go back and look at the LePage's
|
| 11 | trial and ask -- take a look at the trial and ask if the
|
| 12 | trial helps to support some of those theories of
|
| 13 | competition, I would say no. I didn't see any testimony
|
| 14 | in the record about economies of scale or scope, which
|
| 15 | would be important, particularly to get at the issue of
|
| 16 | whether LePage's or any other competitor would remain
|
| 17 | viable in the face of these practices.
|
| 18 | There was no predatory pricing claim.
|
| 19 | Plaintiffs agreed that LePage's was pricing above cost.
|
| 20 | In fact, by my calculations, even if you took all of the
|
| 21 | discount programs at 3M, no matter what the products were,
|
| 22 | attribute all the discounts to tape, it would still be
|
| 23 | pricing above cost.
|
| 24 | I didn't see anything about profit sacrifice
|
| 25 | that I could infer from the opinion. So, there was |
139
| 1 | nothing that fit my particular interest in pursuing these
|
| 2 | kinds of Section 2 cases.
|
| 3 | There was no time claim at all. It was a
|
| 4 | bundling case, not a tying case. There was also no showing
|
| 5 | of market power with respect to any product other than
|
| 6 | transparent tape. So, the kind of leveraging theory you
|
| 7 | might expect to see in a time case was not present either.
|
| 8 | Now, the jury did find, interestingly, no
|
| 9 | exclusion under Section 1, but they did find a violation
|
| 10 | under Section 2. So, this leaves me with a puzzle of what
|
| 11 | the legacy is of "LePage's vs. 3M". I think for a while
|
| 12 | the Commission may have though this case was unusual, but
|
| 13 | it's pretty clear now that the Third Circuit opinion has,
|
| 14 | let's say, encouraged a lot of litigation surrounding
|
| 15 | these kinds of practices.
|
| 16 | So, I went back and asked myself, what should
|
| 17 | the principles be here. And I would say, speaking very
|
| 18 | broadly, if the rebates associated with bundling reduce
|
| 19 | consumer welfare by impairing rivals' ability to make
|
| 20 | competitive offers to potential customers, that's going to
|
| 21 | be something generally that's going to give me concern. I
|
| 22 | am not going to say it's necessarily anticompetitive, but
|
| 23 | that would give me great pause.
|
| 24 | And that general rule takes into account
|
| 25 | efficiencies and allows price increases by firms, as long |
140
| 1 | as they don't impair rivals' ability to compete. But that
|
| 2 | general rule is really not very helpful from a process
|
| 3 | point of view. It's really too broad to make applicable.
|
| 4 | So, I would say the following. I'd say, there
|
| 5 | are conditions under which one may be anticompetitive, but
|
| 6 | none of them fit LePage's.
|
| 7 | And, just quickly, because I think we're running
|
| 8 | out of time, here's some examples of situations in which I
|
| 9 | think bundling might be anticompetitive, none of which
|
| 10 | fits the LePage's case.
|
| 11 | The first would be traditional contractual tying
|
| 12 | of the kind that we saw in Jefferson Parish. The second
|
| 13 | would be predation through profit sacrifice of the kind
|
| 14 | where bundling was used in the form it was in the
|
| 15 | Microsoft case, and perhaps I'd include Dentsply there as
|
| 16 | well. The third might be monopoly maintenance through the
|
| 17 | creation of barriers to entry, which is, at least my
|
| 18 | interpretation of "SmithKline versus Eli Lilly," a case I
|
| 19 | was not involved in, where at least the court stated that
|
| 20 | the sale of monopoly products were used to harm
|
| 21 | competition in a non-monopoly market.
|
| 22 | Now, where does this leave us? We need a
|
| 23 | workable test. I wish I could come here and tell you I
|
| 24 | figured out what that test is. I have read many papers
|
| 25 | written by folks in the agencies and elsewhere suggesting |
141
| 1 | various tests.
|
| 2 | I still not have seen one that I am entirely
|
| 3 | happy with, but a couple things strike me as important
|
| 4 | when and if we get such a test. One is that, weakening a
|
| 5 | rival should not be sufficient to condemn a monopolist,
|
| 6 | otherwise we will be discouraging firms from innovating
|
| 7 | and growing and being successful, which I think would be
|
| 8 | harmful to our competitive process.
|
| 9 | Secondly, while it would be very nice to have an
|
| 10 | incremental cost benefit test for certain kinds of
|
| 11 | bundling, there are a lot of difficulties in putting that
|
| 12 | test into play that I won't bore you with here. So, we
|
| 13 | have more work to do there.
|
| 14 | Third, we might say that for a bundled rebate
|
| 15 | program to be anticompetitive, it at least necessarily
|
| 16 | ought to be the case that the incremental costs associated
|
| 17 | with the available discounts exceed the incremental
|
| 18 | profits associated with the incremental sales that
|
| 19 | generate. If you take that language, I think you can
|
| 20 | create a viable safe harbor at least that would at least
|
| 21 | give firms some comfort that certain practices would be
|
| 22 | presumed to be legitimate.
|
| 23 | And I actually believe, having done my work in
|
| 24 | LePage's, that the behavior of 3M would actually satisfy
|
| 25 | this safe harbor test. But you don't want to condemn |
142
| 1 | nondiscriminatory price cuts in single markets and you
|
| 2 | want to be careful not to penalize policies that exclude
|
| 3 | less efficient competitors.
|
| 4 | That's a different issue because if you want a
|
| 5 | test that's workable for a firm that's engaged in a
|
| 6 | policy, it's very hard to say you shouldn't exclude a less
|
| 7 | efficient competitor because the firm is not going to know
|
| 8 | typically whether its competitors are more or less
|
| 9 | efficient.
|
| 10 | So, this test really is not going to be a
|
| 11 | perfect test and probably never will be.
|
| 12 | A workable rule should be one that's clear and
|
| 13 | manageable. We don't want businesses to say what I hear a
|
| 14 | lot in recent years, which is we have no idea which
|
| 15 | practices we can engage in or not because anything that
|
| 16 | seems to have any bundling aspect to it could lead to a
|
| 17 | Third Circuit lawsuit.
|
| 18 | Now, as far as the thoughts I have given you, I
|
| 19 | just happened to go back and look on the web recently at
|
| 20 | the AMC's tentative recommendations. I assume they're
|
| 21 | still tentative. And I found myself in agreement with
|
| 22 | their recommendations in the areas I am talking about.
|
| 23 | There are some other areas I would disagree.
|
| 24 | But I noticed that the AMC tentatively is
|
| 25 | recommending no need to revise the antitrust laws to apply |
143
| 1 | to high tech industries. And I agree very strongly with
|
| 2 | that.
|
| 3 | The AMC is proposing no need for Congress to
|
| 4 | amend Section 2. And I agree strongly with that as well.
|
| 5 | And, finally, it looks like the AMC is thinking
|
| 6 | of recommending additional clarity and improvement in
|
| 7 | Section 2, particularly with respect to areas such as
|
| 8 | bundling. And I agree strongly with that as well.
|
| 9 | Thank you very much.
|
| 10 | (Applause.)
|
| 11 | MS. GRIMM: I'd like to thank all of our
|
| 12 | panelists.
|
| 13 | We are going to take a 15-minute break now.
|
| 14 | We'll reconvene in 15 minute for our round-table
|
| 15 | discussion.
|
| 16 | (A brief recess was taken.)
|
| 17 | MS. GRIMM: Before we get to our questions and
|
| 18 | round-table discussion, I would like to introduce our
|
| 19 | fourth panelist, who will discuss some of the ideas that
|
| 20 | have been advanced by our other panelists this afternoon,
|
| 21 | as well as some of his own ideas about Section 2.
|
| 22 | Carl Shapiro, our fourth panelist, is the
|
| 23 | Transamerica Professor of Business Strategy at the Haas
|
| 24 | School of Business at the University of California at
|
| 25 | Berkeley. He also is Director of the Institute of |
144
| 1 | Business and Economic Research and Professor of Economics
|
| 2 | in the Economics Department at U.C. Berkeley.
|
| 3 | He earned his Ph.D. in economics at MIT in 1981;
|
| 4 | taught at Princeton University during the 1980s; and has
|
| 5 | been at Berkeley since 1990.
|
| 6 | He has been editor of the "Journal of Economic
|
| 7 | Perspectives," and a Fellow for the Center for Advanced
|
| 8 | Study in the Behavioral Sciences.
|
| 9 | Professor Shapiro has published extensively and
|
| 10 | his current research interests include antitrust
|
| 11 | economics, intellectual property and licensing, product
|
| 12 | standards and compatibility, and the economics of networks
|
| 13 | and interconnection.
|
| 14 | Professor Shapiro served as Deputy Assistant
|
| 15 | Attorney General for Economics in the Antitrust Division
|
| 16 | of the U.S. Department of Justice in 1995 and 1996.
|
| 17 | Carl.
|
| 18 | MR. SHAPIRO: Thank you very much. I don't have
|
| 19 | any slides. I am going to cover some ideas I have and
|
| 20 | then comment on and kind of get the discussion going about
|
| 21 | each of the previous panelists.
|
| 22 | You probably already picked up the theme here
|
| 23 | is that we get up here and we reminisce about the cases
|
| 24 | that were brought or investigated while we were at the
|
| 25 | Antitrust Division. Okay? We really appreciate you |
145
| 1 | coming out here because we all have a love for the
|
| 2 | Antitrust Division. FTC, too. And we sort of appreciate
|
| 3 | your coming out here so we don't have to go again to D.C.
|
| 4 | One of the themes that we've picked up here and
|
| 5 | throughout many of these hearings is that Section 2 cases
|
| 6 | are inherently really hard because it's a single-firm
|
| 7 | conduct and it's not like a cartel case. They're really
|
| 8 | hard and there's always elements and you have to be very
|
| 9 | careful.
|
| 10 | And I don't disagree with any of that, but I
|
| 11 | want to focus on they seem to be harder than they need to
|
| 12 | be in some cases. And it's one of my themes, intersecting
|
| 13 | with the role of patents and plus innovation and
|
| 14 | Section 2.
|
| 15 | And I'm going to depart from the DOJ reminiscing
|
| 16 | and actually talk about the Unocal case, which was brought
|
| 17 | by the FTC, and which I served as an expert witness for
|
| 18 | complaint counsel. And that was litigated at the -- by an
|
| 19 | administrative law judge, before the administrative law
|
| 20 | judge.
|
| 21 | So, let me just quickly remind you of that case
|
| 22 | or tell you about the case. So, Unocal had some patents
|
| 23 | -- had patents -- came to have patents during the '90s on
|
| 24 | reformulated gasoline. The State of California through
|
| 25 | the California Air Resources Board, CARB, established |
146
| 1 | regulations for gasoline in order to make the
|
| 2 | cleaner-burning reformulated gasoline.
|
| 3 | And it came to pass that the regulations that
|
| 4 | were adopted, that Unocal's patents, apparently or very
|
| 5 | likely, many of the refineries would have to infringe
|
| 6 | those patents for a large fraction of the gasoline they
|
| 7 | would make if it would comply with the state regulations.
|
| 8 | So, and the allegation was that Unocal had acted
|
| 9 | deceptively by leading the industry members to believe
|
| 10 | that its patents would be -- that either it did not have
|
| 11 | patents or would make them available on a royalty-free
|
| 12 | basis. That was the representation when the regulations
|
| 13 | were being formulated and that Unocal then later sought to
|
| 14 | get royalties. That was the allegation of deceptive
|
| 15 | conduct.
|
| 16 | So, you would think -- well, let's say I would
|
| 17 | think, at least, maybe you would think, that this should
|
| 18 | be the sort of Section 2 case, and I guess it was FTC
|
| 19 | Section 5, and I'm not distinguishing those for my purpose
|
| 20 | here, that it would be relatively straightforward.
|
| 21 | Big factual question about whether Unocal acted
|
| 22 | deceptively. They vigorously denied that they did so.
|
| 23 | The FTC or certainly complaint counsel was arguing they
|
| 24 | had. I simply assumed that they had for the purposes of
|
| 25 | evaluating market power and competitive effect. That was |
147
| 1 | the fact question. If they had not engaged in any
|
| 2 | deception, I believed there was nothing to the case. That
|
| 3 | was my understanding, as I recall it.
|
| 4 | So, if they acted deceptively, and let's take
|
| 5 | the really cleanest version, they led people to believe
|
| 6 | patents would be available on a royalty-free basis.
|
| 7 | Regulations are selected. Literally billions of dollars
|
| 8 | are invested by refiners to comply with these regulations,
|
| 9 | made CARB gasoline, as it is called, and then they
|
| 10 | asserted patents.
|
| 11 | So, the reason I would say this should be, to my
|
| 12 | way of viewing, a relatively simple case because the
|
| 13 | conduct alleged and assumed by me, as an expert at least,
|
| 14 | deception is not something that we have to wring our hands
|
| 15 | over, oh, is that something that's procompetitive, is it
|
| 16 | important that companies engage in that sometimes. It's
|
| 17 | not like discounting. It's not like product innovation.
|
| 18 | Deception.
|
| 19 | So, now then the question is, okay, we don't
|
| 20 | really have to worry about stifling deception, okay. So,
|
| 21 | does it have a significant effect on prices, on market
|
| 22 | power? And if they represented that the patents would be
|
| 23 | available royalty-free and are later seeking something
|
| 24 | like five cents a gallon, to throw out a number, for
|
| 25 | pretty much the whole industry a very large fraction of |
148
| 1 | the gasoline that would be produced, well, that's a price
|
| 2 | increase. There's very strong evidence that would be
|
| 3 | passed to the final consumers, motorists. Not that that
|
| 4 | matters so much because, even if not, it would be borne by
|
| 5 | the direct customers of the technology, refiners, who
|
| 6 | would be using the technology. And so you get right away
|
| 7 | the competitive effects without any real business
|
| 8 | justification for the conduct that's alleged or
|
| 9 | challenged.
|
| 10 | And yet, Unocal raised many, many arguments.
|
| 11 | We do not know how the administrative law judge or the
|
| 12 | commission or subsequent appeals court might have reacted
|
| 13 | to these. We do know from other cases, the case of --
|
| 14 | the Rambus case. There are a variety of Rambus
|
| 15 | cases that also involve similar allegations regarding
|
| 16 | standards and patents. And we know from other cases I
|
| 17 | won't get into that the courts have tended to say, well,
|
| 18 | wait a minute, you have a patent and so you get some
|
| 19 | market power associated with the patent, and so we should
|
| 20 | be very careful not to jump on -- not to conclude that,
|
| 21 | just because there's market power, somehow it has to do
|
| 22 | with anticompetitive conduct, because patents may very
|
| 23 | well confer market power in a perfectly desirable way.
|
| 24 | So, I guess I'm raising a concern that what
|
| 25 | should be a simple case, there seems to be, in some |
149
| 1 | quarters at least, sort of a worship of patents that
|
| 2 | therefore mixes up market power attributable to the
|
| 3 | innovation versus market power -- additional market power
|
| 4 | that comes about from conduct, just the sort of thing that
|
| 5 | Tim was mentioning, actually, look at additional effects
|
| 6 | of the conduct.
|
| 7 | And the economic opportunities of hold up I
|
| 8 | think are very clear, going back at least to Oliver
|
| 9 | Williamson, my distinguished colleague here at Berkeley,
|
| 10 | and yet these were denied essentially by Unocal and its
|
| 11 | economic expert. That is to say, the notion that once
|
| 12 | refiners had invested enormous sums in order to comply
|
| 13 | with the regulations, that would necessarily put Unocal in
|
| 14 | a stronger bargaining position to get royalties that they
|
| 15 | could not have gotten earlier.
|
| 16 | So, I would say it's relatively fundamental
|
| 17 | economic principles, fairly clear fact pattern, and yet we
|
| 18 | have -- and, for example, the whole Antitrust debate about
|
| 19 | defining the relevant market. Defendants can often, in
|
| 20 | this case at least, try to make that very complicated,
|
| 21 | exactly which technologies are in the market and which
|
| 22 | ones are substitutes, and what was the best alternative,
|
| 23 | and how good was it, and how much -- they even argued, our
|
| 24 | technology is so good that people would have picked it
|
| 25 | anyhow and, therefore, even if we engaged in deception, it |
150
| 1 | wouldn't matter.
|
| 2 | Well, I just don't think that's right because
|
| 3 | there's additional market power that results from lock in.
|
| 4 | So, sometimes the elements that we always think
|
| 5 | of for Section 2 cases: defining the market, measuring
|
| 6 | the market power; being cognizant of preexisting market
|
| 7 | power, in this case because of patents, I think we need to
|
| 8 | be careful not to lose sight of what may be a simple or
|
| 9 | more direct argument that can get us to analysis without
|
| 10 | doing -- without necessarily following some of these steps
|
| 11 | and without getting tied up particularly in market
|
| 12 | definition. And, again, Tim, I know, emphasized that he
|
| 13 | really, as most economists, if we can, we want to get to
|
| 14 | competitive effects. And market definition may or may not
|
| 15 | be helpful in getting us there in market shares.
|
| 16 | And if you think about the cases I've described
|
| 17 | today, measuring exactly which share of how much of the
|
| 18 | gasoline infringes or might infringe and what other
|
| 19 | technologies are being used is a distraction,
|
| 20 | fundamentally a distraction to what's being looked at
|
| 21 | here.
|
| 22 | And that came in in terms of remedy as well. My
|
| 23 | testimony was, we should restore competition, which means
|
| 24 | they should license these patents on a royalty-free basis,
|
| 25 | as they had represented under my working assumption. And |
151
| 1 | yet Unocal argued that, well, our technology is so good
|
| 2 | that we should be able to charge more than that, even if
|
| 3 | we engaged in deception, because under competition somehow
|
| 4 | they would have been able to charge a lot.
|
| 5 | Then you ask, well, then why did you act
|
| 6 | deceptively. And they say, well, we didn't. Well, what
|
| 7 | if you have. So, you go back and forth. All right.
|
| 8 | So, while I'm not expecting the DOJ or FTC to
|
| 9 | suggest that we throw out market definition, for example,
|
| 10 | in Section 2 cases. I do think looking for shortcuts that
|
| 11 | are reliable is a good thing to do.
|
| 12 | Let me go on to say something about the previous
|
| 13 | speakers now that I've made some points about some of my
|
| 14 | own thoughts about Unocal.
|
| 15 | So, Tim first, Professor Bresnahan. Very
|
| 16 | gracious of him to come up here to Berkeley and appreciate
|
| 17 | his kind words about Berkeley. I will try to reciprocate
|
| 18 | and I will make two trips to Stanford in the next week for
|
| 19 | conferences there, and with pleasure.
|
| 20 | I took some of what you said, Tim, to be
|
| 21 | suggesting that we could think of screening cases based on
|
| 22 | whether there's a theory of harm that the conduct would
|
| 23 | lead to a significant increase in market power, or let's
|
| 24 | put that differently, relax the constraints on pricing
|
| 25 | that are facing the firm that's accused, or the defendant |
152
| 1 | firm.
|
| 2 | And I think that's a really good way to go. So,
|
| 3 | I support that.
|
| 4 | One way I like to think about it is we could ask
|
| 5 | if the conduct is directed at certain competitors or maybe
|
| 6 | at certain distributors who then would be important for
|
| 7 | certain other competitors in your Dentsply case, we could
|
| 8 | ask, if the conduct was really effective and eliminated
|
| 9 | those competitors, a certain class or group of
|
| 10 | competitors, would the firm be able to significantly raise
|
| 11 | price. Or, alternatively, if those competitors were fully
|
| 12 | enabled, would that lead prices to fall significantly.
|
| 13 | If that's true, then we need to proceed further
|
| 14 | in the inquiry. If not, because the price is really
|
| 15 | governed by some other set of dynamics, you know, in the
|
| 16 | case of patented drugs, if you get rid of the generic
|
| 17 | competition, that would usually lead to a higher price,
|
| 18 | but it could be in some cases that competition from other
|
| 19 | patented drugs is what's driving price or, in principle,
|
| 20 | that sort of competition, and then we could stop that
|
| 21 | inquiry if the targets were not really providing sufficient
|
| 22 | competitive discipline. So, I am very supportive of that
|
| 23 | line.
|
| 24 | You said at some point, Tim, that it was very
|
| 25 | hard to do some sort of balancing, you know, particularly |
153
| 1 | quantifying the balancing of net effects, harm to
|
| 2 | consumers, benefits to consumers. And so I guess the
|
| 3 | economic theorists, I guess that's going to include me
|
| 4 | now, may like to measure all these things and do this in
|
| 5 | our models, but in practice that balancing would be hard
|
| 6 | to do. It is hard to do.
|
| 7 | One thing we might do is then focus more on the
|
| 8 | competitive process, rather than necessarily a particular
|
| 9 | outcome.
|
| 10 | But you also said the defendant could show that
|
| 11 | the practices were efficient and that would be a defense.
|
| 12 | So, if there was anticompetitive danger, the defense could
|
| 13 | come back and say the practices were efficient. I don't
|
| 14 | know what that means in practice. I guess I'd like to
|
| 15 | hear more from you about that. Because there is typically
|
| 16 | going to be some story about, oh, this has lower prices
|
| 17 | for some customers so it's efficient, or this is going to
|
| 18 | prevent free riding, so I need to have exclusive dealing
|
| 19 | here. There's going to be some efficiency story and I
|
| 20 | don't understand how you can avoid doing some balancing
|
| 21 | after the efficiency flag is raised and now are we done.
|
| 22 | I don't think you mean they're done just because the
|
| 23 | defense raises the efficiency argument. So, what happens
|
| 24 | next?
|
| 25 | My last comment was on -- I don't want to get |
154
| 1 | into Microsoft. Believe me, I really don't want to get
|
| 2 | into Microsoft. But you did mention -- I like your term,
|
| 3 | the "remedy fizzle." I don't know if you coined that
|
| 4 | term, but I like it. You took some responsibility, I
|
| 5 | think --
|
| 6 | MR. BRESNAHAN: I lived that term.
|
| 7 | MR. SHAPIRO: For years, right? I just wanted
|
| 8 | to share the responsibility because, having testified for
|
| 9 | the states at the remedy phase, I want to share that
|
| 10 | responsibility with you.
|
| 11 | MR. SHAPIRO: Rich -- next, Rich Gilbert. I
|
| 12 | really liked to hear what you had to say about interfaces,
|
| 13 | Rich, because this seems to me -- I kept coming -- this
|
| 14 | came up when I heard you talk about IBM and Microsoft and
|
| 15 | other examples, it seems to me, going back to at least
|
| 16 | IBM, and probably selling machines in the 19th century or
|
| 17 | something, you've often got this pattern where, I have a
|
| 18 | product and I innovate, I improve it and, as part of
|
| 19 | improving it, I change the interface or I start producing
|
| 20 | a complementary product that needs to be compatible and
|
| 21 | it's innovative and very often intellectual property
|
| 22 | rights are used to control or secure an interface. And
|
| 23 | yet we know from the telecommunications, we know from
|
| 24 | other network industries, that controlling interfaces can
|
| 25 | lead to a certain octopus-like nature from what might be a |
155
| 1 | secure monopoly in one product initially.
|
| 2 | And speaking for myself, I get really torn
|
| 3 | because I feel like, well, fine, the monopolist, if you
|
| 4 | want to call them, improved their product. Integration,
|
| 5 | where different components are integrated together, is a
|
| 6 | very important element of improved performance, and so how
|
| 7 | are we going to draw these boundaries. You know, do we
|
| 8 | want to treat interfaces differently, for example, either
|
| 9 | under a copyright or patents or how does it intersect with
|
| 10 | antitrust. I think these things are hard and I wonder if
|
| 11 | you want to say more about that.
|
| 12 | I was -- it was shocking to me, I have to say,
|
| 13 | to have an economist tell lawyers to focus on the process
|
| 14 | rather than the outcome. I just --
|
| 15 | MR. GILBERT: Not the first today.
|
| 16 | MR. SHAPIRO: I know, it's true. This is all
|
| 17 | the more shocking because lawyers are very good at process
|
| 18 | in my experience and economists are always thinking about
|
| 19 | these outcomes and are often blind to the process. So, I
|
| 20 | just -- I don't know, we might have to revoke your card.
|
| 21 | I don't know.
|
| 22 | And then -- well, I guess I was maybe not
|
| 23 | shocked, but a little surprised that you said, well, the
|
| 24 | courts have done fine because all of this is hard. If
|
| 25 | it's sham innovation that's your standard at the end, that |
156
| 1 | seems very hard for plaintiffs. And maybe that's what you
|
| 2 | want. I mean, what would it take -- what would count
|
| 3 | as a sham? Could you give us an example? For example, to
|
| 4 | say where, well, the product is a little better but they
|
| 5 | didn't have to do it this way, for example. What would be
|
| 6 | a sham? You know, I think it's sort of ironic when I
|
| 7 | think about Microsoft -- I said I wouldn't talk about it
|
| 8 | much -- but one of the things Microsoft really pushed
|
| 9 | throughout the trial was freedom to design their product
|
| 10 | the way they wanted to and the great benefit of
|
| 11 | integrating different features, as opposed to more
|
| 12 | components or modular.
|
| 13 | Well, what is it now, eight, ten years later? I
|
| 14 | think they're really having trouble because what the
|
| 15 | computer science community always does know is, no, that's
|
| 16 | not good design. Good design is modular and basically
|
| 17 | people on the other side are telling Microsoft, you
|
| 18 | wouldn't do this except for strategic reasons. And now in
|
| 19 | a way that's sort of spaghetti code or the increasingly
|
| 20 | complexity of Windows has made it very, very hard for them
|
| 21 | to meet deadlines in terms of coming out with new versions
|
| 22 | and a lot of other problems they've had.
|
| 23 | So, what would you do in that case to say, well,
|
| 24 | you don't have to design it this way, or maybe you don't
|
| 25 | want to go there if it's not a sham. Any company can |
157
| 1 | choose how to design their product, even if it's not
|
| 2 | something they would choose to do except for strategic or
|
| 3 | exclusionary reasons. Or is that too intensive. I don't
|
| 4 | know.
|
| 5 | But maybe, and you can confirm this, Rich,
|
| 6 | you're saying it's so hard to do these cases, that it's
|
| 7 | true a sham innovation standard is very hard for a
|
| 8 | plaintiff, but that's okay and we're just not going to get
|
| 9 | many cases. And maybe that's where we're at. Is that
|
| 10 | what you support?
|
| 11 | Dan. I will finish soon here. Dan, there's a
|
| 12 | lot to say, but I noticed you were emphasizing the
|
| 13 | somewhat novel nature of network effects and the coining
|
| 14 | of the application "barrier to entry" in the mid to late
|
| 15 | '90s by you and Joel Klein, I guess.
|
| 16 | I have to tell a little story. So, Mike Katz
|
| 17 | and I did work on network effects going back to the '80s.
|
| 18 | And so we're working -- (laughter). No, that's neither
|
| 19 | here nor there. Academics can do anything, but until it
|
| 20 | comes into practice... So -- but I just want to tell a
|
| 21 | little story around that.
|
| 22 | So, we're working in the early '80s and we're
|
| 23 | working on the network effect. And actually personal
|
| 24 | computers and computer software is a good example of
|
| 25 | applications -- that was our example, actually, |
158
| 1 | applications that run on an operating system.
|
| 2 | And Mike said to me -- and we're getting kind of
|
| 3 | excited about this and I guess we got published in a top
|
| 4 | journal, and Mike says, this is great, but I have to tell
|
| 5 | you, I have a friend who is doing a lot more with this.
|
| 6 | Not a friend. I should say, a former classmate. So, he
|
| 7 | says, back when he was at Harvard, there was this guy and
|
| 8 | he was making a lot of money on this. The guy's name was
|
| 9 | Bill Gates.
|
| 10 | So, we often think, oh, we work out these
|
| 11 | theories, but often after somebody else puts them into
|
| 12 | practice and understands them pretty well, then the law
|
| 13 | can kind of catch up with that and maybe academics as
|
| 14 | well.
|
| 15 | Okay, I'll leave it at that.
|
| 16 | MS. GRIMM: Tim, would you like to start off
|
| 17 | here and respond?
|
| 18 | MR. BRESNAHAN: Yes, I want to start off. I'm
|
| 19 | not sure I want to respond. I really like Carl's
|
| 20 | restatement of my screening idea. That was exactly what I
|
| 21 | was trying to say.
|
| 22 | Let me take on hard-to-balance because I don't
|
| 23 | think I'm against balancing. And I want to use the
|
| 24 | example of sham innovation because I think that's pretty
|
| 25 | interesting. |
159
| 1 | The art of balancing, I'm against two things
|
| 2 | that sounds like balancing. One is a burden-shifting
|
| 3 | argument that suggests either an efficiency defense,
|
| 4 | defendant has to show that one rule really is better than
|
| 5 | the other quantitatively, or in a plaintiff's case where
|
| 6 | some sort of efficiency defense has been raised, an
|
| 7 | argument that plaintiff has to show that the world is
|
| 8 | going to be better off without the market power.
|
| 9 | I think that those procedures in which one party
|
| 10 | or the other has to sort of calculate the counterattack
|
| 11 | from the rule with precision are not going to go very far.
|
| 12 | And I guess I wouldn't go all the way to saying
|
| 13 | we should only like the competitive process. But, you
|
| 14 | know, a courtroom is a hostile environment for numbers.
|
| 15 | That's just a fact. There are things that courts are
|
| 16 | better at than numbers. So, a quantitative balancing I
|
| 17 | think is going to be very difficult.
|
| 18 | If we were going to have something, for
|
| 19 | example, bigger than sham innovation, what if a
|
| 20 | court were going to say, you know, cutting off future
|
| 21 | races to replace Office and Windows, cutting off the
|
| 22 | widespread distribution of new innovations in the PC
|
| 23 | business sounds like a lot of harm to competition to me.
|
| 24 | There's maybe a lot of zeros at the end of the numbers.
|
| 25 | Mixing the code between the early stage browser and |
160
| 1 | the operating system, you know, you really got to hold
|
| 2 | your nose to call that innovation. Maybe there was
|
| 3 | something innovative to it. Maybe there were some
|
| 4 | benefits to integration, but it doesn't sound very
|
| 5 | innovative to me. So in this case the balance is
|
| 6 | pretty obvious.
|
| 7 | At that level of a balancing test, I'd be very
|
| 8 | comfortable, and I think I'd be comfortable with a broader
|
| 9 | definition than just the innovation has to be literally a
|
| 10 | sham. I guess I'd be comfortable with the view that the
|
| 11 | court can feel that the efficiencies are either clearly
|
| 12 | smaller or clearly -- not smaller in a quantitative sense,
|
| 13 | but in a salient sense or in a quality of evidence sense
|
| 14 | than the market power or vice versa. So, I'd be in favor
|
| 15 | of balancing. I just don't want to do it first.
|
| 16 | And I think the question that Rich raised
|
| 17 | earlier about, all the traditional tests are going
|
| 18 | to look pretty bad for innovation, I guess I would want
|
| 19 | a balancing test in that area. There's a lot of things
|
| 20 | that can get labeled as innovation. There's a lot of
|
| 21 | things which may seem like "innovation" to the defendant
|
| 22 | but which are dramatically less innovative than what
|
| 23 | other firms in the industry can do. I think this is
|
| 24 | one of the enduring lessons of the Microsoft case.
|
| 25 | On one of my trips to Silicon Valley to discuss |
161
| 1 | the Microsoft case, I talked to a roomful of people and somebody
|
| 2 | said, weren't they accused of "innovating too fast." And
|
| 3 | somebody else said, they can't possibly be guilty of
|
| 4 | innovating too fast; those guys (Microsoft) have never
|
| 5 | innovated too fast in their lives; they never innovate fast
|
| 6 | enough. And stuff like that will come out in a courtroom.
|
| 7 | For this reason, I think that a standard that
|
| 8 | innovation has to be a sham is too narrow.
|
| 9 | MS. GRIMM: Professor Gilbert?
|
| 10 | MR. GILBERT: Well, when I started this project
|
| 11 | of looking at standards for innovation, I did a lot of
|
| 12 | reading. And one of the papers I came across was the
|
| 13 | paper by a Mark Popofsky. And Mark, in that paper,
|
| 14 | advocated basically different standards for different
|
| 15 | types of conduct, very much a process-oriented approach.
|
| 16 | And my initial reaction when I read that paper
|
| 17 | was I sort of reeled back and said, oh, this doesn't make
|
| 18 | any sense at all where we're going to put everything that
|
| 19 | goes on in the economy in a separate category and have a
|
| 20 | different set of antitrust rules for it. I guess at that
|
| 21 | point I still had my economist card.
|
| 22 | But the more I looked at this area, the more I
|
| 23 | started to think, how do we actually do this analysis and
|
| 24 | what do you have to take into account to do the analysis
|
| 25 | right, the more I was led to the conclusion that maybe |
162
| 1 | Mark got it right, that there were certain things that you
|
| 2 | do and a lot of things you can't do, and that different
|
| 3 | standards apply to different types of conduct.
|
| 4 | I mean, certainly the failure to innovate is not
|
| 5 | an antitrust violation, even though it's really what we're
|
| 6 | concerned about or should be concerned about.
|
| 7 | Other problems in this -- along this line, I
|
| 8 | have a paper with Mike Reardon where we look at
|
| 9 | technological tying. And the point of that paper is that
|
| 10 | there are lots of different outcomes. And even if you had
|
| 11 | really good information, you could do an analysis and you
|
| 12 | really could examine the problem, you don't know which
|
| 13 | equilibrium outcome is going to occur in the market. And
|
| 14 | there could be good outcomes from technological tying and
|
| 15 | there could be bad outcomes from technological tying. But
|
| 16 | putting a court into the position of trying to figure out
|
| 17 | which equilibrium the market is at and which one is
|
| 18 | better, that's a tough place to be.
|
| 19 | But I do understand that a lot of this conduct
|
| 20 | can have very undesirable consequences. If there are less
|
| 21 | restrictive alternatives, and you can identify them and
|
| 22 | really carve them out from the conduct, well, that's
|
| 23 | great. But unfortunately, lots of times the restriction
|
| 24 | that goes along with an innovation is inherent in the
|
| 25 | innovation. That's where it's difficult. I think, of |
163
| 1 | course, if you can separate it out, that's fine, it's a
|
| 2 | lot easier.
|
| 3 | You mentioned IP protection. Yeah, it would be
|
| 4 | nice if we could -- it's hard to find an academic these
|
| 5 | days who wouldn't like to see lesser IP protections, and
|
| 6 | particularly for things that have network externalities,
|
| 7 | the other barriers to entry like interface standards. But
|
| 8 | that's a little bit out of our area.
|
| 9 | Let me talk a little bit about sham innovation.
|
| 10 | Again, I'm very sympathetic to the concept that just
|
| 11 | calling it innovation should not be able to protect all
|
| 12 | kinds of undesirable conduct and consequences. That just
|
| 13 | seems pretty obvious.
|
| 14 | But how you actually measure how discrete an
|
| 15 | innovation has to be before it is not a sham brings you
|
| 16 | right into the kind of numbers that Tim was saying are
|
| 17 | very hard for a court or anybody else to do. What number
|
| 18 | is big enough? And it's not just the innovation need,
|
| 19 | it's when the innovation occurs and how it occurs. Is it
|
| 20 | rolled out in every market, does that make it a sham or
|
| 21 | not?
|
| 22 | And I come back to this unilateral refusal to
|
| 23 | deal analogy. Without defending -- I don't want to defend
|
| 24 | a "Trinko" approach, but I just find it very odd that
|
| 25 | innovation that has similar consequences should be held to |
164
| 1 | a higher standard.
|
| 2 | So, I still think there are things that are
|
| 3 | unlawful. I don't think that innovation should be able to
|
| 4 | protect all kinds of activity. But when you are looking
|
| 5 | hard to do, it's almost impossibly hard to take into
|
| 6 | account all of the incentive effects and the chilling
|
| 7 | effects if you get it wrong.
|
| 8 | And the bottom line, it seems to me, is that
|
| 9 | most of the time we're not going to have a problem and you
|
| 10 | should just be careful about chilling innovation by
|
| 11 | intervening where there might be a problem unless you're
|
| 12 | absolutely, absolutely sure that that's the case.
|
| 13 | MS. GRIMM: Professor Rubinfeld?
|
| 14 | MR. RUBINFELD: I don't have anything to offer
|
| 15 | specifically on that debate. I just have a couple quick
|
| 16 | comments.
|
| 17 | First of all, most of my good ideas actually
|
| 18 | come from Carl Shapiro one way or another. So, my only
|
| 19 | intimation was trying to get the courts to see that as
|
| 20 | well.
|
| 21 | The other thing -- that actually was a serious
|
| 22 | comment. But the other slightly more serious comment is
|
| 23 | that there is an interesting theme I've noticed just at
|
| 24 | least from this group, and that is, when we -- before we
|
| 25 | |
165
| 1 | went off to Washington in one extent or another, we were,
|
| 2 | let's say each of us in our own way, somewhat more
|
| 3 | theoretically inclined in thinking about some of these
|
| 4 | issues. And the effect of the Washington experience I
|
| 5 | think on all of us to one degree or another is really for
|
| 6 | us to worry about finding something that's really
|
| 7 | operational that will actually help the agencies and
|
| 8 | others really resolve practical problems.
|
| 9 | And so the emphasis on process, and I would put
|
| 10 | it as sort of finding workable kind of second best
|
| 11 | solutions, is the natural thing to think about. And I
|
| 12 | think that's something I do a lot of.
|
| 13 | In another context, for example, I was struck in
|
| 14 | a lot of mergers I worked on that we had, I think, at the
|
| 15 | division, and also probably at the FTC as well, some very
|
| 16 | sophisticated simulation software, which only as far as I
|
| 17 | could tell one or two people understood, and not all of
|
| 18 | them were in the agency. If you know the folks I'm
|
| 19 | talking about, you know what I mean.
|
| 20 | And it would have taken in many cases something
|
| 21 | like six to eight weeks to make it actually functional,
|
| 22 | which is hard to do under a Hart-Scott-Rodino. So, after I
|
| 23 | left, I actually, with my co-author, Roy Epstein, wrote
|
| 24 | some new software and came up with a much simplified
|
| 25 | procedure which, while greatly simplified, actually is |
166
| 1 | something you can do within the thirty-day period.
|
| 2 | So, a lot of our work has been driven by that
|
| 3 | common theme. And I think with respect to sham
|
| 4 | litigation, that's sort of the same issue I think we're
|
| 5 | all heading towards, which is, we see a problem and now we
|
| 6 | have to sort of help to think about what would be a
|
| 7 | workable solution for the courts.
|
| 8 | MS. GRIMM: I'd like to give our -- all of you
|
| 9 | panelists an opportunity to kind of question each other,
|
| 10 | if you'd like to, as Carl did for all of you, or to
|
| 11 | respond to any of the points made by each other. And then
|
| 12 | we'll ask a couple questions on our own.
|
| 13 | MR. BRESNAHAN: I'd like to take the bait that
|
| 14 | Carl offered us in discussing the Unocal matter, because I
|
| 15 | bet that most economists would agree with him that,
|
| 16 | if there's some amount of market power or power to
|
| 17 | exclude associated with a patent, and if some act,
|
| 18 | deception is an extreme, but there might be others,
|
| 19 | some act or deception to embed it into an interface
|
| 20 | standard, or maybe even just embedding it in an interface
|
| 21 | standard in a way that doesn't have any technical
|
| 22 | benefits, there's some act that extends the coverage of
|
| 23 | that patent and gives the firm that holds the patent a lot
|
| 24 | more market power than it would otherwise have, that
|
| 25 | that's very troubling. |
167
| 1 | And this is one of the disciplinary divides I
|
| 2 | think you see between economists and attorneys.
|
| 3 | Economists are more eager to take that position.
|
| 4 | I suspect that one of the problems with that is
|
| 5 | that, patent law hasn't been particularly successful --
|
| 6 | forgetting antitrust law for a minute. Patent law hasn't
|
| 7 | been particularly successful at delineating the power to
|
| 8 | exclude in any particular patent conveys on its owner.
|
| 9 | So, when you get into these cases in the
|
| 10 | pharmaceutical industry where the patent on the original
|
| 11 | molecule is running out but there's a new patent on, the
|
| 12 | same molecule but packaged into a lozenge form or something
|
| 13 | like that, that it's actually not completely transparent,
|
| 14 | what's the right answer to the question, "how much
|
| 15 | market power does the patent provide?" And when the
|
| 16 | pharmaceutical firm starts playing Carom shots off the
|
| 17 | enormous complexities of the regulatory process under
|
| 18 | Hatch-Waxman, what is the answer to the question, "how
|
| 19 | much market power was conveyed by the original patent?"
|
| 20 | So that even if we're fairly comfortable with
|
| 21 | the idea that creation of additional market power beyond
|
| 22 | what the patent originally would have given that can be
|
| 23 | a thing that can be very hard to determine in a legal
|
| 24 | sense.
|
| 25 | There probably is a near consensus among academic |
168
| 1 | economists that patent policy in the United States over
|
| 2 | protects the patent holder. I think I agree with Carl on
|
| 3 | that. There's this other problem that patent policy is
|
| 4 | too vague, that patents simply don't look like property rights
|
| 5 | here. You have to go to courts or to the regulatory
|
| 6 | system to find out who owns what. And that -- the antitrust
|
| 7 | doctrine, Carl quoted the traditional antitrust doctrine that,
|
| 8 | intellectual property law if what it is and we ask
|
| 9 | whether there's additional market power on top of that.
|
| 10 | That may be more attractive in its economics than its law
|
| 11 | because it's hard to determine how much market power there
|
| 12 | would have been absent the anticompetitive acts.
|
| 13 | MR. GILBERT: I'd kind of like to reinforce what
|
| 14 | Tim said earlier, Carl, and I think also Dan as well.
|
| 15 | While a lot of our discussions today might be
|
| 16 | interpreted as suggesting that Section 2 analysis is very
|
| 17 | hard to do and therefore we shouldn't do it, and there's a
|
| 18 | lot of ways in which I think that's absolutely wrong, and
|
| 19 | that is Section 2 analysis isn't that hard and should be
|
| 20 | done, I do think that the law creates a road map to make
|
| 21 | Section 2 analysis unnecessarily difficult. You've got to
|
| 22 | have -- you know, you've got to identify the market, the
|
| 23 | product market, the geographic market, you have standing,
|
| 24 | you have all of these things. In all of these cases, I
|
| 25 | know cases I have been involved in, I'm sure everybody |
169
| 1 | else, it seems like you never get to the question.
|
| 2 | You know, the relevant question is: Does the
|
| 3 | conduct really raise prices. And most of the time that's
|
| 4 | pretty obvious whether it does or doesn't and you don't
|
| 5 | have to do all this other stuff. And I think the law
|
| 6 | often puts us in a position of having to go through this
|
| 7 | kind of rogue set of steps that's in many ways very, very
|
| 8 | counterproductive.
|
| 9 | MR. SHAPIRO: Well, two things. The first one
|
| 10 | is to emphasize my concerns about the fetish over patents
|
| 11 | in intellectual property rights, therefore in some cases
|
| 12 | being a little blind to the fact that they can be
|
| 13 | leveraged, if you want to use that word, and you can get
|
| 14 | more power than was granted with the patent, particularly
|
| 15 | with patents that are very iffy. And there's a whole set
|
| 16 | of these questions about that.
|
| 17 | I mean, I guess it's outside of Section 2, but
|
| 18 | these pharmaceutical settlements cases, like the Shering
|
| 19 | case the FTC brought, and where the Second Circuit has
|
| 20 | gone with those cases was the tamoxifen case and seeing
|
| 21 | the patent as, oh, well, even if you paid off a competitor
|
| 22 | to leave because you have a patent, somehow it's okay, it
|
| 23 | doesn't mean you've stated an antitrust claim, that's
|
| 24 | something the -- you know, even if that's outside
|
| 25 | Section 2, that thinking is something that both agencies |
170
| 1 | should really head off.
|
| 2 | And I guess there's an IP report still coming.
|
| 3 | There's -- that seems to be a very important role to
|
| 4 | delineate the importance of patents, yes, and the reward,
|
| 5 | yes, but there's a limited power that is granted, and
|
| 6 | beyond that, we can have abuses.
|
| 7 | I would shift topics a little bit and actually
|
| 8 | ask a question of Dan that I skipped when I was standing
|
| 9 | up.
|
| 10 | I'm curious, Dan, in your discussion of
|
| 11 | LePage's, whether you -- I guess you favor a bright line
|
| 12 | test of comparing price to marginal cost for additional
|
| 13 | units sold in a bundle. Or maybe, what about comparing
|
| 14 | marginal revenue to marginal cost to see whether the extra
|
| 15 | sale and bundling was profitable or not, a kind of profit
|
| 16 | sacrifice test.
|
| 17 | So, would you favor either of those? I mean,
|
| 18 | you're objecting to LePage's as being vague. So, here are
|
| 19 | two potential standards that are a lot more specific. I
|
| 20 | guess I'm talking about a safe harbor, either if the price
|
| 21 | is above marginal cost or if the marginal revenue is above
|
| 22 | marginal cost, then the bundling is okay. Of course, even
|
| 23 | if it's not, we assume you want to look first back to
|
| 24 | scope and so forth. So, there's two questions related to
|
| 25 | scope. |
171
| 1 | If the program is limited, there's only a few
|
| 2 | customers or a short period of time, if that's the case,
|
| 3 | would you just wave it through? It just doesn't matter
|
| 4 | what the structure of the program is to you because it
|
| 5 | couldn't have anticompetitive effects or not?
|
| 6 | And then related to that, I don't know if you're
|
| 7 | familiar with the EU's approach to this, but they're
|
| 8 | required to share methodology and calculating volume
|
| 9 | discounts, multi-product or single product, and whether
|
| 10 | you think that's something that the U.S. should pick up
|
| 11 | on.
|
| 12 | MR. RUBINFELD: Good questions, Carl. I
|
| 13 | actually am not familiar with the EU side, so I am not
|
| 14 | going to try to answer that.
|
| 15 | With respect to the workable test, you're right,
|
| 16 | I was suggesting just a safe harbor and I think I would
|
| 17 | accept your clarification. I was looking for a profit
|
| 18 | sacrifice kind of test, so I would compare marginal
|
| 19 | revenue and marginal cost, that's if marginal revenue is
|
| 20 | different from price, but only to get a safe harbor.
|
| 21 | The problem in extending that test is that,
|
| 22 | while I think there's some bundling cases which I think
|
| 23 | are appropriately seen as really being an extension of a
|
| 24 | predatory pricing case and probably ought to come under
|
| 25 | Brooke Group, I think there are other kinds of bundling |
172
| 1 | practices which probably are not seen that way. So, the
|
| 2 | safe harbor I don't think ought to be seen as
|
| 3 | characterizing all, all types of bundling. Other types of
|
| 4 | bundling might seem more smart with respect to other kinds
|
| 5 | of exclusionary conduct of the kind we talked about
|
| 6 | earlier today.
|
| 7 | The other thing that you asked me about my point
|
| 8 | about the effect of this initial program being very
|
| 9 | limited. To me that is quite important because -- I may
|
| 10 | hear something to the contrary in a second -- but it seems
|
| 11 | to me that if there's a practice that cannot be shown to
|
| 12 | either have the effect and be sufficiently exclusionary
|
| 13 | that it makes a competitor not viable or perhaps even has
|
| 14 | no effect on its ability to operate at an efficient scale.
|
| 15 | I don't see how that practice ought to be considered
|
| 16 | anticompetitive.
|
| 17 | So, I think you do -- in my opinion, you do have
|
| 18 | to show that if there's exclusion, it's substantial enough
|
| 19 | to really matter from the point of view of the potential
|
| 20 | competitiveness of the firm that's being affected.
|
| 21 | We can debate whether we should focus on volume
|
| 22 | scale or efficient scale, but certainly there ought to be
|
| 23 | some measurable effect.
|
| 24 | MS. LEE: Dan, you had said in your presentation
|
| 25 | that a variant on the profit sacrifice test would be |
173
| 1 | appropriate to use as a general standard for all Section 2
|
| 2 | conduct.
|
| 3 | I was hoping that you could refine that a little
|
| 4 | bit, in particular, you know, how is this different from
|
| 5 | the traditional profit sacrifice test, whatever that may
|
| 6 | be, and how does it differ from the no economic sense
|
| 7 | test?
|
| 8 | MR. RUBINFELD: That's a great question. I
|
| 9 | think I really can't -- without going back to my drawing
|
| 10 | board for maybe a few years, I don't think I can answer
|
| 11 | that very well.
|
| 12 | The reason why I was saying a variant in my
|
| 13 | comments is that I have been trying to follow some of the
|
| 14 | debate in the literature among the folks who prefer more
|
| 15 | of a balancing test to a profit sacrifice test. And it's
|
| 16 | not that hard to come up with hypotheticals that would
|
| 17 | defeat almost any version of a profit sacrifice test under
|
| 18 | certain circumstances.
|
| 19 | And so what I was imagining was that one would
|
| 20 | be able to come up with either a more robust rule that was
|
| 21 | not subject to too many of these hypotheticals, or maybe a
|
| 22 | complex rule that said under certain circumstances we do
|
| 23 | the test one way and under other circumstances another.
|
| 24 | But, unfortunately, I don't really have an
|
| 25 | answer to that question. I am hoping, Jim, that you and |
174
| 1 | others at the Division will work hard to give me an
|
| 2 | answer.
|
| 3 | MS. LEE: Okay. That was a good way to deflect
|
| 4 | the question.
|
| 5 | MR. RUBINFELD: Others here may have an answer.
|
| 6 | MS. LEE: Let me also get you to react to Tim's
|
| 7 | proposal in terms of how we should evaluate Section 2
|
| 8 | cases, I would call it a step-wise rule of reason. Tim,
|
| 9 | please feel free to disagree with me if you don't think I
|
| 10 | am charactering that appropriately.
|
| 11 | MR. RUBINFELD: You are asking me that question?
|
| 12 | MS. LEE: Yes. How would it be different from a
|
| 13 | variant of the profit sacrifice test that you think would
|
| 14 | be appropriate.
|
| 15 | MR. RUBINFELD: Well, I guess without being too
|
| 16 | specific, I have some of the same reactions I guess others
|
| 17 | on the panel have expressed based upon my own experience
|
| 18 | both in the Division and working on private cases, and
|
| 19 | that is the cases often get bogged down in complex debates
|
| 20 | about issues like market definition, without really
|
| 21 | talking about competitive effects.
|
| 22 | So, I'm actually -- at the level Tim is talking
|
| 23 | about, I'm very symptomatic with his suggestion. I think
|
| 24 | the pharmaceutical cases for me are really an excellent
|
| 25 | example of that. I have been involved in a number of |
175
| 1 | these where there's a huge battle about market definition,
|
| 2 | which can be a very tricky issue in pharma cases for a lot
|
| 3 | of reasons, and yet I thought that -- the answer to the
|
| 4 | question, how you define the relevant market, at least if
|
| 5 | you are using the guidelines, really has almost no impact
|
| 6 | on whether there's a competitive effect.
|
| 7 | If you think that a generic would have entered
|
| 8 | earlier, and the generic most of the time is going to
|
| 9 | enter at a substantial discount off the price of the brand
|
| 10 | product, there is likely to be an effect. It's going to
|
| 11 | be the rare case where competition is driven just by other
|
| 12 | branded products.
|
| 13 | Now, if you think that's the case, then the real
|
| 14 | battle is going to be on issues such as causation, whether
|
| 15 | the practice itself had procompetitive benefits, and so
|
| 16 | on. So, there will still be a lot to debate, but the
|
| 17 | debate will be about whether this competitive effect A and
|
| 18 | B, whether there are justifications that say that that
|
| 19 | procompetitive effect was worth it.
|
| 20 | Rather than debate, which can get pretty far off
|
| 21 | the subject, or market power -- certainly most, if not
|
| 22 | all, successful brand products generate a lot of market
|
| 23 | power. That's the point of Hatch-Waxman to some extent,
|
| 24 | or the point of patent laws generally. And -- but the
|
| 25 | point of Hatch-Waxman in part is to encourage entry to |
176
| 1 | benefit consumers. And the effect of that entry is going
|
| 2 | to be to reduce some of that market power.
|
| 3 | And I don't think any of that should be very
|
| 4 | controversial and yet I have seen a number of cases where
|
| 5 | the battles over whether firms have market power seem to
|
| 6 | take prominence. And so a process that in my view would
|
| 7 | move us more quickly to the heart of the cases would be a
|
| 8 | constructive process.
|
| 9 | Ms. Lee: Tim, let me ask you to clarify
|
| 10 | something that I didn't quite understand about your
|
| 11 | proposed way of analysis.
|
| 12 | In particular you had suggested that, well, if
|
| 13 | you look at -- if you first establish a causal effect
|
| 14 | between the act and then the effect, this gets you around
|
| 15 | the whole complex processes of trying to figure out what
|
| 16 | the appropriate but-for world is when you do the
|
| 17 | traditional sort of economic efficiency analysis.
|
| 18 | I don't quite see that in terms of, to establish
|
| 19 | causality, don't you have to establish in some sense what
|
| 20 | the world would have been absent the exclusionary act?
|
| 21 | MR. BRESNAHAN: That's a good question.
|
| 22 | I agree that to establish causality you need to
|
| 23 | say what the world would have been like in a competitive
|
| 24 | sense absent the anticompetitive act.
|
| 25 | I think the force of my argument is to -- is |
177
| 1 | really procedural. It's to move the things which are
|
| 2 | going to be most difficult for courts to do back in this
|
| 3 | sequence. So, I mean, you heard us all economists say,
|
| 4 | it's often easier to see whether there's a competitive
|
| 5 | effect than to get market power right. I think that's
|
| 6 | probably going to be true.
|
| 7 | Certainly if there's a Section 2 case there,
|
| 8 | it's going to be easy to see what the competitive effect
|
| 9 | is. And then if you can't see it, there's no Section 2
|
| 10 | case there.
|
| 11 | Similarly, that the challenged conduct causes
|
| 12 | the market to be less competitive, that's an inquiry that
|
| 13 | can be undertaken within the four walls of what causes
|
| 14 | competition, without any balancing against the efficiency
|
| 15 | of the challenged conduct. Does it change the conditions
|
| 16 | of the competition? And I bet a lot of cases will follow
|
| 17 | thereto, and that's within the four walls of ordinary
|
| 18 | antitrust analysis. Is the reason that the market is less
|
| 19 | competitive because the challenged conduct raises entry
|
| 20 | barriers, raises them in a way that, you know, the
|
| 21 | entrants and third parties can't get around to the
|
| 22 | relevant time frame. Those are all difficult tests to
|
| 23 | pass.
|
| 24 | So, most Section 2 inquiries should fall by the
|
| 25 | wayside. I just want them to fall by the wayside cheaply. |
178
| 1 | And then you come to the last thing, which as
|
| 2 | we've all said is really, really hard, you know, you've
|
| 3 | got causation, there's some challenged conduct which is
|
| 4 | changing the conditions of competition, but there's also
|
| 5 | something good about it. You know, it's innovative or
|
| 6 | it's a price cut so it's especially good for customers,
|
| 7 | and now we've got to do this balancing, which I think is a
|
| 8 | very, very difficult thing to do.
|
| 9 | So, I just want to reduce the incidence of the
|
| 10 | balancing. Rather than leaping to that right away, go
|
| 11 | through other things first and discard cases. And I
|
| 12 | think that the causation -- the causation inquiry which
|
| 13 | says, is the challenged conduct holding entry barriers
|
| 14 | high is an easier counter-factual inquiry than, is the
|
| 15 | extent to which it's holding entry barriers high worse
|
| 16 | than its countervailing efficiency. It's got one less
|
| 17 | difficulty.
|
| 18 | So that would be how I would proceed. And the
|
| 19 | basic idea is to save wear and tear on the system, which
|
| 20 | is potentially the result.
|
| 21 | MS. LEE: Thank you for the clarification.
|
| 22 | Rich, I wanted to ask you, you had said you have
|
| 23 | became more sympathetic to the idea that in different
|
| 24 | Section 2 matters different standards should apply.
|
| 25 | How would one go about determining the best |
179
| 1 | standards to apply in each situation?
|
| 2 | MR. GILBERT: Again, a very good question.
|
| 3 | Certainly what sets innovation apart is the
|
| 4 | temporal linkage and very complicated linkage between the
|
| 5 | conduct at issue and the investment research and
|
| 6 | development that create the innovation and the prospects
|
| 7 | that any antitrust venture that would show that kind of
|
| 8 | very beneficial investment. And suppose you had a case
|
| 9 | where you didn't think that linkage was all that
|
| 10 | important, so you intervene in that case. But then if you
|
| 11 | do that, that also creates a precedence for there being
|
| 12 | other cases the linkage could be very important, and you
|
| 13 | definitely don't want to chill innovation in those other
|
| 14 | cases.
|
| 15 | If you think about how some of those early cases
|
| 16 | -- if some of those early cases came out differently,
|
| 17 | because almost all the cases that I can see ultimately
|
| 18 | basically are pretty close to a sham innovation test. If
|
| 19 | they had done something very different from that, what the
|
| 20 | implications would be for people actually involved in
|
| 21 | product design could be kind of interesting.
|
| 22 | Now, there is a lot of conduct where I don't
|
| 23 | think those issue are at all significant. You know, they
|
| 24 | may be present to some extent, but they're just not
|
| 25 | significant. And so if you're talking about ordinary |
180
| 1 | exclusive dealing or bundling or whatever, I think in many
|
| 2 | of those cases you can if not forget about, certainly
|
| 3 | discount, the more complicated intertemporal effects. And
|
| 4 | the analysis I think becomes much easier. And the sort of
|
| 5 | rule of reason analysis becomes much more possible.
|
| 6 | Weighing of benefits and costs becomes more reasonable.
|
| 7 | MS. LEE: Carl, do you have anything you want to
|
| 8 | say in addition to what you said already about general
|
| 9 | standards? You had said in your comments that you were
|
| 10 | very sympathetic to a standards approach.
|
| 11 | Is there anything else you would like to add?
|
| 12 | MR. SHAPIRO: Well, you called it a structured
|
| 13 | -- what did you call it?
|
| 14 | MS. LEE: No, I called it a step-wise.
|
| 15 | MR. SHAPIRO: Good, that's the ticket.
|
| 16 | MS. LEE: I think that's what it was.
|
| 17 | MR. SHAPIRO: So, I think of it in terms of
|
| 18 | screens. Traditionally, the monopoly power screen. You
|
| 19 | have a lot of power, and if you don't, then Section 2
|
| 20 | doesn't apply.
|
| 21 | I think I would push for: Does the conduct hold
|
| 22 | up the prospect to leading to significant increase in
|
| 23 | market power, okay, as actually a better question to use
|
| 24 | as a screen.
|
| 25 | Now, the reason I think the traditional screen |
181
| 1 | has been applied, it's been assumed if you don't have any
|
| 2 | power to start you, you can't manufacture something from
|
| 3 | nothing. And that may be true in a lot of cases, although
|
| 4 | not always. Maybe deception turns up.
|
| 5 | Furthermore, even if you have power to begin
|
| 6 | with, if the conduct couldn't add much to it, maybe you
|
| 7 | have a patent, then we can dismiss that case, we don't
|
| 8 | have to go anywhere. So, you would get something knocked
|
| 9 | out on this increment screen that you wouldn't get knocked
|
| 10 | out based on a preexisting traditional power screen.
|
| 11 | So, I think it's a lot more closely tied to what
|
| 12 | Tim was saying at the top of the program here about
|
| 13 | looking at effects and increment. And there are ways to
|
| 14 | do that, implement that, and I have written about that and
|
| 15 | other people have, too. So, that's a general concept I
|
| 16 | think that cuts across a lot of cases.
|
| 17 | At the same time, I agree with Rich that -- and
|
| 18 | I think Dan -- well, profit sacrifice may apply in some
|
| 19 | cases but not others, so then you have to be more nuanced.
|
| 20 | You know, profit sacrifice would not apply in the Unocal
|
| 21 | case.
|
| 22 | MS. LEE: So, let me ask you the same question I
|
| 23 | asked Rich.
|
| 24 | Do you have a suggestion about the methodology
|
| 25 | of figuring out, well, which is the best approach in each |
182
| 1 | type of matter?
|
| 2 | MR. SHAPIRO: It would be very unwise for me to
|
| 3 | get into that at this late hour.
|
| 4 | MS. GRIMM: I just have one question on
|
| 5 | remedies, and this is for Tim. Again, on the Microsoft
|
| 6 | remedy which you labeled a fizzle and you said the remedy
|
| 7 | in AT&T from your point of view was successful.
|
| 8 | I was wondering if could share any views with us
|
| 9 | on appropriate remedies in Section 2 cases, perhaps
|
| 10 | structural versus the conduct remedies.
|
| 11 | MR. BRESNAHAN: I'm almost certain there's no
|
| 12 | general law of remedies in Section 2 cases because
|
| 13 | Section 2 cases are so context specific and so fact dense.
|
| 14 | You know, in the structural remedy that was
|
| 15 | negotiated rather than imposed by a court in AT&T, I think
|
| 16 | the logic of that was caused by an attempt to minimize the
|
| 17 | harm to competition and innovation by walling off the rest
|
| 18 | of the industry (by vertical disintegration) from the
|
| 19 | necessarily regulated sector of telephony, local phones.
|
| 20 | And that's just a very specific argument.
|
| 21 | So, some principle that has remedies that are
|
| 22 | reasonably proportional to the harm to competition that's
|
| 23 | been proved, I think it's going to -- I think it's going
|
| 24 | to be very hard to go farther than that to a broader abstract
|
| 25 | statement. |
183
| 1 | MR. SHAPIRO: If I could just make a quick
|
| 2 | comment. I thought about Microsoft remedies in context
|
| 3 | here. At one end you have, sin no more, don't do what you
|
| 4 | did before, narrowly defined, maybe defined to reflect the
|
| 5 | market changing. And, you know, that doesn't seem to me
|
| 6 | that does much to restore competition if there's been real
|
| 7 | damage with some lasting effect, okay, if the case was
|
| 8 | significant to begin with.
|
| 9 | One of the things that was interesting in that
|
| 10 | case was that -- and I think it's true in a lot of cases
|
| 11 | -- it's very hard to know exactly what the effects are.
|
| 12 | So, you can't say, ah, we're trying to engineer the market
|
| 13 | to return to a certain state and that's what we mean by
|
| 14 | restoring competition.
|
| 15 | So, again, in that context, really the case was
|
| 16 | about raising entry barriers, as Tim put. My view was,
|
| 17 | you should have a remedy that lowered entry barriers and
|
| 18 | then come what may. Maybe entry will occur, maybe it
|
| 19 | won't.
|
| 20 | But sin no more seems to me it's probably going
|
| 21 | to be too weak in most cases where the case was worth
|
| 22 | bringing to begin with.
|
| 23 | MS. LEE: Let me ask a follow-up to that.
|
| 24 | If the only suitable remedy is a sin no more
|
| 25 | remedy, do you think the agency should bring a Section 2 |
184
| 1 | case in that instance?
|
| 2 | MR. SHAPIRO: Well, there still could be some
|
| 3 | deterrent effects. And there are private cases that
|
| 4 | follow on, for example, that could have a major role. And
|
| 5 | there were private cases in the Microsoft case that
|
| 6 | involved a lot of money.
|
| 7 | So, it could well be. I guess I would hope if
|
| 8 | it's a major case that either agency could come up with
|
| 9 | something a little more effective and maybe even creative.
|
| 10 | But, at the same time, partly from the Microsoft
|
| 11 | experience, it's very hard for a court to impose a remedy
|
| 12 | when the company says this is crazy, it won't work, you'll
|
| 13 | destroy all sorts of good things, and the government
|
| 14 | agency, you know, yeah, there's information but it's hard
|
| 15 | to know. So, I think it's very hard. And so if you are
|
| 16 | stuck with sin no more, it could still be worth bringing,
|
| 17 | sure.
|
| 18 | MS. LEE: Let me just solicit the other
|
| 19 | panelists about that. Anything different or anything to
|
| 20 | add?
|
| 21 | MR. BRESNAHAN: Yes, I guess I'd be more
|
| 22 | conservative on this ground than Carl. It's hard to get a
|
| 23 | lot in deterrence in this area of antitrust law because
|
| 24 | it's so hard to -- you know, we're never going to have a
|
| 25 | doctrine that says these specific practices are |
185
| 1 | anticompetitive. I mean, guys will just know not to do
|
| 2 | those particular practices. It's much more complex than
|
| 3 | that.
|
| 4 | So, other than generally wanting to keep the
|
| 5 | idea that there might be this prosecution of particularly
|
| 6 | egregious anticompetitive acts, this is not a great area
|
| 7 | where you can get an awful lot of deterrence out of --
|
| 8 | you know, out of a case where there's a remedy that
|
| 9 | doesn't do anything.
|
| 10 | So, I'd be less -- I'd put less emphasis on
|
| 11 | deterrence and, more emphasis on the view that it
|
| 12 | should really be looking for cases where you can make
|
| 13 | a big difference for the American consumer.
|
| 14 | I mean, before I was in government, in
|
| 15 | connection with Microsoft, I took the position, don't
|
| 16 | bring it unless you're going to do something really
|
| 17 | big, which I went on to say, probably meant don't bring
|
| 18 | it, although that turned out to be wrong. The government
|
| 19 | did ask for a remedy that would have changed the
|
| 20 | conditions of competition.
|
| 21 | I think these experiences are rare, important
|
| 22 | and efficacious in the first instance, and seeking
|
| 23 | deterrence only, you know, only perhaps in flagrant
|
| 24 | examples.
|
| 25 | MR. GILBERT: Sometimes, not always of course, |
186
| 1 | the case that dominance leads to conduct that is
|
| 2 | persistent and durable, that companies in dominant
|
| 3 | positions tend to do the same sort of anticompetitive
|
| 4 | things. And it's also the case that that dominance is
|
| 5 | persistent, that even if you try to break it up, forces
|
| 6 | are going to tend to recreate it. And I wouldn't say
|
| 7 | that's always true, but that's sometimes true.
|
| 8 | But I also say that, even in those cases where
|
| 9 | you cannot have a real structural remedy, that structural
|
| 10 | remedies wouldn't be very effective, a big case like this
|
| 11 | brought by DOJ or FTC has a lot of consequences for these
|
| 12 | companies. And I think you have a significant deterrence
|
| 13 | effect.
|
| 14 | MR. RUBINFELD: The only thing that I was going
|
| 15 | to add is, these remedies come out of course not in just
|
| 16 | in court decisions we're talking about, but also in
|
| 17 | consent decrees that are reached. And I think it makes a
|
| 18 | big difference how you craft a consent decree. You know,
|
| 19 | I can think of some cases which I was involved in where we
|
| 20 | literally got a promise never to do A again and nothing
|
| 21 | more. There were other cases where the consent decree
|
| 22 | really laid out fairly carefully what we meant by not
|
| 23 | doing it again, not only for this company, but also the
|
| 24 | consent decree sent a clear message since the consent
|
| 25 | decree can be part of the public record. |
187
| 1 | So, you can get some deterrence even in a
|
| 2 | situation where the structural remedy doesn't work if you
|
| 3 | craft the right consent decree. And, obviously, it
|
| 4 | depends on every case, but I think obviously the agencies
|
| 5 | should and I am sure do think hard about exactly how to
|
| 6 | did that. And that's an important exercise.
|
| 7 | MR. SHAPIRO: Let me just clarify. There was
|
| 8 | kind of a sin no more at one extreme and then I heard a
|
| 9 | couple of people talking about structural remedies.
|
| 10 | There's a lot of running room in between.
|
| 11 | MS. LEE: Agreed.
|
| 12 | MS. GRIMM: Well, my watch says it is 4:30. I
|
| 13 | would like to thank all of our panelists for being here
|
| 14 | this afternoon and sharing with us their very insightful
|
| 15 | ideas.
|
| 16 | I would also like to thank again the University
|
| 17 | of California at Berkeley for their hospitality.
|
| 18 | Would everyone please join me in giving our
|
| 19 | panelists a round of applause.
|
| 20 | (Applause.)
|
| 21 | (Whereupon, at 4:30 p.m., the hearing was
|
| 22 | concluded.)
|
| 23 |
|
| 24 |
|
| 25 | |
188
| 1 | C E R T I F I C A T I O N O F R E P O R T E R
|
| 2 |
|
| 3 | DOCKET/FILE NUMBER: P062106
|
| 4 | CASE TITLE: SECTION 2 HEARING, PREDATORY PRICING
|
| 5 | DATE: JANUARY 31, 2007
|
| 6 |
|
| 7 | I HEREBY CERTIFY that the transcript contained
|
| 8 | herein is a full and accurate transcript of the notes
|
| 9 | taken by me at the hearing on the above cause before the
|
| 10 | FEDERAL TRADE COMMISSION to the best of my knowledge and
|
| 11 | belief.
|
| 12 |
|
| 13 |
|
| 14 | | | ______________________________ |
|
| 15 | | | KATHLEEN CARR MEHEEN, CSR 8748 |
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
|